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Abbreviations 
Ad adamantyl 
aq. aqueous 
atm atmosphere 
ATR diam. diamond for reflection attenuated total reflectance 
BARF Tetrakis[3,5-bis(trifluormethyl)phenyl]borat 
BINAP 2,2’-bis(diphenylphosphion)-1,1’-binaphthyl 
BINOL 1,1’-Bi-2-naphtol 
BOC tert-butoxycarbonyl 
BOX bisoxazoline 2,2-dimethyl-2,2-bis(4’alkyoxoxazoline )propame ligand 
BozPHOS 1-(2-(2,5-dimethylphospholan-1-yl)phenyl)-2,5-dimethylphospholane 1-
oxide  
BSA N,O-bis(trimethylsily1)-acetamide 
calcd calculated 
cat. catalyst 
cH cyclohexane 
COD 1,5-cyclooctadiene 
cond. condensator 
DABCO 1,4-diazabicyclo[2.2.2]octane 
DAIB 3-exo-(dimethylamino)isoborneol 
dba trans,trans-dibenzylideneacetone 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
DCM dichloromethane 
de diastereomeric excess 
DIBAL diisobutylaluminium 
DIOP 2,3-O-isopropylidene-2,3-dihydroxy-4,7-bis(diphenylphosphino)butane 
DMAC dimethylacetamide 
DME ethylene glycol dimethyl ether 
DMF N,N-dimethylformamide 
DMSO dimethyl sulfoxide 
DPPA diphenylphosphoryl azide 
dr diastereomeric ratio 
ee enantiomeric excess 
eq. equivalent 
ES / ESI electron spray ionisation 
EWG electron withdrawing group 
h hour 
HMBC Heteronuclear Multiple Bond Coherence 
HTE high throughput experimentation 
LDA lithium diisopropylamide 
Me-
DuPHOS 
1,2-bis(phospholano)benzene 
MeIm 1-methyl imidazole 
Mes mesityl 
min  minute 
MS molecular sieve 
Ms methanesulfonyl 
Abbreviations 
 
II 
NBS N-bromosuccinimide 
NHC N-heterocyclic carbenes 
o.n. over night 
PCy3 tricyclohexylphosphine 
PMP 1,2,2,6,6-pentamethylpiperidine 
(R,S)-PPFA N,N-dimethyl-(S)-1-[(R)-2-(diphenylphosphino)ferrocenyl]ethylamine 
quant. quantitative 
rac racemic 
recrist. recristallization 
rt room temperature 
SALEN N,N’ -bis(salicylaldehydo)ethylenediamine 
sat. saturated 
soln. solution 
solv. solvent 
TADDOL α,α,α',α’ -tetraphenyl-1,3-dioxolan-4,5-dimethanol 
TBAF tetra-n-butylammonium fluoride 
TBDMS tert-butyldimethylsilyl 
TBDPS tert-butyldiphenylsilyl 
TBP trigonal bipyramidal 
TC thiophene carboxylate 
Tf trifluoromethanesulfonyl 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
TIPS triisopropylsilyl 
TLC thin layer chromatography 
TMEDA N,N,N',N'-tetramethylethylenediamine 
TMS trimethylsilyl 
tol. toluene 
TON turn over number 
Ts 4-toluenesulfonyl 
TSA toluene sulfonic acid 
VT variable temperature 
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RESUME FRANCAIS 
1 Introduction 
De nos jours le nombre de ligands utilisés pour la catalyse asymétrique ne cesse de 
croître. Néanmoins l’ emploi généralisé d’ un ligand donné reste limité et donc la 
recherche de nouvelles classes de ligands est d’ une grande importance.  
 
Le but de ce travail était de synthétiser de nouveaux ligands chiraux dérivés de la 
structure 1-(2-alkoxyaryl)-alkylamine énantiomériquement pure montrée dans la 
Fig. 1. 
 
NH2
O
R’
R
R’’
 
Fig. 1 
 
La base de cette structure est un 1,3-aminoalcool. Tandis que les 1,2-aminoalcools 
sont facilement accessibles par exemple à partir de produits naturels; par réduction 
d’ acides aminés ou par des modifications aux dérivés du camphre, etc., l’ obtention d’  
1,3-aminoalcool est plus difficile et par conséquent ils sont  rarement utilisés comme 
auxiliaire ou ligands chiraux pour la catalyse.  
 
La structure montrée dans la Fig. 1 est le produit de départ pour la synthèse de 
nouvelles classes de ligands. Ce produit a les avantages suivants:  
- les groupes fonctionnels amine et hydroxy sont facilement modifiables, 
- la structure est rigidifiée par le group aryle,  
- le centre stéréogénique  du substituant benzylique transmet l’ information 
chirale.  
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IV 
Dans ce cadre de cette thèse, quatre classes différentes de ligands ont été envisagées 
(Fig. 2): 
 
- ligands chiraux C3-symétriques (A) (en collaboration avec Prof. Licini, 
Padova, I) 
- ligands [N2O2] C2-symétriques (B) 
- ligands de type phosphoramidite (C) 
- ligands de type carbène hautement encombrés (D). 
 
N
ROH OH
OH
R
R
O
N
P O
R R
N N
OH
R R
OH
R= tBu, iPr, Me
X= OTf  or  I ,  BF4
R
O
Me
N
+
O
R
Me
N
X
OR
NH2
R
R = Me
R = Me
R = tBu
A
B C
D
R = Me, iPr, tBu
R’ = 6-Me, 3,5-tBu
R’’ = H, Me
 
Fig. 2 
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V 
2 Des ligands chiraux (pseudo) C3-symétriques aux atranes 
 
Historiquement on parlait d’ un atrane lorsque la triéthanolamine était complexée avec 
un métal. De nos jours ce terme est beaucoup plus générale. Les trois bras 
éthanoliques peuvent être remplacés par des structures plus complexes. Ceci mène à 
des molécules ressemblant à la Fig. 3. 
 
N
O
O
OSi
O
Me
Me Me
Me
Me
Me
Me
 
Fig. 3: Structure C3-symétrique d’un silatrane. 
 
Dans ce cas, la triéthanolamine est remplacée par une tri((2-aryloxy)methyl)amine 
coordonnée avec un silicium substitué avec un groupe méthoxy.  
 
Les caractéristiques de ce type de structure sont une forte polarisation de la liaison N-
métal qui varie selon le métal et les substituants équatoriaux , une chiralité hélicale 
intrinsèque qui peut être contrôlée par un ou plusieurs centres stéréogéniques en 
positions benzyliques. Ces propriétés rendent ce type de complexes très intéressants 
pour leur étude.  
 
Les atranes ont été utilisés comme catalyseur dans des réactions organiques 
spécifiques comme phosphatrane dans des réactions aza-/thia-Michael, Strecker ou 
Morita-Baylis-Hillman (base de Lewis), comme titanatrane dans des réactions d’ aza-
Diels-Alder (acide de Lewis) ou de sulfoxidation, ou bien en tant que vanadatrane 
dans une réaction d’ époxidation.  
 
Le but était la synthèse de la triphénolamine montré dans la Fig. 4 pour la tester dans 
la réaction de sulfoxidation dans un projet en collaboration avec le groupe du 
Professeur Licini.  
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N
Me
Me
Me
OH OH
OH
R
R
R
R = H, tButyl, Phenyl etc
 
Fig. 4 
 
L’ amine secondaire 9 a été obtenue via des réactions connues. Elle a été transformée 
en formamide 10 avec de bons rendements. Le produit 20 (trois méthyle en positions 
benzylique et trois méthoxy en positions ortho) est obtenu par réaction entre le 
formamide 10 et l’ anisyle de lithium. L’ iminium formé est ensuite traitée avec le 
Grignard de méthyle. Malheureusement ce produit n’ a pas pu être cristallisé et la 
chromatographie menait à la décomposition complète de ce dernier. Suite à cette 
instabilité la synthèse du produit 20 avec un degré de substitution mineur à été 
envisagé, ce qui donnait une série de composés 7, 21, 22, 24 présentée dans le 
Schéma 1. Une augmentation de la stabilité a été observée lors d’ une substitution 
moindre. 
 
NH2
MeOMe
N
H
Me MeOMe OMe
Li
OMe
N
Me
OMe OMe
MeO
N
Me
OH OH
OH
N
O
Me Me
H
OMe OMe
N
Me
Me
Me
OMe OMe
MeO
N
O
Me Me
H
OMe OMe
N
R
R
Me
R R
R
98% ee
R-1b 9
a)
b)    (COCl)2
c)    MeMgCl
       Et2O
d)    HCl/Et2O, 32%
10
20
TMEDA
1) condensation
2) alkylation
ou 
amination réductrice
par Ti(OiPr)4, Pd/C, H2
20: R1, R2 = Me; R3, R4, R5 = OMe
   7: R1, R2 = Me; R3, R4, R5 = H
21: R1, R2 = Me; R3, R4 = H, R5 = OMe
22: R1, R2 = Me; R3, R4 = OMe, R5 = H
24: R1, R2 = H; R3, R4, R5 = OMe
10
HC(OEt)3 (10 eq.)
p-TsOH (10 mol%)
130 °C
24 h, 81%
2724
3 1 4
2
5
 
Schéma 1 
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Par contre l’ instabilité des produits n’ a pas permis la déprotection des groupes 
phénoliques, même dans le cas du produit le plus stable 24 (Schéma 1). 
 
Dans une deuxième approche une voie sans protection du phénol a mené au produit 
27 désiré (Schéma 2). Malheureusement, avec cette approche un degré de substitution 
majeur dans la position benzylique n’ était pas possible.  
 
N
MeOH OH
OH
N
H
MeOH OH Me OH
OH
O
N
NH2
MeOH OH
CHO
N
H
MeOH OH
NaBH4
salicyl-
aldehyde
MeOH, MS
40 °C
90%
+
1) MeOH, MS
2) Pd/C, H2, 3 atm 
100%
27
 
Schéma 2 
 
Le groupe du Professeur Licini a testé le catalyseur 39 avec un analogue du ligand 27, 
qui a montré des sélectivités très basses. On a supposé qu’ une substitution avec un 
phényle en position 3 de l’ aryle permettrait une meilleure projection de la chiralité 
hélicale dans le centre réactif du catalyseur (Fig. 5).  
 
 
 
Fig. 5 
 
Un aminophénole avec une telle substitution a été synthétisé selon une méthodologie 
élaborée auparavant dans notre groupe (Schéma 3).  
 
N
Me
O
O
O Ti
Me
Me O
Pri
39
N
Me
O
O
OM
Ph
Ph Ph
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Ph
N
H
OH
PhMe
OBn
Me
NH2
Ph
OBn
Ph
N
OH
Ph
OBn
OH
CHO
Ph Ph
N
OH
Ph
OBn
CHO
Ph
OBn
NH2
OH
Ph
MeLi, THF
-78 °C, 24 h,
-30 °C, 20 h
40 %
1) Pb(OAc)4
K2CO3, CH2Cl2
2) AcOH, H2O,
20 h, rt
60 %
95% ee95% de
50 51 52
CHCl3/MeOH
K2CO3
44 %
MeOH, reflux
MS 3Å
91 %
BnBr
44 49 50
 
Schéma 3 
 
Dans le cadre de la collaboration le nouvel aminophénol a été utilisé pour synthétiser 
le titanatrane 54. Celui-ci montrait des caractéristiques particulaires: tandis qu’ en 
présence de traces d’ eau le titanatrane correspondant (sans le centre stéréogénique) 
forme instantanément le dimère 55 (avec un pont µ-oxo linéaire et avec les deux 
ligands trisphénolamines complexés avec de rotations hélicales opposées), 54 ne 
forme pas ce dimère même en présence d’ eau. Cette observation indique que la 
formation découle d’ un procès énantiodiscriminant (Fig. 6).  
 
N
Me
O
O
OTi
PhPh OPr
Ph
OO
O Ti
Ph
Ph
Ph
N
N
O
O
O
Ti
PhPh
Ph
O
monomérique
54
i
dimère
55
 
Fig. 6 
 
Il reste à confirmer que cette molécule peut réellement transmettre plus efficacement 
l’ information chirale dans la sulfoxidation et ainsi mener à une meilleure sélectivité.  
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3 Synthèse de nouveaux ligands de forme [N2O2] 
 
Le représentant le plus connu des ligands de forme [N2O2] est le salen de Jacobsen, il 
a montré des sélectivités dans plusieurs réactions. Tandis que les centres 
stéréogéniques de ce ligand sont localisés sur le pont éthylène, un ligand très 
similaire, le ligand de Bolm les possède sur des sulfoximines. La combinaison de ces 
deux ligands pourra aboutir à un ligand qui sera facilement accessible à partir des 
aminophénols (Schéma 4). 
 
OH
N N
OH
R R
N NS S
OH OH
Tol
TolO
ON N
Bu OH
Bu Bu
OHt
t t
tBu
 
Schéma 4 
 
En général, les ligands [N2O2] de cette forme proposée A existent dans un équilibre de 
tautomérie avec leur forme cyclisé B.  
 
N
OH
N
OH
R R
O
N
H
O
N
H
R
R
R
R
A B
 
Schéma 5 
 
Ayant constaté qu’ un substituant encombrant comme le tert-butyl en position 
benzylique évite que la double base de Schiff A soit en équilibre avec sa forme 
cyclisée B, la synthèse d’ un ligand qui existe majoritairement sous sa forme A était 
donc devenue possible (Schéma 6). 
 
Bolm Jacobsen 
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X 
NH2
Bu
OH
N
H Bu
O
N
HBu
O
H H
 
OH
N N
OH
Bu But t(CHO)2
CH2Cl2
Na2SO4
23 °C
95%5a
t
traces dans le 1H-RMN
58
t t
 
Schéma 6 
 
Une autre manière de stabiliser la forme diimine d’ un tel ligand pourrait être la 
substitution du pont éthylène avec deux phényls. Pour cette raison la synthèse selon le 
Schéma 7 a été élaborée et il a été confirmé que cette structure existe uniquement sous 
sa forme diimine.  
 
N N
PhPh
Me Me
MsO OMs
OO
Ph Ph
N
OH
N
OH
PhPh
Me Me
NH2
OMs
Me
NH2
OH
Me
TiCl4, C6H6, 
rt, 4 d, 96%
LDA (4 eq.), 
THF, 0 °C, 80%
63
64 60
20 eq.
1a
1) (BOC)2O
2) MsCl, Et3N
3) HCl/dioxane
 
Schéma 7 
 
Il reste à fournir la preuve d’ une application utile de ces deux nouveaux ligands.  
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4 Un nouveau ligand de type phosphoramidite 
 
Les ligands monodentes les plus efficaces sont probablement les phosphoramidites 
d’ une structure similaire à celle montrée dans la Fig. 7.  
 
O
O
P N
 
Fig. 7 
 
A partir de l’ amine secondaire 26, la complexation d’ un phosphor entre les deux 
groupes phénoliques et l’ azote fournirait le ligand phosphoramidite 65 qui pourrait 
représenter une nouvelle classe de ligands phosphoramidites. Due à l’ oxydation 
relativement facile du phosphore, le phosphoramidite 65 a été protégé par 
complexation avec du borane (Schéma 8), qui peut être facilement enlevé avec du 
DABCO in situ. . 
 
N
H
Me MeOH OH
N
Me Me
O OP
BH3
N
Me Me
O OP
(R,R)-26
1) PCl3/Et3N
    THF, 0 °C, 12 h
2) BH3.Me2S
    toluene, -78 °C
    12 h, 67 % (R,R)-65(R,R)-65.BH3
DABCO
50 °C, 12 h
52 %
31P-NMR: 113 ppm
 
Schéma 8 
 
Le ligand 65 a été testé dans des réactions asymétriques comme l’ addition 
asymétrique 1,4 sur la cyclohéxanone ou la hydrosilylation du styrene avec un succès 
modéré (Schéma 9). 
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Schéma 9 
 
Une analyse aux rayon-x du ligand phosphoramidite complexé avec du borane a 
montré que la conformation préférentielle est celle où les groupes méthyles sont en 
pseudo-équatoriale et pointent à l’ opposé du site actif. Ceci explique les rendements 
optiques faibles (Fig. 8). 
 
Fig. 8 
 
 
 
 
5 Des nouveaux carbènes de symétrie C2 puissants dans l’arylation 
asymétrique intramoléculaire D d’amides 
 
Les carbènes N-hétérocycliques sont des ligands assez prometteurs dans la chimie 
organométallique et dans la catalyse. Néanmoins il a très peut d’ exemple de réactions 
métallocatalysées asymétriquement en présence de tels ligands est encore pauvre. Le 
ligand dérivé du phényléthylamine montré dans la Fig. 9 pourrait être facilement 
modifié en position benzylique et en position ortho en utilisant les 1-(2-alkoxyaryl)-
alkylamines pour sa synthèse.  
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Tandis que la synthèse de l’ imidazolium 66 substitué avec des méthyl en position 
benzylique a été possible sous conditions standard, pour ceux substitués avec l’ iso-
propyle ou le tert-butyle, une autre voie a dû être trouvée. Celle-ci est présentée dans 
le Schéma 10.  
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+
MeO OMe
R R
 
I
R = tBu: (S)-5b
R = iPr: (R)-4b
R = tBu: (S,S)-66c.I
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    AgOTf
3) NaI, acétone
 
Schéma 10 
 
Ces trois analogues ainsi obtenus ont été testés dans la synthèse des oxindole par 
l’ arylation asymétrique intramoléculaire α d’ amide catalysée par le palladium 
(Schéma 11). 
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O O
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Me N
Me
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Me
N+N
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O O
Me Me
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Me Me
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BF4
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Yield: 72%
ee: 16%
X
66c.I
i i
Yield: 93%
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Schéma 11 
 
En utilisant un petit substituant comme le méthyle puis des substituants plus 
encombrants (iso-propyle, tert-butyle), on observe une nette amélioration de la 
Résumé français 
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stéréosélectivité qui va de 16% pour le méthyle à 77% pour l’ iso-propyle et même 
85% pour le tert-butyl (Schéma 11).  
 
Encouragé par ces résultats et dans le but d’ étudier l’ influence stérique du substituant 
en position ortho, les deux nouveaux imidazoliums ont été synthétisés (Fig. 10). 
Lorsqu’ on remplace un méthoxy par un proton dans la même réaction décrit dans le 
Schéma 11, on observe une perte de sélectivité. Par contre, un méthyle en position 
ortho améliore la sélectivité (93%), ceci est la meilleure sélectivité observée dans 
cette réaction. On peut alors conclure qu’ il s’ agit bien d’ un effet stérique.  
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Me Me
N N
+
Bu Bu
H H
II t t
(R,R)-79b.I
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t t
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Fig. 10 
 
Dans le cas de la transformation de 75d en 76d à l’ aide du ligand (S,S)-66c·I la 
stéréochimie absolue de la molécule 76d a été déterminée aux rayons X après 
bromination et cristallisation (Schéma 12).  
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I. General Introduction 
I.1. Concept and Strategy 
I.1.1. Induction of Chiral Information 
There are three principle ways to induce chiral information into achiral or prochiral 
molecules: 
 
- by the use of chiral auxiliaries 
- by the use of enzymes 
- by the use of chiral catalysts 
 
The incorporation of chiral auxiliaries into a prochiral molecule represents a powerful 
method to transfer chiral information from an existing to a new stereogenic centre. 
Nowadays, the stereochemical outcome of such reactions generally can be predicted 
by the application of well established open transition state 1,2- and 1,3-asymmetric 
induction models such as ”Felkin-Anh” or ”Anti-Felkin”, or by closed transition state 
chelation-involved Zimmermann-Traxler models. A major drawback of this strategy 
is that the chiral auxiliary has to be installed and removed, and this adds two steps to a 
synthetic sequence. 
 
Chiral catalysts have a big advantage over chiral auxiliaries as the introduction and 
cleavage is avoided. Furthermore by its very nature a chiral catalyst continues to carry 
out this task until it gets deactivated by a side reaction or until there is no substrate 
left to transform. Enzymes, the catalysts of nature, provide another powerful tool to 
form very selectively new stereogenic centres. These biological catalysts often reach 
activities which are by far superior to the small man-made organic or transition metal 
based catalysts. Their major drawback is their usually very narrow substrate range due 
to their highly specific chiral pockets. Hence the creation of artificial enzymes and 
catalytically active antibodies has attracted attention for their potential to overcome 
this problem. 
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Often a more convenient way for catalytic chiral induction is the application of 
synthetic catalysts. Probably the first chiral organic catalyst was quinine, found in 
1912 by Bredig and Fiske, which was found to give less than 10% enantiomeric 
excess in the formation of mandelonitril from benzaldehyde (Scheme 1).1,2  
 
O
H
OH
CN
N
MeO
OH N
HCN
cat.*
*
cat.*
quinine
 
Scheme 1: Probably the first asymmetric catalyzed reaction.  
 
Since then, many (often naturally occurring) chiral organic molecules such as proline 
or quinuclidine derivatives have found applications as catalysts for asymmetric 
transformations. Today organocatalysts although providing spectacular results often 
exhibit low reactivity and need to be added in large quantity (10-30 %). Alternatively, 
metals, “dressed up”  with organic molecules as ligands, can create a chiral 
environment and hence lead to the induction of asymmetry in metal catalyzed 
processes.  
Over the past thirty years, a large number of different ligand classes – whereas a class 
is defined by a ligand core structure and different variants thereof – has been 
synthesised, and the number of catalytic reactions to which they are applied shows 
very impressive growths. In addition, new technologies allow rapid identification of 
selective ligands by ligand screening with high throughput experimentation (HTE) of 
ligand libraries. Further chemical modifications of lead structures furnish easily 
accessible, highly active and highly selective ligands.  
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I.1.2. General Considerations about ligand ”design” 
” Developing a new ligand is usually extremely time consuming; in addition, there is 
no guarantee of success as there is no such thing as ligand design.”  (Johannes de 
Vries and Laurent Lefort).3 Nonetheless the term ” ligand design”  is an expression 
often used to describe a strategy for finding and modifying ligands for new transition 
metal based catalysts. In particular an organic molecule found to be an effective 
ligand is systematically or randomly modified to improve selectivity and activity of 
the catalyst. Most often highly efficient ligands were found by serendipity and were 
later systematically optimized usually based on experience and insights gained over a 
period of time. Knowledge about the reaction mechanism can also provide useful 
information for the improvement of a given ligand.4 In recent years, the help of 
computational models increasingly plays an important role. This is of special 
importance in industry where the predictability is crucial for keeping the development 
costs low.5 Like HTE, computational methods only help to evaluate the potential of a 
known ligand and to give suggestions on which point its structure can be improved, 
but it usually does not give suggestions for a new ligand class.  
 
Therefore the development of such new ligand core structures still depends on 
creative inventions by chemists and no HTE or molecular modelling can replace this 
work for the time being. 
I.1.3. Privileged ligands 
Ligands are often optimised very specifically for one particular system, sometimes 
even just for a narrow class of substrates. As soon as they are used in another reaction, 
selectivity, activity and the substrates tolerance change completely.  
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TADDOLBOX
DuPhos
 
Figure 1: Privileged ligand structures. 
 
Nonetheless, there are a few so called “privileged ligands” , (e.g. BINOL and BINAP, 
SALEN, DuPhos, BOX and TADDOL, see Figure 1), which show a broader range of 
applications.6,7 The factors which make these ligand classes special and of wide 
applicability is still under debate. No clear rules have emerged and to find new 
ligands showing high levels of enantiocontrol in many different metal-catalysed 
reactions remains therefore largely a matter of chance. 
I.1.4. Symmetry 
Several cooperative factors contribute to lead to high selectivity in an asymmetric 
reaction: The most important contribution is provided by the steric and electronic 
properties of a ligand and of course, the judicious choice of the metal. Various other 
attractive intermolecular interactions like pi-pi stacking, σ-pi interactions, hydrogen 
bonding and solvation effects also play important roles.  
Another contribution comes from the symmetry properties of the complex. Symmetry 
often stands in connection with beauty and harmony. But the introduction of 
symmetry elements into an auxiliary which should induce asymmetry is not obvious. 
The most obvious requirements to obtain enantioface differentiation in the reaction 
centre is asymmetry.8 
The introduction of rotational symmetry Cn>1 into a ligand divides the space centred 
on the coordinated metal into n sections around the Cn-axis. Consequently there are n 
equal possibilities for a substrate to approach, ending up all in an identical 
intermediate, which facilitates the design of a ligand (Figure 2).  
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M
C2
C2-rotational symmetry devides
the space into two identical halfs
 
Figure 2 
 
Furthermore, it also depends on the geometry of the catalytic intermediates and 
transition states, which rotational symmetry on a ligand is favourable. C2-symmetric 
ligands coordinated to a square-planar or tetrahedral complex generates two 
homotopic or identical open binding sites (a) (Figure 3). In octahedral complexes, 
depending on whether there is another spectator ligand participating, three 
diastereotopic (c) or two diastereotopic sets of homotopic binding sites are available 
(d).  
A
BC
A
BC
A
BC D
A = B A = B = CA = B A = B = CA = D
B = C
square planar octahedral
a b c d e
A B A B
mono-
bi-
tri-
dentate
 
Figure 3 
 
For C3-symmetric tridentate ligands in square-planar complexes, two of three ligand 
binding atoms will coordinate whereas one will not reach the metal (b). The two 
residual metal binding sites are therefore diastereotopic (unless the ligand binding 
atoms exchange dynamically over time). In octahedral coordination, a C3-symmetric 
ligand creates three homotopic empty binding sites and therefore reduces the amount 
of possible diastereomeric intermediates/transition states (e). This illustration makes 
clear, that a higher rotational symmetry can help to simplify a catalytic system.9 
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I.2. Aminoalcohols 
I.2.1. Natural abundance of aminoalcohols 
Aminoalcohols are common structural elements in nature (e.g. Vancomycin10 
(antibiotic), Desferrisalmycin B11 (antibiotic, siderophore-drug) or Streptothricin F12 
(antibiotic)).13 Among them, especially the structures derived fromWKH -aminoacids, 
ephedrine and norephedrine and cinchona alkaloids have proved to be synthetically 
useful chiral auxiliaries or chiral ligands.14-18 
1,2-aminoalcohols are particularly accessible for example by the reduction of amino 
acids, derivatization of camphor, or other ubiquitous chiral molecules. The two 
different functionalities give an easy access to oxazolidines19, oxazolines20, 
oxazolidinones21-23 and oxazaphospholidines24,25, which all together provide a rich 
library of highly useful auxiliaries for asymmetric synthesis and catalysis.  
The structural motive of 1,3-aminoalcohols (or γ-aminoalcohols) can also be found in 
many natural products such as hydroxylated amino acids26, amino sugars27, alkaloids 
((+)-Hygroline28) and antibiotics ((+)-Negamycine29 and Nikkomycine B26) (Figure 
4).  
 
NH2 N
N COOH
Me Me Me
H
O
N
Me
OH
Me
N
N
O
OH OH
O O
H
NH3
+
N
H
OH
OH
Me O COOH
(+)-Negamycine (antibiotic) (+)-Hygroline (natural alcaloid)
Nikkomycine B (antibiotic)
 
Figure 4: Natural J-aminoalcohols. 
 
In general, this motive in nature belongs to much more complex natural structures 
which make isolation expensive and low yielding. Due to the lack of an abundant 
natural source, the study of chiral 1,3-aminoalcohols as a chiral source has seen scarce 
development.  
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I.3. Chiral 1,3-Aminophenols, source, synthesis and applications 
I.3.1. 1-(2’-Alkoxyaryl)-alkylamines 
The main part of this work will deal with the synthesis of new chiral aminophenol-
derived ligands and their use in asymmetric catalysis.  
 
NH2
O
R’
R
R’’
variation of size
variation of size and 
electronic properties
binding sites and/or
access point for the 
funcionalizations
1
2’
α
β γ
 
Figure 5: 1-(2’-Alkoxyaryl)-alkylamine: suitable building block for new chiral ligands? 
 
The core structure of 1-(2’ -Alkoxyaryl)-alkylamine (Figure 5) belongs to the class of 
1,3-aminoalcohols and presents an interesting building block for the construction of 
new ligands. The chiral information is located in the benzylic position and the aryl 
ring rigidifies a potential six-membered metallacycle. The two functional groups, i.e. 
amine and phenol, present good ligand binding sites, or, via functional group 
transformation, they can easily be turned into different functionalities, and they 
present the linking points for building up more complex structures. Modification of 
the benzylic and aromatic substituents R and R’ ’  will allow the study of their 
influence in chiral induction by steric or electronic effects.  
I.3.2. Synthesis of 1-(2’-alkoxyaryl)-alkylamines 
a) Racemic synthesis and optical resolution 
Many methods for alkylation of imines or reductive amination of ketones have been 
reported. Both allow an easy access to the racemic 1-(2’ -alkoxyaryl)-ethylamines. The 
first optically active 1-(2’ -methoxyphenyl)-ethylamine derivative was described in the 
1970’ s, synthesized by Eschweiler Clark reductive amination and resolved by salt 
formation with tartaric acid or mandelic acid.30-33 Although different asymmetric 
syntheses of these building blocks have been elaborated, for bulky benzylic 
substituents (e.g. tert-butyl or iso-propyl) on the 1-(2’ -alkoxyaryl)-alkylamines, this is 
still the method of choice (Scheme 2).34  
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Scheme 2: Synthesis of tert-butyl aminophenol.  
 
Access to both enantiomers of a ligand is important and therefore optical resolution 
remains a good method to achieve this.  
b) Asymmetric reduction 
Nonetheless, different strategies were elaborated for an asymmetric synthesis. The 
chiral auxiliary (+)-phenylethylamine was used in the group VIII metal catalysed 
hydrogenolysis (in particular Ni, Pd and Pt) to obtain the optically active 1-(2’ -
methoxyphenyl)-ethylamine35 by the diastereoselective reduction of the 
corresponding ketimine and subsequent cleavage of the auxiliary in a one-pot reaction 
(Scheme 3, Eq. 1). High selectivity of up to 90% ee were obtained in the Pd/H2 
reduction by Hogeveen and coworkers (Eq. 2).36  
 
N
MeMe
OMe
N
H
Me Me
OMe
NH2
Me
OMe
N
MeMe
OMe
H2
group VIII metal
0-50°C
1-300 bar
H2, Pd/C
>90% de
* *
THF
Eq. 1
Eq. 2
 
Scheme 3 
Subsequently, different chiral auxiliaries and reducing agents were used. Palmieri 
reported the diastereoselective reduction of 2-imidoylphenols to o-
hydroxybenzylamines with various α-substituents (Me, Et, Pr, iBu, Ph, iPr, tBu).37 In 
this sodium borohydride reduction, the addition of cerium chloride increased reaction 
rate and diastereoselectivity, the latter being in the range of 78 to 95% de, except for 
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Ph and iPr, where higher selectivity was observed without cerium chloride. A separate 
study of the reductive cleavage of the chiral auxiliary phenylethylamine by 
hydrogenolysis has been reported by Kündig and coworkers in which Perlman’ s 
catalyst Pd(OH)2/C turned out to cleave most selectively and provide the enantiopure 
aminophenol in good yield (Scheme 4). 38 
 
N
OH
MeMe
N
H
OH
Me Me
NH2
OH
Me
NaBH4, CeCl3
 
MeOH, -90 °C
Pd(OH)2 / H2
93% de
>96% after recryst.
89%
>96% ee
 
Scheme 4 
 
The synthesis of 2-methoxyphenylethylamine by asymmetric hydrosilylation of the 
corresponding ketoxime in the presence of [Rh(COD)Cl]2 and (-)-DIOP afforded low 
enantioselectivities of 16.5% ee.39 In an enantioselective transfer-hydrogenation of 
imines using a chiral catalyst and Hantzsch ester (2,6-Dimethyl-3,5-
dimethoxycarbonyl-1,4-dihydropyridine) as the hydride donor, 80% ee were obtained 
for 1-(2-methoxyphenyl)-ethyl)-amine as reported recently by List and coworkers 
(Scheme 5).40 
 
N
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PMP
N
H
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PMP
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O
O
P
O
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 PrPr
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PrPr
N
H
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Scheme 5 
c) Asymmetric alkylation of aldimines 
Phenylethylamine also has been successfully applied as chiral auxiliary in the 
diastereoselective addition of alkyl lithium reagents to imines, although, the 
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diastereomeric excess were in the range of 24% to 52% for the synthesis of 1-(2’ -
alkoxyphenyl)-alkylamine.41 Chiral oxime ethers also have been applied as 
auxiliaries, but again, for o-alkoxybenzylidene imines, only moderate selectivities (de 
64% to 76%) were obtained.42,43 More recently, phenylglycinol was used by Kündig 
and coworkers as the chiral auxiliary for the diastereoselective addition of methyl 
lithium and, depending on the substitution pattern of the arylidene imine, selectivities 
of over 96% de were achieved (Scheme 6).38  
 
N
OH
Ph
OMe
H
N
H OH
Me Ph
OMe
NH2
Me
OMe
Pb(OAc)4, K2CO3 
then
AcOH H2O/THF
MeLi 
THF 
-80 °C to 0 °C
>96% de
 
Scheme 6 
 
More recently, Charette and coworkers reported a multicomponent one-pot procedure 
for the synthesis of free α-chiral amines from aldehydes.44,45 Copper catalyzed dialkyl 
zinc addition to N-phosphinoylimines in the presence of Me-DuPHOS Monoxide 
(BozPHOS) delivered the corresponding 1-(o-methoxyphenyl)-propylamine in an 
enantiomeric excess of 95%. The same catalytic system using ligand (R,S)-PPFA and 
diethyl zinc furnished various α-arylpropylamines in high selectivity in the range of 
84% to 97% ee, and 1-(o-methoxyphenyl)-propylamine gave the best ee of 97%.46 
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H Et
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NH2NH2
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O Ph
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O Ph
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OMe
P
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P
P
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H
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L*: (R,S)-PPFA
[(BozPHOS)2Cu]
 
Scheme 7 
(Charette, 2005) 
(Wang, 2005) 
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d) Enantioselective reduction and stereospecific SN2 reaction 
The application of the diastereoselective alkylation using phenylglycinol (vide supra) 
to 3,5-di-tert-butyl-salicylaldimine was not successful and led to the development of a 
different approach by Kündig and coworkers.38 Corey-Bakshi-Shibita-reduction 
(CBS-reduction) of 3,5-di-tert-butyl-2-methoxyacetophenone with catalytic amount 
of oxazaborolidine afforded the alcohol in 90% ee. The nitrogen was introduced by 
stereospecific SN2 reaction with bis(p-nitrophenyl)phosphoryl azide (NO2-DPPA) 
although partial racemization was observed after hydrogenation of the azide. 
O
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Bu
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Me
Bu
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Me
N3
Bu
Bu
N
B O
Me
Ph
Ph
H3B
OMe
Me
NH2
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Bu
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(+)-(R)
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(+)-(S)
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BH3SMe2, -20 °C
H2, Pd
RT
t
t
t
t
t
t
t
t
85%
NO2-DPPA:
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Scheme 8 
I.4. Ligands based on the building block aminophenol 
Kündig and Meier first introduced this building block into a (phosphinophenyl)-
benzoxazine P,N-Ligand in order to study the difference of a six-membered 
benzoxazine and an oxazoline.47 Due to the larger ring size, the benzylic alkyl group 
was believed to be closer to a reaction centre than in the oxazoline five-membered 
ring. The oxazine ligand gave very similar inductions in a range of catalytic reactions 
(palladium catalysed asymmetric Heck-reaction, palladium catalysed asymmetric 
allylic substitution, rhodium catalysed hydrosilylation, iridium catalysed 
hydrogenation of olefins and copper catalysed Diels-Alder reaction). The results 
obtained in Palladium catalyzed alllylic substitution is shown in Scheme 9. 
 
CHAPTER I 
General Introduction 
 
12 
N
O
Bu
PPh2
t
N
O
PPh2
But
R R
OAc
R R
CH(CO2Me)2
[Pd(η3-C3H5)Cl]2 (1 mol%)
L* (2.5 mol%)
CH2(CO2Me)2, BSA
KOAc, CH2Cl2
23 °C, 2 h 
R = Ph         94% ee                                     95% ee
       Me            82% ee                                     79% ee
       Pr          74% ee                                     69% ee   
 
Scheme 9 
 
X-ray structure comparison of these two ligands revealed that the 6-membered 
oxazine ring adopts a pseudo boat conformation and that this leads to a chiral 
environment that is virtually identical in the two systems. With the oxazine derived 
ligand being more difficult to synthesize, the phox ligand remains winning in this 
comparison. 
 
For diethyl zinc addition to aldehydes, a wide range of aminoalcohol derived ligands 
have been probed. An N-substituted aminophenol was used in this reaction, giving 
selectivities from 81% ee up to 97% ee.  
 
N
H
MePh
OH
O
OH
(R,R)
86%
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L* (6 mol%)
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Scheme 10 
 
(R)-1-(2’ -methoxyphenyl)-ethylamine also served in the synthesis of chiral 
benzazapine. The secondary amine was obtained by diastereoselective MeLi addition 
to the chiral iminie (dr: 8,5:1). This was then used in the synthesis of the chiral 
benzazepine (Scheme 11).  
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Scheme 11: Synthesis of C2-symmetric aminophenol and benzazepine. 
 
Both secondary amines were used in enantioselective lithiation / silylation of a phenyl 
carbamate chromium complex.48-50 It is interesting to note that the opposite inductions 
and complementary enantioselectivities are obtained for the two open chain Li-
amides.  
N
Me Me
Li
OMe OMe
NLi
Me
Me
N
Me Me
Li
O
N(iPr)2
O
SiMe3
(CO)3Cr
O
N(iPr)2
O
(CO)3Cr
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Me3SiCl (3 eq.)
THF, -78 °C
(R,R)
48%
62% ee (S)
(S,S)
85%
81% ee (S)
(R,R)
56%
39% ee (S)
 
Scheme 12: Asymmetric lithiation / silylation of arene chromium tricarbonyl complex. 
 
During the course of this work, a Feringa-type phosphoramidite ligand incorporating 
the 1-(2’ -methoxyphenyl)-ethylamine fragment was developed by Alexakis.51-54 It has 
proven to be highly efficient in the asymmetric iridium-catalysed allylic alkylation 
and superior in stereo- as well as regiochemistry compared to the same ligand lacking 
the methoxy groups. The same trend has been observed for a copper catalysed version 
with Grignard reagents.  
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Scheme 13 
 
A similar observation was recently made by Ojima and coworkers.55 A library of 
atropoisomeric biphenol based phosphoramidite ligands was synthesized for a ligand 
design study on an asymmetric allylic alkylation–desymmetrization reaction. Again, 
the best selectivity was obtained with the ligand with the bisphenylethylamine 
fragment bearing one ortho-methoxy group. 
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Scheme 14 
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I.5. Project outline 
The main goal of this work is the synthesis of new chiral ligands based on the 
enantiomerically pure building blocks 1-(2-alkoxyphenyl)-alkylamines and 
substituted analogues shown in Figure 6.  
NH2
Me
OR
NH2
OR
MeMe
OR
Bu
NH2
OR
Me
NH2
Bu
Bu
t
t
OR
Pr
NH2
R = H
R = Me
1a
1b
2a
2b
3a
3b
4a
4b
5a
5b
ti
 
Figure 6 
 
 
This work will focus on the synthesis of four ligand classes as depicted in Figure 7. 
 
A) Participating in a collaborative work with the group of Prof. Licini (Padova, It), 
the synthesis of a chiral C3-symmetric tripodal trisphenolamine ligand (A) for the use 
in early transition metal catalysed asymmetric oxidation reactions was of great 
interest (Chapter II).  
N
ROH OH
OH
R
R
O
N
P O
R R
N N
OH
R R
OH
R= tBu, iPr, Me
X= OTf  or  I ,  BF4
R
O
Me
N
+
O
R
Me
N
X
OR
NH2
R
R = Me
R = Me
R = tBu
A
B C
D
R = Me, iPr, tBu
R’ = 6-Me, 3,5-tBu
R’’ = H, Me
 
Figure 7 
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B) Second, the similarity of these building blocks with salicylidene imines led to the 
synthesis of new chiral [N2O2] ligands which merge the structural elements of Bolms 
hydroxyphenylsulfoximine derived ligands and coworkers and Jacobsens salen ligand 
(Chapter III). 
C) A new chiral phosphoramidite ligand (C) would allow the introduction of a new 
rigid core structure for this ligand class (Chapter IV).  
D) A still limited number of successful chiral NHC-carbene ligands in asymmetric 
catalytic reactions motivated for the synthesis of a new highly bulky modification of 
the phenylethylamine derived N-heterocyclic carbene ligand (Chapter V).  
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II. From 2-Hydroxyphenyl-ethylamine to New Chiral Helical 
Atrane Complexes 
II.1. Atranes: An Introduction 
The first complex of trisethanolamine and a metal (bismuth hydroxide) was used in 1940 for 
pharmacological studies.56 It was then Voronkov and coworkers in 1982 who published their 
complexes of trisethanolamine with the group 14 elements silicon and germanium, naming 
them silatranes and germatranes.57-59 So far, almost all main group elements and many 
transition metals have been complexed to this ligand with its characteristic and very simple 
structure. Interestingly, this ligand often forms pentacoordinated complexes. This is the case 
even with metals that usually prefer octahedral coordination. In addition, most of these atranes 
proved to be very stable towards hydrolysis. A variety of structural modifications on these 
ligands have been published. The ring size is not restricted to a five membered ring as six and 
even a few larger rings are also known. The most prominent members are presented in 
Figure 8. 
Ti
N
OO
O
OPh Ph
Ph
Me
Me
P
N
NN N
Ph Ph
Ph
Si
N
OO O
OMe
N
NN N
Me Me
MeP
H
Ti
O
N
O O
O
Me
Me
Me
Me
Me
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Pr
(M,M,M)
(R,R,R) (R,R,R)
N
O O OTiMe
Me Me
Me
Me
Me
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N
N
N
N
(ClO4-)2
i
 
 
Figure 8: Different atranes and similar structures.59-66 
(Voronkov 1965) (Anderegg, 1977) (Verkade, 1989) 
(Bonchio, 1997) (Verkade, 2000) 
(Bringmann, 2003) (Kol, 2001) 
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II.1.1. Definition of Atranes 
The complexation of trisethanolamine to a metal leads to a complex which is generally called 
metallatrane. These structures consist of two bridgehead atoms (in this case the metal and the 
nitrogen atom) which are bridged by three three-atom moieties (Figure 9).67 The two 
bridgehead atoms can be interacting forming a [3.3.3.0] tricyclic system with a transannular 
N-E bond (E for any element). These systems are generally called atranes (A). In case the 
distance of the two bridgehead atoms lies between the sum of the two van der Waals radii and 
a normal transannular bond, these structures are called quasi-atranes (B). Finally, if the 
distance is bigger than the two van der Waals radii, a [3.3.3] bicyclic structure is produced 
and the term pro-atrane is used (C).  
 
E
N
YY Y
Z
E
N
YY Y
Z
(A) (B) (C)
E
N
YY Y
Z
 
Figure 9: Atrane (A), quasi-atrane (B) and pro-atrane (C). 
 
The nomenclature for these atranes follows some general rules67: The type of interaction 
between the two bridgehead atoms defines whether the term pro-, quasi- or no prefix is used. 
Depending on the bridgehead element E, the structure is called elementatrane. As an example 
for silicon silatrane is used (it also was named triptych-siloxazolidinei following the IUPAC 
1957 nomenclature68), for germanium germatrane, for phosphorus phosphatrane etc. Also the 
three binding atoms Y can be varied, and precede the name, (if Y is oxygen, no prefix to the 
name is made). For example: if Y is nitrogen and E is silicon, the structure is called 
azasilatrane, if Y is methylens and E is a carbon as well, it is called carbacarbatrane. If in 
addition there is no transannular bond present, it is called pro-carbacarbatrane.  
 
In an article about atranes published in 1993 Verkade states “three curious features about 
these football-shaped molecules which make these aesthetically attractive species exceedingly 
interesting to study.” 69 
 
                                                 
i
 A triptych (from the Greek tri-WKUHHSW\FK IROGis divided into three sections, or three carved panels 
which are hinged together. 
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- The degree of delocalization of the nitrogen p-orbital into the (usually) d-orbital of the 
element E is easily varied from a transannular 3-centre-4e- bond system to simple 
dipolar interactions with a distance of the two van der Waals radii by the variation of 
the element E, its substitutents Z or the binding atoms Y.  
- The transannular bond itself enhances the electron density on the element E. 
- Exchange reactions of the type LE Æ LE’  and LE Æ L’ E are possible, which is quite 
uncommon for highly chelating ligands69,70  
 
The E-N distance in general depends primarily on the element that is coordinated to the tripod 
ligand. Going from carbon to silicon to germanium, the E-N distance becomes shorter due to 
increasing nN-σ*EZ orbital interaction.  
A weaker effect has been observed and calculated from the electronegativity of the three 
coordinated binding atoms Y, and even smaller for the trans oriented substituent Z. With 
increasing electronegativity of Y (-CH2 < -NR < -O) or R (H < F) the transannular bond 
becomes shorter.71-74 But also steric interactions as well as ring strain play an important role 
(vide infra).75,76 
 
These features have important consequences on the reactivity of atranes:  
 
The donor interaction of the nitrogen with the metal increases electron density on the latter. 
Although the electron density on the element E (e.g. E = Si) increases, it causes a polarization 
of all the bonds, resulting in bond lengthening and therefore in a net increase in Lewis 
acidity.77,78 In fact, uncommonly strong dipole moments have been measured along the 
transannular bond of boratrane, silatrane, titanatrane and vanadatrane complexes.79 In 
phosphatranes, the transannular bond dramatically increases the basicity of the phosphorous 
due to the donation from the nitrogen lone pair.67 As another consequence, these 
phosphatranes show an extraordinary reactivity for example as Lewis base catalysts in 
Morita-Baylis-Hillman reactions. 
 
Until the end of the last century, a typical structural representation of an atrane has three five-
membered rings hinged together. It was first the group of Holmes who introduced a new class 
of silatranes possessing three phenoxy substituents on the bridgehead nitrogen, forming three 
six-membered silacycles (Figure 10).72 The new atranes allowed a much easier evaluation of 
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the effect of the apical ligand onto the transannular bond. With these ligands a variation of 
over 0.7 Å in the Si-N distance was observed while the analogous series with five-membered 
rings ranged only over 0.15 Å.73 The incorporation of tert-butyl groups neighbouring the 
apical ligand allowed to study their steric effects on the transannular bond, which results in a 
decrease in range of Si-N distance to 0.166 Å, indicating a reduction in flexibility of the 
triptych structure.74 
Si
O
N
O
O
O
Me
Me
Me
Me
Me
Me
Me
 
Figure 10: C3 symmetric silatrane with six-membered metallacycles. 
 
To date, atranes not only from silicon,59 phosphorous61 and boron80 have been synthesised, 
but also main group metal- and transition metal-complexes are documented: Sn81, Al82,83, 
Sb84, V79, Ti62,85, Fe86, Bi56,84, Ta87, Li88,89, Na88. Even H+ can serve to stabilize this structural 
entity.88  
II.1.2. Tris(2-hydroxybenzyl)amine derived atranes possess a helical structure. 
Crystal structures of metallatranes with tris(2-hydroxybenzyl)amine derivatives as ligands 
(gallatranes and indatranes from Koch,90 silatrane from Holmes,72 titanatrane from Kol and 
Verkade,62,91) all show a distortion of the aryl ring plans towards the N-E axis, forming an 
overall helical structure and therefore the molecules are chiral consisting of a pair of 
enantiomers. This twist is originated in the ring strain of the six membered metallacycle 
(Figure 11). 
N
O
O
O E
Z
N
O
O
OE
Z
(M)(P)
EE
Side view
Top view
 
Figure 11: Intrinsic chirality of atranes with six-membered metallacycles. 
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Kim and Verkade obtained a pentacoordinated alumatrane chelated by a tris-phenoxide ligand 
which shows a for alumatranes uncommon monomeric behaviour as well in gas-phase as in 
solution.85 
Al
N
N
O
O
O
Me
Me
Me
Me
Me
Me
HMe
Me
 
Figure 12: Monomeric alumatrane, unusual for aluminium complexes. 
 
Recently, a C3-symmetric tripodal ligand possessing three axially chiral biaryl subunits was 
investigated (Figure 13). This ligand coordinated to Ti exhibits a very narrow internal cavity 
leading to low stability of the complex making it highly moisture sensitive, whereas 
previously reported atrane systems are usually stable towards moisture.65 
(M,M,M)
N
O O OTiMe
Me Me
Me
Me
Me
Cl
 
Figure 13: Example of a pro-titanatrane. 
 
II.1.3. Atranes in organic reactions  
a) Atranes as a reagent 
An application of the transannular interaction can be found in the palladium catalysed cross-
coupling reaction of phenylsilatrane with aryltriflates (Scheme 15).92 Initially the idea was to 
apply the 1-phenyl-silatrane as a reagent which could allow avoiding toxic fluorine additives 
since the atrane nitrogen could take over this function. As it turned out, this dative bond was 
not sufficiently strong to promote transfer of phenyl in the absence of fluoride.  
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Scheme 15: Unsuccessful application of the effect of the dative N-Si bond. 
 
b) Atranes in catalysis 
It is the phosphatrane system, which has found most versatile applications in organic and also 
polymer chemistry (Figure 14).93 It has been shown to be active in several reactions like 
aza-/thia-Michael reaction and Strecker reaction,94 cyanosilylation of aldehydes and ketones,95 
transesterification,96 nucleophilic aromatic substitution97 and Morita-Baylis-Hillman 
reaction98,99. In addition it has been used for Buchwald-Hartwig amination100 and Stille101-103 
reactions as a promising ligand.  
N
N N
R
R
RP
N
 
Figure 14: Azaphosphatranes, highly useful Lewis base catalyst and ligand. 
 
Other catalytic reactions, where atranes have found application are detailed below: 
A titanatrane for the aza-Diels-Alder reaction 
An interesting example of catalytic activity of a trisphenolamine derived atrane was found by 
the group of Mahon (Scheme 16). An air- and moisture-stable titanatrane triflate proved to be 
an excellent Lewis acidic catalyst for the aza-Diels-Alder reaction.104 It was shown that the 
reactivity depended strongly on the apical ligand of the catalyst. The titanatrane with an apical 
isopropoxy ligand appeared to be poorly reactive for a range of synthetic transformations for 
which Lewis acidic titanium alkoxides and phenolates have been used previously. An apical 
triflate ligand significantly enhanced its activity and let the catalyst compete with the best 
known catalysts available for this reaction.105-107 
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Scheme 16: Aza-Diels-Alder catalyzed by a titanatrane complex. 
 
Epoxidation with a vanadatrane 
In the Vanadium-dependent haloperoxidase, vanadium exists in its highest oxidation state 
V(V) with a trigonal bipyramidal (TBP) geometry. The amine trisphenolate ligand seems to 
provide a “natural environment”  for vanadium, and was therefore studied as an example to 
mimic the biological system.108 The trisphenolamine derived vanadatrane provides a poorly 
active catalyst (2-5 turnovers per day) in the oxidation of styrene and stilbene with tert-butyl 
hydroperoxide (Scheme 17). 
V
O
N
O O
O
Cl
Cl
Cl
Cl
Cl
Clcat.:
R
R = H, Ph R = H, Ph
O Rt-Bu-OOH, 5 mol% cat
CH2Cl2, RT
 
Scheme 17: Epoxidation using a vanadatrane. 
 
Titanium and zirconium complexes of the trisphenolamine ligand were also tested in lactide 
polymerization.91,109,110 In comparison to hexacoordinated titanium and zirconium catalysts, 
the tripod ligand forces a pentacoordination and the catalysts showed increased activity due to 
the reduced coordination number. In addition, the zirconium based catalyst was substantially 
more active than the corresponding titanium complex. 
c) Asymmetric catalysis 
There are only very few examples where a metallatrane was used as a catalyst in an 
asymmetric reaction. Noteworthy are only three examples where a chiral atrane complex 
afforded products in over 80% enantiomeric excess.  
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The use of chiral trisalkanolamine ligands in the catalytic system of zirconium mediated 
enantioselective opening of meso-epoxides with silyl azides allowed the zirconium not to 
loose its ligand during the course of the reaction, as it was the case in the original system with 
dimethyl tartrate (Scheme 18). Therefore the catalytic system showed an increase of 
selectivity from nearly racemic to 93% ee (A).111-114 The same catalyst was used for 
asymmetric halogenation, again with excellent results (B).112 
N
OH
3
O
OTMS
N3
O
OTMS
Br
+ Zr(OtBu)4
THF
-3 tBuOH
L-Zr-OtBu
H2O
THF
(L-Zr-OH)2-tBuOH
cat.:
Detailed structure
unknown.
cat. 
TMSN3, TMS-TFA
CH2Cl2, 25 °C 93% ee
cat., allylBr 
TMSN3
C6H5Cl, 25 °C 95% ee
(A)
(B)
 
Scheme 18: Dinuclear zirconatrane catalyst for meso-epoxide ring-opening. 
 
In a second system a chiral trisalkanolamine ligand was used in the titanium mediated 
sulfoxidation. Here, phenyl substitution proved to be most effective (Scheme 19).115 This 
ligand brought a drastic increase in catalyst activity. It also reduced the complexity of the 
possible titanium complex intermediates in solution. This made a more detailed analysis of 
the system possible than with the original diethyl tartrate ligand.63,113,116  
TiO
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Ph
Ph
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OO
84% ee
..
PhCMe2OOH
TON 1000
+
77:23
94%
 
Scheme 19: Titanatrane catalyzed asymmetric sulfoxidation. 
 
The combination of the same chiral phenyl substituted trisalkanolamine and zirconium 
provides an even more effective catalyst, affording sulfoxides with ee’ s up to 91%.117 
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II.2. Interest 
The interest in asymmetric Lewis acidic catalysts and the expertise in the successful synthesis 
of chiral α-alkylaminophenols were instrumental in entering a collaboration research project 
with the group of Prof. G. Licini (Padova, I). This project was pursued in the framework of a 
COST (action D24).i  
 
The catalytic activity of trisphenolamine derived titanatranes in aza-Diels-Alder, Baeyer-
Villiger and sulfoxidation reactions makes this relatively unknown ligand class highly 
attractive.118 The chiral building blocks 1-(2-hydroxyphenyl)-alkylamine are the bridging key 
element from the achiral trisphenolamine to its chiral analogue. The intrinsic helical chirality 
of atranes derived from this ligand could be controlled by the benzylic stereogenic centre. The 
effort of this work was aimed at synthesizing a trisphenolamine ligand carrying three benzylic 
stereogenic centres, since the ligand synthesis elaborated by the group of Prof. G. Licini is 
restricted to the introduction of a single stereogenic centre. Due to the proposed change in the 
coordination sphere from trigonal bipyramidal pentacoordination to octahedral 
hexacoordination during the catalytic cycle of the sulfoxidation reaction, three chiral 
substituents are highly preferential for an efficient chiral induction.63  
 
                                                 
i
 COST: European Cooperation in the field of Scientific and Technological research. 
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II.3. Attempted synthesis of tripod ligand 8: Retrosynthetic analysis 
Although the C3-symmetric tertiary amine 7 possessing three stereogenic centres has been 
synthesized recently, the synthesis of ligand 8 with additional three ortho-hydroxyl groups is 
only known in its achiral version 6 (Figure 15).119 
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Me
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OH OH
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Me
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R = H, tButyl, Phenyl etc
 
Figure 15: C3-symmetric ligands. 
 
As mentioned above, the chiral non-racemic 1-(2-hydroxyphenyl)-ethylamine (1a) previously 
reported from this group appeared to be a suitable building block to obtain in few steps the 
tripod ligand 8. The retrosynthetic analysis gives rise to three possible disconnections: 
cleavage of bond A, B or C (Scheme 20).  
 
With a phenol protection in place, a possibility to introduce the third phenol moiety is by 
reductive amination (path A) of an ortho-alkyloxyacetophenone with 9 in the presence of 
sodium cyanoborohydride. This reaction should yield the C3-symmetric-isomer, most 
probably in a mixture with the C1-isomer 1b. Two problems have to be considered for this 
approach: The steric crowding around the secondary amine 9 may be a problem, and ketones 
are less reactive than aldehydes in reductive amination.120 
 
A second approach consists in the formation of an iminium ion by the condensation with 
acetaldehyde followed by nucleophilic aryl lithium attack (path B). This is assumed to be 
difficult because of enamine formation. The condensation of ortho-alkyloxybenzaldehyde 
with the secondary amine in the presence of a Lewis acid and/or water scavenger (e.g. TiCl4, 
(F3CSO2)2O, etc.) followed by alkylation (path C) would be a reasonable alternative.  
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Scheme 20: Retrosynthetic analysis. 
 
A very similar approach was successfully carried out by Wyatt in the synthesis of 7119: The 
phenyl group was introduced by reaction of a phenyl lithium with formamide derivative 12 
(Scheme 21). Transformation of the alcohol function into a leaving group (addition of TiCl4, 
Tf2O or (ClCO)2) allowed the formation of the iminium intermediate 14. Grignard addition 
provided the desired tertiary amine 7. The starting formamid 12 can be obtained by treatment 
of the secondary amine 11 with triethyl ortho-formate in the presence of p-toluene sulfonic 
acid. This double nucleophilic addition is particularly interesting because the 
diastereoselectivity achieved for the amine 7 was 4 to 1 in favour of the C3-isomer. The 
authors reported that other synthetic strategies based on alkylation, reductive amination or 
carbenoid chemistry were unsuccessful.119 
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Scheme 21: Synthesis of tertiary amine 2 by Wyatt.119 
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II.4. First approach to the synthesis of the trisphenolamine ligand 3 
II.4.1. Phenol protection 
Since the most convenient synthesis of the building block 1-(2-hydroxyphenyl)-ethylamine 1a 
provides directly the free alcohol function (see chapter I), the phenol had to be selectively 
protected due to the presence of a more nucleophilic primary amine function.  
 
The O-selective methyl protection of aminophenol 1a was carried out via N-protection 
through a trifluoroacetamide group and subsequent phenol deprotonation / methylation. The 
free amine 1b was obtained in 80% yield after the treatment with sodium hydroxide (Scheme 
22).  
NH2
OH
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N
H
O
F
F
F
OH
Meslow addition of 
(F3CCO)2O NH2
Me
OMe
a) NaH, -12 °C
    DMF, 2 h
b) MeI
    24 h, 23 °C
c) NaOH
    1 h, 23 °C
R-1a R-15 R-1b
0 °C
80% over 2 steps
 
Scheme 22: Methylation of the aminophenol. 
 
II.4.2. Introduction of the second stereogenic centre 
The secondary amine 9 was synthesized following published procedures as shown in Scheme 
23. 48,121 
NH2
MeOMe
N
H
Me MeOMe OMe
ee 98 % (C2:CS  99.9:0.1 after recrist.)
R-1b 9
ref121
2-methoxyacetophenone
Ti(OiPr)4 (3 eq), neat
then 10 % Pd/C (0,5 mol%),
H2, 1 atm, 23 °C
88%, dr 6.7:1
ref48
1) 2-methoxybenzaldhyde
    EtOH, MS 4 Å
    20 °C, 16 h, 98%
2) 3 eq. MeLi
    THF, - 60 °C, 66h
    66%, dr 8.5:1
 
Scheme 23: Preparation of 9. 
 
Amine 9 was then heated to 130 °C in triethyl ortho-formate in the presence of a catalytic 
amount of p-toluene sulfonic acid, and the ethanol produced was removed by distillation 
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during the reaction (Scheme 24). In this way, good yield of the formamide 10 was obtained 
after evaporation of excess triethyl ortho-formate.  
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Scheme 24: Formylation of 9. 
 
II.4.3. Model reactions 
To probe the reactivity of anisyl lithium towards nucleophilic 1,2-addition, a couple of model 
reactions were carried out. Directed ortho lithiation of anisol (n-BuLi, TMEDA, ether) 
followed by reaction with DMF and hydrolysis afforded anisaldehyde as the sole 
product.122,123 
 
N,N-dibenzylformamide 17 was synthesised from dibenzylamine 16 by the procedure shown 
below (Scheme 25). Reaction of 17 with anisyl lithium, followed by oxalyl chloride and 
subsequent alkylation with methyl magnesium bromide gave the tertiary amine 18 in 44% 
yield after column chromatography (Scheme 25). This model study showed that Wyatt’ s 
procedure to generate highly hindered tertiary amines is also suitable for the introduction of 
anisyl in place of phenyl lithium.  
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Scheme 25: Synthesis of the tertiary amine 18. 
 
The conditions for this double nucleophilic addition to a formamide was subsequently applied 
to bis[(2-methoxyphenyl)ethyl)formamide (10). In contrast to N,N-dibenzylformamide (17), 
where a complete addition was observed using 1.1 equivalents, the reaction show in Scheme 
26 stopped after about 50% conversion.  
Addition of at least three equivalents of anisyl lithium was required for full conversion of 
formamide 10 to anisaldehyde 19 and the corresponding secondary amine 9. 
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Scheme 26: Initial attempts to synthesize the C3-ligand. 
 
This optimization was then included into the double nucleophilic reaction sequence. 
Formamide 10 was alkylated by anisyl lithium and converted to the iminium with 
oxalylchloride and subsequently methyl-Grignard was added in order to obtain the protected 
amine 20 (Scheme 27). 
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       Et2O10
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Scheme 27: Attempted formation of protected ligand 8. 
 
Although before column chromatography the crude 1H-NMR contained the quartet of the 
benzylic protons and the doublet for the three methyl groups, after column chromatography 
these signals were not present anymore, and only decomposition products were found. 
 
II.4.4. Variation of the substituents  
Faced with the lack of stability of 20, we probed the reaction sequence as detailed below. 
a) Variation of the methoxy groups 
Three benzylic substitutions, zero methoxy groups: To obtain the tertiary amine without 
ortho-methoxy groups, Whitesell’ s amine (11) was prepared by following a literature 
procedure (Scheme 28).36  
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Scheme 28: Synthesis of Whitesell amine (11). 
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Formylation of 11 with triethyl ortho-formate gave the formamide 12 in a good yield 
(Scheme 29).  
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Scheme 29: Arylation / iminium formation / methylation of 12. 
 
Wyatt’ s tertiary amine synthesis (conversion from 12 to 7) was reproduced with comparable 
yields.i For the synthesis of amine 21 (1 methoxy group), di(phenylethyl)formamide (12) was 
reacted with anisyl lithium to obtain the corresponding amine 21 in 60 to 70% estimated yield 
by 1H-NMR and 10% isolated yields.  
 
Compounds 22 and 20 were synthesized by addition of either phenyl lithium (affording amine 
22) or anisyl lithium (affording 20) to the formamide 10 (Scheme 30).  
a)
b) (COCl)2
c) MeMgCl
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Me Me
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Ar
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Scheme 30: Synthesis of tertiary amines starting with the formamide 10. 
 
                                                 
i
 Phenyl lithium was prepared from phenyl iodide and n-BuLi.124  
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All structures were identified by 1H-NMR spectroscopy. The structures of the amines 20, 21 
and 22 (3, 1 or 2 methoxy groups respectively) were confirmed by ESI-MS spectroscopy. The 
isolation of all three new tertiary amines in pure form is an unsolved problem, especially for 
compound 20 (vide infra: unsolved problems).  
 
b) Variation of the benzylic substitution 
The lack of stability of 20 is most probably ascribed to steric crowding around the nitrogen 
atom.  
In order to gain information about the dependence of the stability on the steric, the tertiary 
amines possessing two or a single benzylic stereogenic centre was envisaged.  
Hence formamide 23 was synthesised from o-anisaldehyde and 2-methoxybenzylamine 
following the sequence described above. The stepwise reductive amination with condensation 
of o-anisaldehyde and 2-methoxybenzylamine and subsequent sodiumborohydrid reduction 
afforded the bis(o-methoxybenzyl)amine in 67% overall yield (Scheme 31).  
Acid catalysed formylation with triethyl ortho-formate gave formamide 23 in 59% yield. 
Subjecting this to the double nucleophilic addition using anisyl lithium, the tertiary amine 24 
was obtained in 16% yield after column chromatography. The low yield is due to partial 
decomposition on triethylamine deactivated silica gel. 
 
In order to obtain amine 25 possessing two stereogenic benzylic centers from formamide 10, 
the Grignard reagent was replaced by sodium borohydride. Unfortunately this did not lead to 
the desired product 25 (Scheme 31). 
 
N
O
ArAr
H
N
O
ArAr
H
NAr
Ar
Ar
Ar = 
OMe
NAr
Ar
Ar
* estimated yields from crude 1H-NMR. 
23 24
10 25
NH2 ArOAr +
1) HCO2H
    CH2Cl2, 4 Å MS
    25 °C, 6 h
2) NaBH4, MeOH
    0 °C, 30 min.    
    67%
3) HC(OEt)3 
    120 °C, 59%
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Scheme 31: Preparation of mono-, and dimethylated trismethoxybenzylamines. 
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II.4.5. Unsolved problems: isolation and stability 
The purification of the trisphenylethylamine 7 was carried out by column chromatography or 
by recristallization from ethanol. Column chromatography of 21 led to about 10% product 
recovery. In the case of 22 having two methoxy groups, ~1% was recovered after a column. 
Amine 20 decomposed completely under chromatographic conditions.  
Extraction with hexane of the crude reaction mixture at -78 °C was the only way to separate 
this amine from impurities.  
 
From the sterically less hindered amine 18 to the highly congested protected ligand 8 the 
stability decreases remarkably. Amine 7 (3 Me groups) and 18 (1 Me group, 1 MeO group) 
can be isolated by column chromatography, amine 21 (3 Me groups, 1 MeO group) and 24 (1 
Me group, 3 MeO groups) instead already decompose on deactivated silica gel and even faster 
on aluminiumoxide (activity I + 10w% H2O). Furthermore they appeared to be sensitive to 
heat. 
 
II.4.6. Possible explanations 
a) Crystallographic data 
The X-ray structure of the tris(phenylethyl)amine (7) indicates a possible reason for this 
instability.119 The nitrogen atom is found to have nearly planar geometry with a C-N-C bond 
angle of 116.7° to 119.6° (Figure 16). The pKa of this amine was found to be 4.9.119 The low 
basicity indicates that the nitrogen lone pair is well shielded and this is supported by the 
crystal structure. Basicity and crystal structure both reveal that there is substantial strain 
which could lead to degradation by the introduction of pi-donor substituents on the adjacent 
aromatic ring. 
NH
MeMe
H
Me
H
C-N-C angles φ: 116.7° to 119.6°
7
φ
 
Figure 16: The crystal structure of 7 (redrawn for illustration) reveals a virtually flat nitrogen centre.119 
CHAPTER II 
From 2-Hydroxyphenyl-ethylamine to New Chiral Helical Atrane Complexes 
 
34 
b) Experimental considerations 
Kibayashi et al. put to good use the lability of such aminophenols as shown in Scheme 32:125 
The α-(hydroxyphenyl)ethyl-moiety which acted as the chiral source was cleaved from a 
tertiary amine by a rearrangement initiated by the Li-phenolate.  
 
O
Me N
Li
Me
3
N
H
Me
3
Me
N
Me
O 3
Li
OH
Me OH
O
Me
 
40 °C
THF
45 min
+
45 min
H2O
 
Scheme 32: Li-acetylene addition to the chiral aminal leading to the cleavage of the chiral auxiliary. 
 
A similar pathway could be operative when 20, 21, 22 or 24 are subject to the action of a 
Lewis acid (e.g. SiO2 or Al2O3). However, these tertiary amines do not contain hydroxy- but 
methoxy-groups and therefore this analogy would need experimental confirmation. 
A second example is the formation of o-quinone methide using ortho-hydroxybenzyl-amine 
(Scheme 33) either by thermolysis (amine: 100 °C, 24 h, ammonium: 80 °C, 1 h) or by 
irradiation (0 °C). 126-129  
O
∆
OH
NMe or hνnm+
[n, m] = [2, 0], [3, 1]
 
Scheme 33: Generation of o-quinone methides from aminophenols. 
 
In view of the above reviewed observations, the lability of 20 and analogues is most likely 
ascribed to a combination of the steric hindrance caused by the three benzylic substituents and 
the three ortho-methoxy groups together with the destabilization of the three N-C benzylic 
bonds by the three pi-donor methoxy substituents (Figure 17).  
20
N
Me
Me
Me
OMe OMe
MeO
 
Figure 17: Proposed decomposition passway of 20. 
The difficulties encountered do not bode well for the step that still remains to be carried out – 
the (Lewis) acid mediated conversion of the methoxy function to the phenol. 
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II.4.7. Deprotection of the methoxy group of the mono methylated ligand. 
Since all the phenol groups should be present for a tripod ligand, the most stable ligand 
candidate for testing the deprotection of the methoxy groups was the mono methylated 
precursor 24.  
From an earlier deprotection study of the bis(1-(2-methoxyphenyl)ethyl)amine (9), it was 
known that several standard deprotection methods for methylarylethers resulted in the 
cleavage of a benzylic C-N bond rather than in conversion to the bisphenol 26.130 The best 
procedure found was the use of aluminium tribromide in benzene at ambient temperature 
(Scheme 34). 
BBr3, -78 °C
or 
PhSH/K2CO3
or other methods
N
H
Me MeOMe OMe
N
H
MeOH Me OH
    AlBr3
20 °C, 8 h     
 benzene
    82 %
NH2
MeOH
1a 9 26
 
Scheme 34: Deprotection of bis(1-(2-methoxyphenyl)ethyl)amine. 
 
The application of this deprotection procedure to the tertiary amine 24, even at 0 °C instead of 
room temperature, resulted in product degradation (Table 1, Entry 1). At -78 °C, no reaction 
took place. Protection of the amine as hydrochloride did not help either (Scheme 35, Table 1, 
Entry 2). 
N
Me
OMe OMe
MeO
N
Me
OH OH
OH
24 27
conditions
 
Scheme 35: Attempted deprotection of 24. 
 
Table 1 
AlBr3 0 °C, Benzene/CH2Cl2 1:1 complex mixture 
AlBr3 -78 °C, Benzene/CH2Cl2 1:1 no reaction 
AlBr3 HCl Salt of 7 0 °C, Benzene/CH2Cl2 1:1 decomposition 
 
Due to this disappointing but expected result, this first approach for the synthesis of a chiral 
tripod ligand was abandoned.  
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II.5. Second approach for the synthesis of the C3-ligand 
II.5.1. Synthetic analysis 
The observation, that not only with increasing the number of benzylic substitution but also 
with increasing the number of ortho-methoxy substituents the stability of the tertiary amine 
decreases, led to the assumption that the steric demand of a protecting group should be kept as 
small as possible. Since methyl is already the smallest protection group, another strategy had 
to be found, and a route without protection was chosen. The following scheme (Scheme 36) 
gives an overview of the second approach. 
MeMgCl
or 
NaBH4
Li
OMe
N
O
Me Me
H
OMe OMe
N
Me
Me
Me
OMe OMe
MeO
N
H
Me MeOMe OMe
N
R’
Me
R
OH OH
OH
1)
2)    (COCl)2
3)    MeMgCl
Deprotection
N
H
MeOH R OH Me
R
OH
OH
O
N
Deprotection
(9 to 26)
ev. 
Lewis acid
9
R = Me: 26
R = H:   28
First Approach:
Second Approach:
salicyl-
aldehyde
10
20
(R = H, Me)
(R = Me)
R = Me: 29
R = H:   30
R = R’ = Me:       8
R = R’ = H:        R-27
R = H, R’ = Me: 31
 
Scheme 36: Second approach towards a chiral trisphenolat ligand. 
 
Here the secondary amines 26 or 28 would be reacted with salicylaldehyde to form the 
benzoxazines 29 or 30 respectively. Reductive cleavage of the C-O bond or selective 
alkylation with methyl-Grignard reagent or reductive cleavage with sodium borohydride 
could then lead to the trisaminophenols 8, R-27 or 30 respectively.  
 
In order to elaborate an initial set of reaction conditions, the sterically least demanding chiral 
methyl substituted trisphenolamine ligand R-27 was targeted (Figure 18).  
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N
MeOH OH
OH
(R)-28
 
Figure 18 
 
II.5.2. Synthesis of benzoxazines  
For oxazine formation using a secondary amine and an aldehyde, there are two representative 
examples depicted in Scheme 37. The reaction can either be performed in an alcoholic solvent 
(A), or in refluxing toluene or benzene and a catalytic amount of p-TSA (B).131-133 Regarding 
the stability of the final ligand the milder conditions were chosen and therefore method (A) 
was applied. 
NH
OH
Ph
MeO
MeO
N
O
Ph
MeO
MeO NO2PhMe
p-TSA
reflux
O2N
CHO
NHCH3
CH3HN
OHOH
OH
CHO
OH
N
O
O
N
OH
Me
Me
A)
B)
hot EtOH, 20 h
 
Scheme 37: Synthesis of benzoxazines. 
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II.6. Second approach for the synthesis of tripod ligands 
II.6.1. Synthesis of the benzoxazine intermediate 
Starting with the condensation of salicylic aldehyde and 1-(2-hydroxyphenyl)-ethyl-
amine (1a), imine 32 was formed in quantitative yields. It was then subjected to 
hydrogenolysis to obtain the secondary amine 28 in 71% overall yield (Scheme 38).  
 
NH2
MeOH
N
MeOH OHO
OH N
H
MeOH OH
+
MeOH
3Å MS
Pd-C/H2
3 atm
MeOH
71% over
2 steps
1a 32 28
 
Scheme 38: Synthesis of 28. 
 
With 28 in hand, its conversion to the oxazine derivative 30 was probed. First amine 28 was 
stirred in methanol in the presence of salicylaldehyde at ambient temperature. After 3 d, only 
the starting material was isolated (Scheme 39; Table 2, Entry 1). Heating to reflux did not 
force the reaction to proceed (Table 2, Entry 2). Next, the reaction was carried out in boiling 
toluene in the presence of p-TSA and the water produced was removed using a Dean-Stark 
condenser. Unfortunately, the desired product was not observed in the 1H-NMR (Table 2, 
Entry 3), but rather decomposition was found. Since protic solvents enhance water cleavage, 
the reaction was refluxed in isopropanol for 24 h. This again resulted in decomposition (Table 
2, Entry 4).  
N
Me
O
OH
OH
H
O
OHN
H
MeOH OH
+ N
O
OH
OH
Me
H
+
conditions see 
table 2
28
30A 30B
 
Scheme 39: Optimization in the formation of benzoxazine 30. 
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Table 2 
 Solvent Temperature Conditions Result 
1 Methanol 25 °C  No reaction 
2 Methanol 65 °C Reflux No reaction 
3 Toluene 110 °C Water trap, p-TSA Decomposition 
4 Isopropanol 80 °C  Decomposition 
5 D3-MeOD 80 °C Pressur tube See NMR in figure  
6 Methanol 40 °C AcOH Yield not determined 
7 Methanol 36 °C AcOH, 3 Å MS, 2 d Yield: 90 % 
 
Then, to be able to control and follow the reaction, the next reaction was heated to 80 °C in 
d3-MeOD for 20 h using a sealed NMR tube (Table 2, Entry 5). After 1.5 h, several new peaks 
could be observed. A new signal at 1.6 ppm appeared, assigned to a species containing a 
XC(H)-C(H)3 spin system (Figure 19). Two new peaks at 5.6 and 6.2 ppm appeared in a 
region typical for Ar-C(H)(OAr)-N methine protons. They were initially interpreted as 
belonging to two different isomers of a benzoxazine ring system. In the region 3.5 to 4.5 ppm 
the NCH2 and NCH signals were overlapping and therefore interpretation was difficult. At 
8.5 ppm there was a new signal rising, which could indicate an imine. With the ring-chain 
tautomerism in mind, an iminium structure could be possible. However, an iminium would 
not be stable in the presence of water produced during the condensation. Therefore the signal 
was assigned to an imine proton. This would indicate a cleavage of a N-C bond.  
After heating for 2 h, the intensity of the signal at 6.2 ppm has decreased, the one at 5.6 ppm 
has grown, which could indicate a change of one regioisomer to another. After 5 h, the imine 
peak at 8.5 ppm presented the major product.  
Although the desired peaks have been observed during the 1H-NMR experiment, the high 
reaction temperature led to decomposition. Again, it is assumed that decomposition proceeds 
via the formation of an ortho-quinone methide (Scheme 40) in keeping with the tentative 
observation of an imine. As a consequence, the reaction had to be repeated at a lower 
temperature. 
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Scheme 40: Possible decomposition pathway from the benzoxazine 30 to the tentatively observed imine 33. 
 
Figure 19: Reaction of salicylaldehyde with 28 in CD3OD. 
 
Therefore the reaction was repeated in methanol at 40 °C, using now acetic acid as the 
catalyst (Table 2, Entry 6). The reaction was monitored by NMR, but did not go to 
completion. In addition still partial decomposition was observed. As a consequence the 
temperature was lowered to 36 °C and 3 Å molecular sieve was added to trap water. These 
conditions afforded 30 in 90% yield (Table 2, Entry 7).  
 
To assign the regio- and stereoisomer of 30, its 1H-NMR spectrum was compared to a similar 
structure, which in the benzoxazine ring also possesses at C(2) a phenyl and at C(4) a methyl 
substitution (Figure 20).134  
New signals 
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Figure 20 
 
The C(2) methine signal of the benzoxazine appears at 6.36 ppm (Jones 6.1 ppm) and the 
C(4) methane signal appears at 4.1 ppm (Jones 3.9 ppm). Figure 21 shows the 1H-NMR 
spectrum of 30 in deuterated chloroform. 
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Figure 21: Proton NMR of 30 in CDCl3. 
 
Structural considerations 
In this cited reference the only conformation found was the one where the phenyl group is 
trans to the methyl substituent. Due to their similarity, it can be assumed that this 
configuration is also present in 30. This received support from NOE experiment as shown in 
Figure 22.  
O
Me
N
OH
OH
H H
NOE
 
Figure 22: NOE experiment on benzoxazine 30. 
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II.6.2. From benzoxazine intermediate 30 to the tertiary amine 27 
A mild method to reductively open an oxazine ring was published by Page and coworkers 
which uses sodium cyanoborohydride at low temperatures promoted by TMSCl as the Lewis 
acid.135 Even though the product was observed in a first reaction, decomposition products 
were observed as well, and crystallization in order to purify the tertiary amine failed so far 
(Table 3, Entry 1). Sodium borohydride was used by Palmieri and coworkers for the opening 
of oxazines.136 This procedure, applied at 0 °C (Table 3, Entry 2) led to complete conversion 
to the desired ligand (R)-27 (Scheme 41). 
conditions
N
MeOH OH
OH
Me OH
OH
O
N
30 R-27
 
Scheme 41: Evaluation of the conditions for the selective benzoxazine cleavage. 
 
Table 3 
 Reagents Conditions Comment 
1 TMS-Cl/NaBH3CN CH3CN, -40 °C yield not determined 
2 NaBH4 0 °C quant. 
 
Attempts to carry out an analogous transformation starting from the N,N-bis(1-(2-
hydroxyphenyl)-ethyl)-amine (26) via the benzoxazine 29 to 31 failed, as did the experiments 
at nucleophilic ring opening of the benzoxazine ring 30 with a Grignard reagent (Scheme 42). 
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Scheme 42 
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II.7. Third approach: attempted racemic synthesis 
Salicylic aldehyde has been condensed with ammonium acetate in the presence of acetic acid 
to obtain the tricyclic structure 34a in 38% yield.137,138 This tricyclic structure opens a way for 
a convenient and short synthesis of racemic triphenolamines bearing three stereogenic 
benzylic centres (Scheme 43).  
O
OH O
ON
O
R R R
R
NH4OAc
reflux,
C6H6 or
C6H5CH3
34a R = H
34b R = 2-Ph
34c R = 2,4-ditBu 
R = H
R = 2-Ph
R = 2,4-ditBu 
 
Scheme 43 
 
To test the viability of this approach the tricyclic structure was repeated using ortho-phenyl 
and 3,5-tert-butyl substituted salicylic aldehyde and the corresponding products were isolated 
in 38% and 16% yield respectively. In the case of the phenyl substitution benzene had to be 
replaced by toluene and the reflux time was prolonged from 3 h to 16 h. In the case of di-tert-
butyl substitution the reaction had to be refluxed for 24 h to obtain a 16 % yield.  
Treatment of the tricyclic structure 34a with methyl magnesium chloride at -78 °C gave a 
mixture of the secondary and the tertiary amines 26 and 8 (Scheme 44). The crude 1H-NMR 
showed two main quartets for the benzylic methyl protons in a ratio of 1.2:1, which 
corresponded to the quartet of the meso- (4.2 ppm) and the C2-isomer (3.9 ppm) of the 
secondary amine.i Only very small quartets were observed more downfield which were 
assumed to be associated with the tertiary amine 8. The ESI-MS spectrum clearly showed a 
peak at m/z 378 ([M+H]+) for the tertiary amine in addition to that of the secondary amine.  
O
ON
O OH
N
Me
Me
Me
OH
OH OH
N
H
Me Me OH
+
34a 8
26
3 eq. MeMgCl
THF, 0 °C
 
Scheme 44 
                                                 
i
 This degradation has been observed in the reaction of P(OPh)3 with a triphenolamine ligand possessing three 
tert-butyl groups in the 5-position of the aryls.139  
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Even though decomposition was expected, attempts to purify this mixture by column 
chromatography gave only the two diastereomeric secondary amines. Attempts of a separation 
by crystallization were not successful.  
 
II.7.1. Attempted formation of Silatranes 
Since trisphenolamine derived silatranes exhibit good resistance towards hydrolysis (see 
introduction), the in situ formation of silatranes could be a possibility to isolate the silyl 
protected trisphenolamine ligands. Furthermore, the introduction of a chiral apical ligand 
would allow the separation of the two helical isomers. In addition, silatranes tend to be 
crystalline which would help to make the purification easier.72-74  
 
Treating the reaction mixture (Scheme 45) with methyltrichlorosilane did not lead to the 
desired silatrane 35 but the free secondary amines were recovered after work up. When the 
reaction was monitored by 1H-NMR, a clear upfield shift of the benzylic protons could be 
observed after methyltrichlorosilane was added. But after hydrolysis and extraction, again the 
secondary amines only were isolated.  
MeSiCl3
Si OOO
Me
N
MeMe
Me
O
Me
N
Me
OSi
MeO
O
N O +TMEDA
3 eq. MeMgCl
0 °C, THF
mixture of 
2° and 3° amine
34a
35
36
 
Scheme 45: Attempted formation of silatranes 
 
Although for asymmetric catalysis, it is highly preferable to have a stereogenic centre on all 
the bridging methylenes, this work has clearly shown that these ligands can not be isolated in 
a satisfying purity. The idea of the synthesis of a chiral trisphenolamine with three stereogenic 
centres has therefore been abandoned.  
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II.8. Coordination chemistry of N-(hydroxyphenylethyl)-N,N-bis-(hydroxy-
benzyl)amine 
II.8.1. Synthesis of an Iron(III) complex exhibiting a helicity controlled by central 
chirality 
The only tripodal triphenolamine ligand synthesized within the course of this work being 
suitable to act as a potential ligand is 27, incorporating one single benzylic stereogenic centre 
(Figure 23).  
The control of the intrinsic helical chirality by the introduction of a single stereogenic centre 
in one of the benzylic positions on a tripod ligand has been studied by Canary and coworkers 
on Zn(II) and Cu(II) complexes of tris(pyridylmethyl)amine ligands.140,141 Nonetheless, a 
chiral complex of the tripod trisphenolamine ligand 27 would be the first chiral complex of 
this structure.  
 
Me
N
OH
OHOH
R-27
 
Figure 23 
 
Following the literature precedent for formation of an air and moisture stable, monomeric and 
crystalline ferratrane, the trilithium salt of the enantiomerically pure ligand (R)-27 was treated 
with iron trichloride in the presence of 1-methylimidazole (1-MeIm) in methanol to obtain a 
dark red solution (Scheme 46).86 
Me
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O Fe
N
N
Me
1) MeLi (3 eq)
2) FeCl3
1-MeIm (3 eq)
MeOH
MeIm = 1-methyl imidazoleR-27 37
 
Scheme 46 
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Slow diffusion of toluene into a dichloromethane solution of complex 37 gave dark red 
crystals suitable for X-ray analysis (Figure 24).  
 
 
   
Figure 24: X-ray structure of 37. 
 
Figure 24 shows the X-ray structure of 37. The (R)-configuration on the benzylic position 
resulted in a (M)-helicity (Λ-rotation) of the ligand around the N-Fe-N axis.  
 
II.8.2. Formation of titanatranes 
 
Within the collaboration with the group of Prof. G. Licini, they have concentrated on the 
synthesis of trisphenolamine 38 possessing a single stereogenic centre on one of the bridging 
methylenes.  
 
The synthesis of ligand 38 was achieved by Licini and coworkers by a modified synthesis for 
achiral trisphenolamines shown in Scheme 47.142,143  
 
The complexation of ligand 38 with titanium tetraisopropoxide led to the formation of an 
enantiomerically pure titanatrane 39 for which the proton NMR showed a single species with 
clearly resolved signals at 0 °C, indicating that only one helical arrangement is present. Its 
application in the sulfoxidation reaction showed a very fast oxidation process but on the other 
hand almost no ee (2%) was obtained.144 
Λ 
Bottom view Side view 
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Scheme 47: Ligand 38 synthesized by the group of Prof. Licini. 
 
This result supports the idea, that the ligand is not capable to transfer the chiral information 
into the reaction centre due a nearly completely open space on the top of the catalyst.  
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II.9. Synthesis of a New Aminophenol 
II.9.1. Ortho-substitution: key for chiral induction 
The idea of the open reaction centre is illustrated in Figure 25 with a 3D model based on 
semi-empirical PM3 calculations.  
 
 
 
 
Figure 25 
 
 
Therefore, four new ligand structures were suggested, of which L4 was assumed to build the 
most effective cavity upon complexation (Figure 26) and hence lead to an extention of the 
helical chirality of the phenol groups into the reaction space. 
 
 
 
 
 
 
   L1            L2 
 
  
 
 
 
   L3            L4 
Figure 26: Proposed ligands (shown in model complexes) to improve stereoselectivity. 
 
Nielsen and coworkers145 concluded from the comparison of titanatrane 40 substituted by two 
tert-butyl groups at the 3 and 5-position of each phenol ring, with TiCl(OC6H6-2,6-Ph2)3146 
41, that phenyl substituents form a deeper pocket (Figure 27).  
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Figure 27 
 
An even more narrow pocket was created by Mindiola and coworkers who substituted the 
tris(phenol)amine ligand with adamantyl groups in ortho-position 42 and managed to remove 
the chlorine from the complex with AgOTf and finally exchange the triflate with BARF anion 
to create a formally 12 e- cationic titanium(IV) complex which was remarkably stable even by 
exposure of the salt to water or oxygen.147 
Considering these observations, the most promising candidate was therefore ligand L4. Hence 
a new aminophenol building block with an ortho-phenyl substitution had to be synthesized.  
II.9.2. Synthesis of a new aminophenol 
As it is outlined in the general introduction, it is most convenient to synthesize the 
aminophenol building blocks via the diastereoselective reduction under Luche conditions (see 
Chapter I).  
OH
Me
NH2
Ph
43
 
Figure 28: Proposed new aminophenol structure 
 
The benzylic alcohol 45 was obtained from 2-hydroxy biphenyl via aldehyde 4462 and 
subsequent alkylation in yields comparable to those reported for similar aminophenols, and 
oxidation afforded the ketone 46 in 42% yields (Scheme 48).38  
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Scheme 48 
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The ketimine 47 was formed in good yield by acid catalysed condensation using azeotropic 
removal of water. Reduction under Luche conditions afforded the secondary amine 48 in 79% 
yield with the (R,R) configuration with a diastereomeric excess of only 79% (determined by 
integration of the benzylic quartets in the 1H-NMR) (Scheme 49).  
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Scheme 49 
 
In view of unsuccessful attempts to improve the diastereomeric purity by crystallization as 
well as to shorten the route and to improve the overall yield, the diastereoselective alkylation 
method described in the introduction (Chapter I) was applied for the synthesis of 43. 
 
Starting with aldehyde 44, the phenol function was protected by formation of the benzylether. 
The following steps were carried out applying reported procedures.38 Condensation of 
aldehyde 49 with (S)-glycinol led to the formation of the aldimine 50 in good yield.  
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Scheme 50 
 
Methyllithium was added to the aldimine 50 at –78°C in THF to give the secondary amine in 
modest yield, but excellent selectivity (39:1) (Scheme 51).  
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Scheme 51 
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Oxidative cleavage of the chiral auxiliary provided the highly enantiomerically enriched 
aminophenols. 
 
Although this sequence is not fully optimized and in particular the benzyl protection group 
appears to cause difficulties in the alkylation step, the amine was obtained in high 
enantioselectivity.  
 
II.10. Formation of a tripod ligand using the new aminophenol building 
blocki 
In the collaboration with the group of Prof. Licini, the access to this new enantiomerically 
enriched chiral aminophenol allowed the synthesis of the new chiral trisphenolamine ligand 
52Â+&O via double nucleophilic substitution and debenzylation sequence previously used for 
ligand 38 (Scheme 47). Final complexation to titanium tetraisopropoxide led to the formation 
of titanatrane 54 (Scheme 52). 
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Scheme 52 
 
The crystal structure of the racemic analogue 55 synthesized by Licini and coworkers revealed 
that it forms a heterochiral dimer in the presence of traces of water. The two ligands on the µ-
oxo bridged dinuclear titanium complex exhibited opposite chirality (Figure 29).148 
 
                                                 
i
 This work has been carried out in collaboration with the group of Prof. Licini. 
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Figure 29: X-ray of 55.149 
 
In contrast, complex 54 did not show the formation of a dimer neither by MS spectroscopy 
nor by 1H-NMR, not even after water addition.  
II.11. Conclusion and Outlook 
Several attempts to synthesize a C3-symmetric chiral trisphenolamine ligand 8 with three 
stereogenic benzylic centres have revealed that this structure lacks of stability for being 
considered as a good ligand. The successful introduction of a single stereogenic centre by two 
different routes allowed the formation of a chiral trisphenolamine based ferratrane and a 
titanatrane. Further investigations will show the potential of ligand 54 in asymmetric 
catalysis, and whether the three phenyl groups in ortho-position efficiently transmit the chiral 
information into the reaction centre.  
N
OH
OHOH
R*
R*
R*
 
Figure 30 
 
A different approach to chiral trisphenolamine ligands would be the introduction of chiral 
ortho-substituents (Figure 30).  
The behaviour of the chiral complex 54 indicates a self-discrimination process between two 
enantiomeric species in the formation of the µ-oxo complex. This fact could be of great 
interest in supramolecular recognition chemistry.  
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III. Synthesis of New [N2O2]-tetradentate Ligands 
III.1. Salen-type Ligand, an Introduction 
Another large class of nitrogen based ligands are the Schiff bases, exhibiting good 
coordination properties. One of the most prominent Schiff base ligands is the salicylaldehyde 
derived salen ligand (N,N’ -bis(salicylaldehydo)ethylenediamine), easily accessible from 
commercially available building blocks, easily tunable and one of the so called privileged 
ligands because of its high efficiency in the transfer of chiral information in a variety of 
different reactions.6 
The history of the salen ligand goes back to 1889, when the first salen ligand and copper 
complex were discovered.150 Since then, salen derived ligands have been studied widely. The 
tetradentate coordination of this ligand resembles the porphyrin framework and hence, 
inspired by cytochrom P450, complexes bearing a salen ligand were used as biomimetics for 
oxidation reactions.151,152 
The first application of a chiral salen ligand was reported in the 1990’ s by Jacobsen and 
coworkers.153,154 The chiral manganese(III) salen complex catalysed the oxidation of 
unfunctionalized olefins with high levels of enantioselectivity (Scheme 53). Nowadays this 
catalyst is still one of the best catalysts for asymmetric epoxidation of (Z)-di- and 
trisubstituted alkenes. 
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Scheme 53: Asymmetric epoxidation with manganese(salen) complex. 
 
(Jacobsen, 1991) 
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The same ligand was found to be highly efficient in a variety of other systems, involving 
different metal centres. The most important examples are listed below (Scheme 54).  
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heme 54: Reactions catalysed by a metal salen complex. 
 
The ring opening of meso-epoxides was successful with a chromium(salen)azide (A), but also 
cobalt(salen) benzoate furnished the corresponding addition product.155,156 Chromium was 
also used for hetero Diels-Alder reactions (B).157 And in the 1,4-addition of carbon and 
nitrogen centred nucleophiles, an aluminium(salen) catalyst (C) showed high efficiency.158 
 
In the 1990’ s, Katsuki presented a similar version of a salen type ligand, containing two 
additional axial chiral binaphthyl groups (Figure 31).159 This catalyst was used for the 
asymmetric epoxidation of unfunctionalized olefins, but asymmetric induction seems to be 
less effective than in the Jacobsen’ s system.  
(Jacobsen, 1997) 
(Jacobsen, 1998) 
(Jacobsen, 2005) 
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Figure 31: Katsuki’s ligand for asymmetric epoxidation of unfunctionalized olefins. 
 
Recently, Bolm reported an interesting variation (Figure 32).160 These ethylene- and aryl-
bridged bissulfoximines were originally investigated for their likeness to salen ligands. The 
corresponding oxo-vanadium complex showed high activity in sulfoxidation reaction, but the 
product was obtained in racemic form.  
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Figure 32: Bissulfoximine oxovanadium complex synthesized by Bolm. 
 
As a consequence, the ligand has been modified; in particular the phenolic groups were 
replaced by 2-methoxynaphthyl. This ligand now showed excellent enantioselectivity in the 
copper-catalyzed asymmetric hetero Diels-Alder reaction.161,162  
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Scheme 55: Modified bissulfoximine ligand.  
 
The striking difference in Jacobsen’ s and Bolm’ s ligand is the position of the stereogenic 
centre. Whereas the chirality induction in the salen ligand is directed from a stereogenic 
ethylene bridge, in Bolm’ s ligand it comes from the stereogenic sulfoximine side arms. 
(Katsuki, 1993) 
(Bolm, 1996) 
(Bolm, 2005) 
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III.2. Combination of Jacobsen’s and Bolm’s Ligand: New [N2O2]-Ligand  
Virtual merging of Jacobsen’ s and Bolm’ s ligand would give an interesting combination. The 
stereogenic centre would be in the benzylic position, as it was in Bolm’ s ligands, whereas the 
sulfoximine is replaced by a simple imine. The resulting ligand could be readily accessible 
from the aminophenol building blocks (Scheme 56). 
 
OH
N N
OH
R R
N NS S
OH OH
Tol
TolO
ON N
Bu OH
Bu Bu
OHt
t t
tBu
 
Scheme 56: Combination of Jacobsen’s and Bolm’s Ligand: New [N2O2]-tetradentate ligand. 
 
III.2.1. Structural comparison 
The high efficiency of the salen ligand is believed not to come directly from the cyclohexane, 
but from the stepped conformation of the complex, which is induced by the diamine backbone 
(Figure 33, A. tert-Butyl groups in 3,3’  and 5,5’  of the salen ligand and hydrogens are omitted 
for clarity).163,164 A model of the postulated ligand shows, that the stepped conformation is 
clearly present, directed by the benzylic stereogenic centres (B).  
 
 
 
Bolm Jacobsen 
CHAPTER III 
New [N2O2]-tetradentate Ligands 
 
57 
 
 
                 
O
N N
O
Mn
Cl
O
O
N N
O
Mn
Cl
O
A B
 
Figure 33. Comparison of the chiral influence of the complexed cyclohexyl-salen (A) and the new ligand 
(B). 
 
III.2.2. Basic discussion about ring-chain tautomerism of oxazines and benzoxazins. 
One of the basic principles which accompanies all imine formations with 
1-(2-hydroxyphenyl)-ethylamine lies in the ring-chain tautomerism of 1,3-oxazines. The 
condensation of a ketone or an aldehyde with an aminophenol building block forms an 
ortho-hydroxybenzylidene imine, in which the ortho-hydroxy group stands favourable for an 
6-endo-trig attack on the imine carbon. The cyclized benzoxazine stands in equilibrium with 
its open chain from.  
In general, ring-chain tautomerism strongly depends on solvent and temperature as well as on 
the aldehyde precursor to from the imine.165-169 In the equilibrium between Schiff base (A) 
and benzoxazine (B) derived from aromatic aldehydes with different acceptor or donor aryl-
substituents (Scheme 57), the ratio goes from 51% ring-form for acceptor (X = p-NO2) to over 
90% chain-form for donating substituents (X = p-iPr, p-NMe2).166,168 
 
 
 
front view 
side view 
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Scheme 57: Ring-chain tautomerism of aryl aldimines 
 
The condensation with aliphatic aldehydes like acetaldehyde, isobutyraldehyde or 
cyclohexane carbaldehyde led in all cases to a ratio of over 9:1 in favour of the benzoxazine 
(B) (Scheme 58).166  
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Scheme 58: Ring-chain tautomerism of aliphatic aldimines 
 
Kanatomi and Murase described the ring-chain tautomerism of bibenz-1,3-oxazines B/B’ with 
the double Schiff base A as outlined in Scheme 59.170  
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Scheme 59: Ring-chain tautomerism of bibenz-1,3-oxazines 
 
In CCl4 only a mixture of both tautomers of bibenzoxazine was observed in the 1H-NMR for 
both R = Me and (CH2)4. In contrast, in pyridine a mixture of Schiff base to oxazine of 4:1 
was found. Whereas in a solution of bibenzoxazine in chlorobenzene at 40 °C only the 
oxazine was present, at 120 °C an equilibrium of oxazine-Schiff base in favour of the Schiff 
base was observed by 1H-NMR.  
These observations led to the conclusion that the double Schiff base ligand can be observed in 
dry, aprotic polar solvents. Additionally, heat can support the formation of the Schiff base.  
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III.3. Results 
Due to the above mentioned reason, the synthesis of a stable, non-tautomerizing double Schiff 
base ligand derived from the 1-(2-hydroxyphenyl)-alkylamine is a challenge itself. Therefore 
this section concentrates on the synthesis of such ligands.  
First, the diimine formation with the methyl protected aminophenol was elaborated. This 
allowed to rule out the ring-chain tautomerism and to study just the steric influence of the 
benzylic substituent.  
 
The formation of a diimine starting from the 1-(2-methoxyphenyl)-ethylamine (1b) building 
block was achieved by condensation (Scheme 60). If the reaction is carried out at 23 °C, the 
initially formed diimine oligomerizes, and therefore a complex mixture was obtained.i 
Running the reaction at 0 °C provided the diimine 56 in a yield of 95%. 
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Scheme 60: Double condensation of the methyl-aminophenol 1b. 
 
The same procedure was applied for the sterically hindered amine 5b. In this case, the diimine 
57 was formed in excellent yields at 23 °C (Scheme 61). Even though imines normally are 
difficult to purify, a simple extraction of the crude mixture with cyclohexane removed the 
sideproduct formed by the condensation of the amine with partially oxidized glyoxal and 
provided a clean product. 
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Scheme 61: Double condensation of the tert-butyl-aminophenol 5b. 
 
                                                 
i
 For a detailed discussion about oligomerization and hexaazaisowurtzitane formation with primary amines and 
glyoxal see ref171. 
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III.3.1. Synthesis of non-tautomerizing salicylamine derived double Schiff base 
tetradentate [N2O2]-ligands 
Being well aware of the ring-chain tautomerism (vide supra), (R)-1-(2-hydroxyphenyl)-
ethylamine 1a was allowed to react with glyoxal. As expected, even at 0 °C only a complex 
mixture was observed (Scheme 62). 1H-NMR reveals that the desired double Schiff base is 
not detectable in this mixture. In addition the 1H-NMR spectrum indicates that the 
benzoxazine oligomerizes. 
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Scheme 62: Double condensation of 1-(2-hydroxyphenyl)-alkylamines. 
 
In contrast, (S)-1-(2-hydroxyphenyl)-neopentylamine 5a reacted cleanly to the double Schiff 
base 58 (Scheme 62). The bulky tert-butyl groups prevented not only oligomerization, but 
also cyclization. Only traces of benzoxazine signals (<1%) were observed in the 1H-NMR.  
 
III.3.2. Complexation assays. 
With the double Schiff base in hand, the synthesis of different complexes was envisaged in 
order to gain some insights in its behaviour in coordination chemistry and catalysis. 
 
For the formation of a neutral complex with a +II metal ion, Cu was chosen for its high 
affinity for N/O-ligands and Ni because it enables a 1H-NMR analysis of the complexed 
ligand. 
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Mixing a hot ethanolic solution of the ligand with a hot ethanolic solution of the metal salt, 
gave in both cases an immediate formation of a dark green (in the case of Cu) and a dark red 
solution (in the case of Ni) respectively, and after cooling a precipitate was formed (Scheme 
63). The Cu-complex 59a and the Ni-complex 59b were confirmed by ESI-MS.  
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Scheme 63: Complexation of the new [N2O2]-ligand.  
 
No complex formation was observed in case of manganese acetate. In addition, the ligand 
appeared to become susceptible for hydrolysis under the given conditions, and only the 
primary amine 5a was isolated. Crystallization of the complexes 59a or 59b was not 
successful. 
III.3.3. A new chiral tetradentate ligand with a benzil diimine backbone 
As described in the introduction of this chapter, the major problem of this new class of 
tetradentate ligands is the ring-chain tautomerism. This equilibrium is dependent not only on 
external factors, but also on the substituent in the α-position of the imines. An electron rich 
aromatic substituent stabilizes the double Schiff base. Furthermore, an aromatic substituent 
would increase the stability of the imine towards hydrolysis. 
Diimine 60 could therefore be a solution to the encountered problems (Figure 34). The two 
phenyl groups on the backbone should both favour the double Schiff base and increase the 
stability towards hydrolysis.  
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Figure 34: Proposed non-tautomerizing double Schiff base ligand 60. 
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Initial trials to perform a double condensation of amine 1a and benzil were unsuccessful. Only 
the monoaddition product was obtained after two days refluxing in toluene in presence of a 
catalytic amount of p-toluene sulfonic acid (Scheme 64). 
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Scheme 64: Unsuccessful double condensation of 1-(2-hydroxyphenyl)-methylamine and benzil. 
 
The same was observed when exchanging toluene and p-TSA by methanol with 20 mol% of 
acetic acid and 3Å MS. Consequently another strategy had to be found.  
A possibility was to protect the phenol functionality, which allowed applying forcing Lewis 
acid conditions. A methanesulfonyl protection would allow the deprotection in the presence of 
the imines under mild conditions, i.e. treatment with LDA at 0 °C.172 
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Scheme 65: Protection of the phenol with a methanesulfonyl group. 
 
Therefore the (R)-1-(2-hydroxyphenyl)-ethylamine 1a was first selectively protected on the 
more nucleophilic amino group with a tert-butyloxycarbonyl group (BOC). Subsequent 
treatment of 61 with mesylchloride in tetrahydrofurane in the presence of triethylamine 
allowed the complete conversion to the mesylated phenol 62. The amine protection was then 
removed by a dioxane solution saturated with hydrochloric acid to give the mesyl protected 
aminophenol as the ammonium salt 63.HCl in 96 % yield over 3 steps (Scheme 65).  
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A) 298 K 
 
 
B) 383 K 
 
 
C) 298 K 
Titanium(IV) tetrachloride smoothly converted the aminophenol 63 into the corresponding 
diimine 64 in 4 days in over 96 % yield, using a 20 fold (2 x 10 fold) excess of the amine with 
respect to benzil. The final diimine 60 was obtained in 80% yield by deprotection of the mesyl 
group of diimine 64 using LDA at 0 °C (Scheme 66).  
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Scheme 66: Synthesis of the benzil bridged double Schiff base ligand 60. 
 
Interestingly, diimines 64 and 60 both form mixtures of two isomers, most probably two 
atropic isomers with restricted rotation around the bridging C-C bond. While the two isomers 
of diimine 64 can be separated by column chromatography, diimine 60 forms an inseparable 
mixture in a ratio of 2:1 at ambient temperature (Spectrum A; Figure 35). To test whether 
these isomers interconvert on heating, diimine 60 was heated in toluene. The VT-NMR 
revealed that at 383 K, it equilibrates to a 1:1 mixture, as can be seen on the aromatic signal at 
6.0 and 6.1 ppm (Spectum B, Figure 35).  
 
Figure 35: VT-NMR of diimine 60 at 298 K (A), 383 K (B), control-measurement 298 K in d8-toluene (C). 
 
In the control-NMR measurement again at room temperature (298 K), a mixture of 1.7:1 was 
observed (Spectrum C; Figure 35). This evidence supports the assumption of two 
atropoisomeric structures. 
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III.3.4. Attempted complexation with ligand 60.  
Under identical conditions as described for ligand 58, complexation of the diphenyl-
substituted ligand 60 with nickel acetate did not proceed to the desired Ni-([N2O2])-complex. 
Probably due to gauche interactions of the two phenyls as well as the allylic strain between 
the phenyl and the adjacent benzylic methyl group, chelation might be difficult.  
 
III.3.5. Application of diimine ligands in asymmetric transition metal catalysed reactions 
Ligand 58 was tested in the dimethyl zinc mediated acetylenation of benzophenone with 
phenylacetylene.173 While with the original salen complex 72% yield and 61% ee were 
obtained, with ligand 58 the reaction did not proceed at all. 
 
In seeking new asymmetric transition metal catalysed reactions, the diimine ligand 57 also 
was applied in the copper catalysed aziridination. Although good activity was observed, an ee 
of only 6% has been observed.  
 
III.4. Conclusion and Outlook 
Despite the difficulties related to these new ligands, it was possible to isolate two new [N2O2]-
ligands, in which the ring-chain tautomeric equilibrium was shifted entirely to the double 
Schiff base for ligand 60, and to >99% for ligand 58.  
 
Although ligand 60 showed difficulties in complexation with Ni acetate, irradiation or heating 
might help the formation of new complexes. Further substitution on the aryl ring might be 
necessary to give an efficient ligand.  
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IV. A New Rigid Phosphoramidite Ligand 
IV.1. Introduction 
Following the success of chiral bidentate phosphine and phosphine/nitrogen ligands, recent 
attention has shifted to include chiral monodentate ligands of the phosphoramidite family.  
Phorsphoramidite ligands are easily modifiable even in high throughput experimentations 
(HTE)3 and they show good enantioselectivities in a variety of asymmetric reactions. 
Probably the most successful structure of a phosphoramidite was introduced by Feringa in 
1996.  
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Figure 36: Representative phosphoramidite ligands. 
 
Although known earlier (Alexakis, 1993)174, phosphoramidites came to the fore with a report 
by Feringa on high enantioselectivity in asymmetric copper catalyzed conjugate addition 
reaction (Scheme 67).175 It is noteworthy that this kind of compounds was initially developed 
as a shift reagent for chiral alcohols, amines and thiols by means of 31P-NMR.175,176 It 
includes the axially chiral BINOL structure and a nitrogen fragment bis(phenylethyl)amine 
bridged by phosphorous (Figure 36). 
Thereafter, one new application followed the other and only a few are shown here to illustrate 
the potency of this ligand class.  
In 2000, Feringa published the rhodium catalyzed asymmetric hydrogenation of 
dehydroamino acid and itaconic acid derivatives with a modified phosphoramidite ligand 
allowing a different approach to enantioenriched α-chiral acids (Scheme 67).177  
(Feringa, 1996) (Alexakis, 2004) (Kündig, 2006) 
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Scheme 67 
 
The efficiency of a slightly modified Feringa-type ligand has been demonstrated to be highly 
enantioselective in the iridium catalyzed asymmetric allylic substitution reaction by Alexakis 
and coworkers (Scheme 68).51,54 The ligand proofed to be highly successful also in rhodium 
catalysed asymmetric hydrogenation, iridium catalyzed asymmetric allylic amination and 
hydrosilylation. The desymmetrisation of 5,8-dibromonaphthalene chromium tricarbonyl was 
achieved via kinetic resolution by the group of Kündig and coworkers with a more bulky 3,3-
Phenyl substituted phorphoramidite.178 
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P N
Me
MeBr
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Cr
COOC
OC Cr
COOC
OC
R X R
CH(CO2Me)2
Br
Cr
COOC
OC
(Sa,S, S)
Pd(dba)2 (5 mol%)
L* (20%)
LiBH4
DME, -10 °C
78%, 97% ee
[Ir(COD)Cl]2 (2 mol%)
L* (4 mol%)
NaHC(CO2Me)2
THF, LiCl up to 98% ee
regio up to >99:1
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+
 
Scheme 68 
 
These phosphorous ligands exhibit reduced donor strength and find increasing interest for the 
use in catalytic processes. However the diversity of chiral monodentate electron deficient 
ligands is quite narrow and therefore new structures have to be found.  
 
(Feringa, 1997) 
(Feringa, 2000) 
(Alexakis, 2004) 
(Kündig, 2006) 
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IV.2. Concept: 
 
As it was outlined in chapter II, the secondary amine 26 is readily available. The two phenolic 
groups and the secondary amine are in a perfect situation to chelate a phosphorous in between 
(Scheme 69). This would allow constructing a new type of a chiral phosphoramidite ligand, 
creating a completely different environment than the above mentioned members of this ligand 
class.  
 
N
H
Me Me
OH OH
N
Me Me
O OP
(R,R)-26 (R,R)-65
 
 
Scheme 69: Proposed synthesis of a new rigid phosphoramidite.  
 
IV.3. Synthesis, Conformational Analysis and Application of the New 
Phosphoramidite Ligand 
IV.3.1. Synthesis 
 
The new rigid phosphoramidite ligand 65 was prepared from the C2-symmetric secondary 
amine 26 by slight modification of the literature procedure for the synthesis of known 
phosphoramidites as shown in Scheme 70. Treatment of the secondary amine 26 (synthesis 
see chapter II) with phosphorous trichloride in the presence of triethylamine leads to the 
desired phosphoramidite. Surprisingly, unlike the known structures of the Feringa-type 
phosphoramidites, this compound is readily oxidized upon short contact with air. Therefore, it 
was conveniently isolated in its borane protected form 65.BH3 by using BH3.Me2S solution (1 
M in THF) as a shelf-stable, crystalline solid in 67% yield. 
 
N
H
Me MeOH OH
N
Me Me
O OP
BH3
N
Me Me
O OP
(R,R)-26
1) PCl3/Et3N
    THF, 0 °C, 12 h
2) BH3.Me2S
    toluene, -78 °C
    12 h, 67 % (R,R)-65(R,R)-65.BH3
DABCO
50 °C, 12 h
52 %
31P-NMR: 113 ppm
 
Scheme 70: Synthesis of a new phosphoramidite ligand. 
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Decomplexation of this complex was readily carried out by treatment with DABCO, 
furnishing cleanly the phosphoramidite 65. The phosphorous signal in the 31P-NMR spectrum 
shows a resonance at 113 ppm. Compared to the Feringa type phosphor-amidite ligands (31P-
NMR shifts in the range of 142 to 155 ppm) this value is remarkably upfield and may be 
indicative of strain in the ring structure. 
 
IV.3.2. Application in catalysisi 
The new phosphoramidite ligand was then applied in a couple of reactions. As described 
above, one of the first reactions in which phosphoramidites were used is the copper catalyzed 
asymmetric conjugate addition of diethyl zinc to cyclohexenone.175,180 
When phosphoramidite ligand 65 was applied in this reaction (Scheme 71), the reaction 
proceeded smoothly in the presence of 2 mol% of copper acetate and 4 mol% of ligand 65. 
Unfortunately the enantiomeric excess did not exceed 9%.  
 
O
N
Me Me
O OP
O
Et*
Et2Zn
Cu(OAc)2.H2O (2 mol%)
L* (4 mol%)
toluene, -30 °C, 3 h
(R,R)-65
> 98 %, 9 % ee
 
Scheme 71 
 
Recently, Johansen and coworkers have reported a highly enantioselective hydrosilylation 
reaction of aromatic alkenes.181 The new chiral phosphoramidite ligand was tested under 
identical conditions to evaluate its efficiency in selectivity and activation of the palladium 
catalyst (Scheme 72). With 1 mol% of catalyst, styrene underwent smooth hydrosilylation 
affording 100% of the silylated product as evident from 1H-NMR spectra. Upon oxidation 
under Tamao conditions, the alcohol was obtained in good yields albeit in low enantiomeric 
excess of 37%.  
 
                                                 
i
 These experiments were carried out in collaboration with Dr. Madhushaw Reniguntala179. 
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HSiCl3, L*, 12 h
[Pd(η3-C3H5)Cl]2
[O]
16 h
> 98%, 99% ee 174
* *
(SA,R,R) (R,R)-65
[O] = KF/KHCO3/H2O2
> 98%, 37% ee
 
Scheme 72: Application of ligand 65 in the hydrosilylation of styrene. 
 
IV.3.3. X-ray crystal structure of the new chiral monodentate phosphoramidite ligand. 
As shown above, ligand 65 performed poorly – i.e. it did not provide the hoped-for high 
asymmetric induction. 
Figure 37 shows a model (MM2) of the phosphoramidite borane complex. Based on this 
model, and knowing that in phosphoramidites the nitrogen atom adjacent to the phosphorous 
atom tends to be (almost) planar,182 a conformational analysis predicts that the 1,3-strain of 
the benzylic substituents would favour an umbrella shaped conformation.  
 
 
Figure 37: Phosphoramidite borane complex model 
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This prediction however turned out to be false in solid state. An X-ray analysis of the borane 
complex (Figure 38) revealed, that the folding of the aryls much exceeds prediction and that 
as a consequence the methyl groups at the stereogenic centers are pseudo-equatorial and point 
away from the reaction zone.  
 
Figure 38: X-ray structure of the new phosphoramidite ligand in a borane complex.  
 
IV.4. Conclusion and Outlook 
A new core structure of a phosphoramidite ligand has successfully been synthesized. Its 
application in asymmetric catalysis showed modest chiral induction in the hydrosilylation of 
styrene.  
 
The crystal structure of this new ligand revealed that the reverse umbrella conformation 
arranges the methyl groups pointing away from the reaction centre. Therefore a transfer of 
chiral information appears to be rather difficult. 
These conclusions and observations are based on the ligand borane complex in the solid state 
and a transposition to the situation in a metal complex in solution is not necessarily adequate. 
Further build-up of constraints in the 6 position of the phenyl fragment may force the 
conformation to be in the expected umbrella form (Figure 39).  
 
N
Me Me
O OP
R R
 
Figure 39: Modification of the phosphoramitie ligand. 
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V. New Bulky C2-Symmetric NHC-Ligands for Pd-Catalysed 
Asymmetric Intramolecular D-Arylation of Amides 
V.1. Carbenes as Ligands 
V.1.1. History of N-Heterocyclic Carbenes as Ligands 
The coordination chemistry of N-heterocyclic carbenes (NHC) as ligands was introduced by 
Öfele and Wanzlick independently when they published the structures and preparations of the 
chromium and mercury complexes respectively, both containing NHC ligands 
(Figure 40).183,184 It was subsequently mainly Lappert who extended first the coordination 
chemistry of these interesting ligands – an example is the rhodium complex shown in 
Figure 40.185,186 
 
N
N
Me
Me
Cr(CO)3
N N
Hg2+
N N
Ph
PhPh
Ph
2 ClO4
N
N
Rh
Cl
Me
Me
 
 
Figure 40: First NHC-complexes. 
 
Only little attention has been drawn towards these ligands until Arduengo presented the first 
isolation and characterization of the free and stable N-heterocyclic carbene shown in Figure 
41.187 The fact that these ligands can be isolated and their properties when coordinated to 
metals or as organocatalysts made these carbenes extremely important in the field of 
organometallics and organic synthesis.  
 
N N AdAd
..
 
 
Figure 41: First free and isolated Carbene. 
(Öfele, 1968) (Wanzlick, 1968) (Lappert, 1975) 
(Arduengo, 1991) 
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V.1.2. Description of Carbenes 
Besides the three most common reactive carbon intermediates, carbanions, carbocations and 
carbon radicals, carbenes were the last structures isolated in a stabilized form. One of the 
reasons of the high reactivity lies in the fact, that they exhibit a sextet in their valence shell 
and are divalent. Carbenes can adopt either a linear (sp-) or a bent (sp2-hybridized) geometry 
(Figure 42). Whereas sp-hybridized carbenes exhibit two non-bonding degenerated orbitals px 
and py, bent sp2-hybridized carbenes feature an unchanged py (called ppi) and an sp2-type 
orbital (called σ).  
 
E
px, py ppi
σ
 
Figure 42: Frontier orbitals depending on the carbene geometry. 
 
The two nonbonding electrons can be distributed into these two orbitals in different ways 
(Figure 43). One electron in each orbital with the same spin orientation gives a triplet state 
(σ1ppi1). If the two electrons are spin paired, they can be either located in the σ-orbital (σ2) 
(generally the more stable configuration), or in the ppi-orbital (ppi2). But also an excited state 
could be envisaged with the electrons located in the σ and in the ppi-orbital (σ1ppi1).  
 
 
 σ1ppi1 σ2 ppi2 σ1ppi1 
 3B1                                   1A1                  1A1                    1B1 
Figure 43: Electron configurations on carbenes. 
 
The ground state spin multiplicity determines the reactivity of carbenes. Single carbenes 
possess an empty and a filled orbital and show therefore an ambiphilic (nucleophilic and 
electrophilic) character. They are generally favoured if the σ-ppi-energy gap is higher than 
2 eV.188 On the other hand, a small energy gap of less than 1.5 eV favours a triplet carbene, 
which exhibits two half occupied orbitals and therefore behaves in general as a diradical.  
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V.1.3. Stabilization of Carbenes 
Carbenes can be stabilized by electron withdrawing neighbouring groups (inductive effect) or 
by pi interaction, where the ppi-orbital overlaps with neighbouring ppi-orbitals (carbene 
mesomeric stabilization). To a smaller extent also sterics affect the stability of carbenes.  
a) Inductive Effect 
The effect of electron withdrawing substitutions has been studied by Harrison189,190 and 
Schäfer191 on the basis of calculations and this has been re-examined more recently.192 
Nowadays it is well established that the electronegativity of σ-withdrawing substituents 
influences the carbene spin multiplicity. The substitution of the carbene with lithium ions 
leads to a triplet carbene, whereas in presence of electron-withdrawing substituents (fluorine 
as the extreme), the singlet ground state is favoured. This was rationalized on the basis of 
perturbation orbital diagrams (Figure 44).188 
2p
X,X
b1
a1
b1
a1
Y,Y
2s
C
ppi(b1) ppi(b1)
σ(a1)
σ(a1)
b2
a1
b2
a1
X X Y C Y
.
.
..
 
 
 
Figure 44: Perturbation orbital diagrams (for the symmetry C2v), showing the influence of the inductive 
effects. Adapted from 188. 
 
As shown in the diagram, if the two substituents X on the carbene are σ-electron-withdrawing 
substituents (as it is the case for NHC-carbenes, where X is nitrogen), the s character of the σ-
orbital of the carbene is increased, the σ-ppi-gap increases and therefore the singlet carbene is 
stabilized (a). In contrast, a σ-electron-donating substituent (e.g. lithium) reduces the s 
character of the nonbonding σ-orbital, raises its energy level and reduces the σ-ppi-gap. A 
triplet carbene gets favoured (b).  
(a) σ-electron-withdrawing substituents            (b) σ-electron-donating substituents 
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b) Mesomeric Effect 
More important for the NHC-ligands is certainly the resonance stabilization of the empty ppi-
orbital. This effect again can also be explained by the perturbation orbital diagram (Figure 
45). 
ppi(b1)
σ
b1
a2
ppi
σ
C
b2u
σ,b2u
px,py
C
σ, b2u
b3u
C
Z,Z
X,X
ppi,b3u
b3g
b3g
b2u
Z
X
b2, a2
b2u
b3u
px,py
ppi,b3u
b2u
X: pi-electron-donating; Z: pi-electron-withdrawing substituents
A) B) C)
 
Figure 45: Perturbation orbital diagrams (C2v and D2h) showing the influence of the mesomeric effects. 
Adapted from 188. 
 
Three different situations can be considered: 
A) (X,X)-Carbenes (where X is a pi-electron donating substituent such as nitrogen) are 
predicted to be bent singlet carbenes.192 The carbene is stabilized by the pi-donation of one of 
the substituents X into the empty ppi-orbital. The nonbonding σ-orbital stays unchanged. 
NHCs belong to this group.193,194 
B) (Z,Z)-carbenes (Z is a pi-electron withdrawing substituent such as boron) are predicted to 
be linear.195 The pi-electron withdrawing substituent interacts with the filled py-orbital of the 
carbene, whereas the px-orbital is not affected. This eliminates the degeneracy of the px and 
py-orbital and stabilizes a singlet carbene. A representative for this group of carbenes are the 
diboryl-196 and the biscarbomethoxycarbene.197 
C) (X,Z) carbenes (X is a pi-electron donating and Z a pi-electron withdrawing substituent) 
combine both interactions. The X substituent interacts with the empty py-orbital, whereas px-
orbital interacts with the empty orbital of Z. Both interactions stabilize the singlet state and 
favour a linear carbene. Aminocyanomethylene198 and phosphinosilylcarbenes199 belong to 
this group. 
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A visualization of the combination of inductive and mesomeric effects is shown in Figure 46. 
It is also clear that the electroneutrality is preserved by a push-pull interaction, which was 
proposed to be necessary for stable carbenes.200  
..
..
..
.. ..
..
diaminocarbenes diborylcarbenes phosphinosilylcarbenes
 
Figure 46: Push-Pull interactions for carbene stabilization.
c) Steric effects 
Due to the expansion of the carbene angle, bulky substituents in general force a linear 
geometry and therefore favour the triplet state. This is the case for di(tert-butyl)- and 
diadamantyl-carbenes, which both are triplet carbenes with wide carbene bond angles (143° 
and 152° respectively).201,202  
 
V.1.4. Synthesis of NHC precursors 
To the class of N-heterocyclic carbenes belong mainly the following four heterocycles shown 
in Figure 47: Imidazolylidenes A, imidazolinylidenes B, triazolylidenes C and pyrazolyl-
idenes D. They are accessible either via deprotonation or via small molecule abstraction from 
the corresponding neutral heterocyclic carbene precursor (as outlined in the following 
paragraphs).  
 
NNR R
..
NNR R
..
N
NNR R
..
N
NR R
R
..
A B C D
 
Figure 47: Different NHCs.  
 
Due to the topic of the present research, the following discussions concentrate on structures A 
and B.  
Most of the NHC-precursors, in general the imidazolium salts, or neutral derivatives thereof, 
are easily synthesized by the following methods: 
A one pot reaction of a primary amine, glyoxal, formaldehyde and an acid, normally HCl or 
HBF4 (Scheme 73).203-206 
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O
O
H
H
+ R NH22 +
O
H H
HX
- 3 H2O
NN
+
RR
X
 
Scheme 73: One pot procedure for imidazolium salt formation. 
 
A stepwise procedure generates first the diimine. This is then cyclized with formaldehyde or 
chloromethylethylether (Scheme 74 ).  
 
O
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EtOCH2Cl
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X
NN
HH
R R-H2O
 
Scheme 74: Stepwise formation of imidazolium salts. 
 
For highly bulky amines or for electron deficient bisimines, the cyclization to the imidazolium 
salt was achieved using silver triflate and chloromethyl pivalate (Scheme 75).207  
AgOTf
chloromethyl
-pivalate
XO
N N
O
Bu But t
N
+
O
N
O
BuBut t
 
Scheme 75: Lewis acid assisted cyclization to the imidazolium satl. 
 
Diimines can be difficult to access due to oligomerization. A switch in the order of addition 
can help. The methanediamine can be formed first, followed by ring closure with glyoxal and 
an acid catalyst (Scheme 76). 205 
 
O
H H
+ R NH22
glyoxal
NN
+
RR
X
N
H
RN
H
R
-H2O
 
Scheme 76: Reversed condensation sequence for imidazolium salt formation. 
 
In a modification of the one pot sequence, added ammonium chloride leads to the imidazol, 
which can be alkylated to form asymmetric imidazolium salts (Scheme 77).208  
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Scheme 77: Synthesis of unsymmetrical azoles. 
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This strategy can be further used for the substitution on the first nitrogen. The use of 
potassium imidazolide allows for nucleophilic substitution of imidazole (Scheme 78, Eq. 1). It 
is also possible to introduce a first aromatic substituent via copper-catalysed coupling reaction 
of aryl iodides and imidazole (Eq. 2).209 
 
NNRKN N
NH N NNAr
R-X
Ar-X
Cu(I)
(Eq. 1)
(Eq. 2)
 
Scheme 78: Introduction of the first substituent via SN or Cu-catalyzed N-arylation. 
 
The ring closure of 1,2 diamines (e.g. derived from the Pd catalysed Buchwald-coupling) with 
ortho-formate also furnishes imidazolium salts (Scheme 79).210 
HC(OEt)3
NH4+BF4-
- 3 EtOH, -3 NH3
NN
+
X
N
H
N
HR R
R R
 
Scheme 79: Cyclization with triethyl-ortho-formate. 
 
Another method for the synthesis of imidazolium salts is the condensation and cyclisation of 
an isonitrile with an imine (Scheme 80).  
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Scheme 80: [3+2]-cycloaddition for imidazolium salt formation. 
 
The advantage of this system is the possibility to introduce a substituent in position 4.211 
 
CHAPTER V 
Carbene Based Ligands From 1-(2-Methoxyphenyl)-alkylamine 
 
78 
V.1.5. Formation of carbenes 
There are different ways to access the N-heterocyclic carbene ligands from their precursors: in 
situ deprotonation by basic metallates, thermolysis of small molecules from neutral ligand 
precursors, and cleavage of the electron rich olefin of a dimerized carbene.  
a) Deprotonation by a basic ligand  
A basic metal bound ligand can be used to in situ deprotonate the imidazolium. An example is 
the at that time unexpected outcome of Öfele’ s chromium reaction, that led to formation of the 
first NHC-chromium complex.  
N
N
+
Me
Me
H
X
N
N
+
Me
Me
Cr(CO)5
[HCr(CO)5]
heat, -H2
 
Scheme 81: Formation of first NHC-chromium complex by Öfele.183 
 
Wanzlick and Herrmann synthesized their complexes by using a similar strategy. The acetate 
ligand from the metal source acts as a Brønsted base (Scheme 82).184,212 
N N
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Scheme 82: Deprotonation by metal acetates. 
 
Metal acetates, acetylacetonates and alkoxylates are often commercially available or easy to 
prepare. This method is therefore used frequently for the synthesis of a variety of complexes. 
A major disadvantage is the incorporation of the imidazolium counter-ion and therefore 
tetrafluoroborate, hexafluorophophate and perchlorate are often used for these reactions.  
 
b) Deprotonation by an external base 
The deprotonation with an external base is also widely used, and a number of suitable bases 
are KOtBu, NEt3, LDA, KH and others (pKa of N,N’ -dialkylimidazolium salts: ~23 in 
(Wanzlick, 1968) 
(Herrmann, 1995) 
(Öfele, 1968) 
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DMSO213, ~20 in THF214) (Scheme 83, eq. 3 and 4). Especially with saturated 
imidazolinylidenes, certain hydride sources and amide bases and alcoholates can add to form 
imidazolidines instead of deprotonation.215 A mild method for deprotonation involves the use 
of potassium hydride in combination with a catalytic amount of NaOtBu or DMSO (used by 
Arduengo187).  
A different strategy to obtain the carbene intermediate is the thermal elimination of small 
molecules such as methanol216 or dimethylamine217 from the neutral carbene precursor and 
subsequent trapping of the carbene by a transition metal fragment (eq. 5). 
N N+Mes Mes
X
N NMes Mes
..KOtBu, THF
N N+Mes Mes
X
N NMes Mes
..KH, THF
NN
N
+Ph
Ph
Ph
X
N
N
N PhPh
Ph
..NaOMe
MeOH N
N
NPh
Ph
Ph
OMe 80 °C
0.1 mbar
(eq. 3)
(eq. 4)
(eq. 5)
 
Scheme 83: Deprotonation with external base or thermal elimination of HOMe, Et2NH etc. 
 
A different method to obtain the N-heterocyclic free carbene is the thermal breakup of the 
carbene dimer. This chemistry was reviewed by Lappert (Scheme 84).185,186 
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Scheme 84: Thermolysis of enetetramines. 
 
The title of Arduengo’ s publication ” A Stable Crystalline Carbene”  conveys the excitement 
and explains why carbenes are not only reactive intermediates, but can be preformed and 
stored for a certain time (by exclusion of air and moisture). In Scheme 85, the formation of 
the first free and crystalline carbene by Arduengo is shown.187 Following this procedure, once 
the carbene is formed, no base has to be used anymore which may be of advantage in many 
cases.  
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Scheme 85: Formation of the first free and crystalline carbene (Arduengo, 1991).187 
 
V.1.6. Complexation with carbene ligands 
Some complexation reactions have already been discussed in the context of the formation of 
the carbene (vide supra), and these methods are also the most commonly used. But isolated 
carbenes described above employ also other complexation strategies.   
 
The preformed free N-heterocyclic carbene can be used to break up a dimeric or oligomeric 
source of the metal precursor such as [(η5-C5Me5)RuCl]4.218 
 
The high stability of most NHC-transition metal complexes makes the exchange of phosphine 
ligands by carbene ligands a favourable process. The most famous example is the preparation 
of the second generation of Grubbs metathesis catalyst, where one tricyclohexylphosphine is 
replaced by an NHC-ligand (Scheme 86).219-222  
 
NN MesMes
..Ru
Cl
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Ph
PCy3
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Ph
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Scheme 86: Synthesis of second generation Grubbs catalyst (Grubbs, 1999). 
 
 
Recently, the preparation of NHC-palladium and nickel complexes by oxidative insertion has 
been presented by Fürstner.223 Thiourea derivatives of imidazolidine were converted into the 
imidazolinium chloride with oxalyl chloride. Oxidative addition with palladium(0) led to the 
formation of the NHC-palladium complex (Scheme 87). 
 
N
S
N Ph N
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N Ph
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N Ph
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Scheme 87: Oxidative insertion for the preparation of NHC-complexes (Fürstner, 2005). 
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NHC-silver complexes can be used as intermediates for complexation reactions via 
transmetallation.224 This indirect way to obtain NHC-complexes presents a convenient and 
practical method. Generally, the formation of silver NHC-complexes from imidazolium salts 
in the presence of silver oxide proceeds smoothly and can be done even in water. 
N N
O O
N+ N
+
NN
N N
O O
N N
NN
Ag
N N
O O
N N
NN
Pd
Cl
Cl
Ag2O
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Pd(MeCN)2Cl2
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2 Cl Cl
 
Scheme 88: silver-NHC complexes as intermediates for metal-NHC complexes (Burgess, 2002).224 
 
V.1.7. Classification of NHC-complexes 
In general textbooks about carbenes, two types of polarization of carbene metal bonds are 
described. There are first the Fischer carbenes, usually transition metal carbene complexes of 
Cr, Mo, W and Fe in a low oxidation state bearing strong pi-acceptor ligands in which the 
carbene ligand carries a heteroatom. The carbene ligand exhibits strong electrophilic 
behaviour. The transition metal carbene bond has significant carbene to metal σ-donation and 
metal to carbene back-donation (A).225  
On the other hand Schrock-type carbenes consist of an allylidene ligand coorinated to a 
transition metal such as Mo, Ti, Ta and W in a high oxidation state. The metal carbene bond 
can be characterized by a balanced interaction of a σ and a pi bond (B) (Figure 48).  
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Figure 48: Orbital interaction in Fischer-type carbenes (A) and Schrock-type carbenes (B). 
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The Wanzlick-Öfele-carbenes (as the coordinated NHCs are also called in honour of their 
inventors) are in singlet state and therefore resemble the Fischer-type carbenes. Due to the 
strong mesomeric and inductive stabilization of the ppi-orbital, they do not display strong pi-
back-bonding. Depending on the metal, they exhibit in some cases ligand to metal pi-
bonding.226 Therefore these carbenes belong to a new class of carbenes, displaying 
advantageous features for being good spectator ligands.  
 
V.1.8. NHC-ligands in asymmetric transition-metal catalyzed reactions 
The ambiphilic nature of NHC-ligands makes them extremly useful as ligands for transition 
metals, and a vast number of active catalysts incorporating and NHC in combination with 
many metals in different oxidation states have been synthesized. This work focuses on the use 
of NHC-bearing catalysts that have found use in asymmetric transition metal catalyzed 
reactions.  
 
Even though the number of NHC-based catalysts showing good to excellent enantio- or 
diastereoselectivity is increasing, the use of chiral NHC-ligands in efficient asymmetric 
transformations is still limited.227,228  
An exciting, highly enantioselective ruthenium metathesis catalyst has been developed by 
Hoveyda (Scheme 89). The modification of Grubbs’  second generation catalyst229,230 consists 
of an axial chiral binaphthyl substituted bidentate imidazolinylidene ligand and the 
benzylidene ligand was replaced by an ortho-isopropoxy benzylidene.231,232 This system 
showed high enantioselectivities in asymmetric ring-closing metathesis. The catalyst is 
tolerant to air and has been used in undistilled THF. 
NN
O
Mes
Ru
O
Pr
Cl
OAr
OAr
Ph
i
5 mol% cat.
air, undistilled THF
22 °C, 1 h
up to 96% ee
 
Scheme 89: Ring opening metathesis catalyzed by a chiral NHC ruthenium complex. 
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Another remarkable system is based on an NHC-iridium catalyst for enantioselective 
hydrogenations by Burgess (Scheme 90).233,234 
 
Ir
N
N
N O
Ad
Pr
Pr
Me Me
i
i
1 bar H2
0.6 mol% cat.
CH2Cl2, 25°C, 2h
>99% yield
  97% ee
BARF
 
Scheme 90: Asymmetric hydrogenation of unfunctionalized alkenes. 
 
This hydrogenation procedure delivers the reduction products of unfunctionalyzed alkenes 
under convenient conditions.  
 
V.1.9. Phenylethylamine derived NHC-ligands 
Since phenylethylamine is commercially available in both enantiomeric forms, chiral NHC-
ligands derived from this amine as shown in Figure 49 have been known for about a 
decade.204,235-239  
 
N N
+
H
Me Me X
 
Figure 49: Phenylethylamine derived ligands.  
 
Up to date, most modifications on this structure have been realized on the imidazolium ring, 
in order to force the phenylethyl group to be oriented towards the metal. The phenyl has been 
replaced by 1-naphthyl and the benzylic methyl substituent exchanged by an ethyl group. In 
Figure 50, a collection of the most important ligands and their modifications is shown. 
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N N
+
H
Me Me Cl
N N
+
H
Me Me
N N
+
H
Me Me
N N
+
H
Me Me
BuBu
Cl
I Clt t
 
Figure 50: Known phenylethylamine derived ligands. 
 
It was in particular the group of Alexakis and coworkers who expanded the series with 
different substitutions on imidazolium and imidazolinium structures (Figure 51).238,240-243 
 
N N
+
H
R R
Ar Ar
N N
+
H
R R
Ar Ar
R’ R’
BF4
BF4
     R =      Ar = 
A   Et        Ph
B   Me      2-Naphth
     R =      Ar =          R’ = 
C   Me      Ph             H
D   Me      Ph             Ph
 
Figure 51: Ligand modifications synthesized by the group of Alexakis. 
 
In a very systematic optimization of the ligand substitutions as well as of the conditions, 
ligand B showed an enantioselectivity of 93% ee in the 1,4-additon to cycloheptenone when 
added to the reaction as a silver carbene complex (Scheme 91). The use of different analogues 
of this ligand as silver salts gave ee’ s from 7 to 76%. In case of cyclohexenone, ee’ s were 
obtained from 21% to 59%.  
N N
Ag
Me Me
Cl
O O
B (2%), Cu(OAc)2
Et2Zn 1.5 eq., 
Et2O,  -78 °C
16 h 95% yield93% ee
B
 
Scheme 91: 1,4-addition using a chiral NHC-ligand. 
 
(Herrmann, 1996) 
(Rivas, 2001) 
(Herrmann, 1996 
Enders, 1996) 
(Mangeney, 2001) 
(Alexakis, 2005) 
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In another case, where a phenylethylamine derived NHC-ligand was used, the asymmetric γ-
selective allylic substitution reaction with Grignard reagents was catalyzed by a copper-NHC 
catalyst.244 a remarkable γ-selectivity of 98:2 and an enantiomeric excess of 70% were 
observed (Scheme 92). 
 
N N
Cu
Me Me
Cl
cat (5%), n-Hex
Et2O,  -20 °C
cat:
TBSO O
N
(Z)
TBSO
Hexn
TBSO+ nHex
98:2
70% ee
 
Scheme 92: Asymmetric copper catalyzed allylic substitution reaction. 
 
These results suggest that phenylethylamine derived NHC carbene ligands are ligands for 
asymmetric catalysis, but that their efficiency is not general. 
 
(Tominaga, 2004) 
CHAPTER V 
Carbene Based Ligands From 1-(2-Methoxyphenyl)-alkylamine 
 
86 
V.2. Results 
V.2.1. Synthesis of the New Bulky NHC-Ligands 
The series of building blocks of chiral 1-(2-alkoxyphenyl)-alkylamines 1b, 4b, 5b (see 
chapter I) would allow to build a small library of new NHC-ligands. They would not be 
modified on the imidazolium ring, but mainly at the benzylic position. An interesting aspect 
of these ligands is also that the methoxy group could play the role of a hemilabile binding site, 
or could just add bulk, which may be beneficial.  
 
Starting from the ortho-methoxyphenylalkylamines 1b, 4b or 5b, the synthesis of 
imidazolium salts 66 was envisaged (Scheme 93).  
R
OMe
NH2
N N
+
MeO OMe
R R X
1b R=Me
4b R=iPr
5b R=tBu
66a R=Me
66b R=iPr
66c R=tBu
 
Scheme 93: Formation of imidazolium salts from the aminophenol building blocks. 
 
Ligand precursor 66a.BF4, was obtained by a standard procedure via condensation with 
formaldehyde and subsequent cyclization with tetrafluoroboronic acid and glyoxal (Scheme 
94).206 
 
NH2
Me
OMe
H2CO
toluene,
then HBF4
then (CHO)2, 
66a.BF4
87%
BF4
N N+
MeMe
O O
Me Me
NH2
Bu
OMe
H2CO
toluene,
then HBF4
then (CHO)2, 
BF4
N N+
BuBu
O O
Me Me
t t t
1b
66c.BF45b
 
Scheme 94: Formation of modified Herrmann-imidazolium salts. 
 
When using the tert-butyl substituted building block 5b, this procedure was not successful. As 
mentioned in chapter III, the diimine 57 is readily accessible via the double condensation of 
the building block with glyoxal. Often, such diimines are used as intermediates to cyclize to 
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an imidazolium salt via ring closure with paraformaldehyde in the presence of concentrated 
hydrochloric acid (Scheme 95).205 Applying these conditions to 57, in our hands this 
procedure resulted in a complex mixture of products.  
 
N NMeO OMe
Bu Bu
N N
+
MeO OMe
Bu Bu
 
HClconc.
Cl
(CH2O)n
tt t t
57 66c.Cl
 
Scheme 95: Unsuccessful cyclization to the carbene precursor. 
 
In both methods, cyclization was prevented probably due to the steric bulk of the diimine 
(Scheme 95). Therefore imidazolium salt 66c was synthesised using more forcing conditions 
developed by the group of Glorius.207 This method was successfully applied to 57 and 
afforded 66c.OTf in 60% (Scheme 96). In contrast, 66a.OTf was obtained in only 11% yield 
by this method. 
 
R
OMe
NH2
a) AgOTf
b) 40 °C, 
    CH2Cl2,
sealed tube
      60% 
N N
R R
O
Me
O
Me
N N
+
MeO OMe
R R
 
OCl Bu
O
OTf
R = tBu: (S)-5b
R = Me: (R)-1b
(CHO)2 
CH2Cl2, 
Na2SO4
t
R = tBu: (S,S)-57
R = Me: (R,R)-56
R = tBu: (S,S)-66c.OTf, 60%
R = Me: (R,R)-66a.OTf, 11%
 
Scheme 96: Lewis acid assisted ring closure to the imidazolium salt. 
 
V.2.2. Variation of the size of the benzylic substituent 
This method would allow the synthesis of analogues of this highly hindered imidazolium salt. 
Using the building block 4b, 66b.OTf with iso-propyl groups in the benzylic position was 
synthesised according to this two-step sequence (Scheme 97). 
 
NH2
Pr
OMe
N N
+
PrPr
O O
Me Me
TfO
1) (CHO)2, 93%
2) chloro-
    methylpivalate,
    AgOTf
    51%
i ii
4b 66b.OTf
 
Scheme 97: Synthesis of the iso-propyl substituted analogue of the imindazolium salt. 
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V.2.3. Counter ion exchange 
Traces of impurities which could not be separated by column chromatography (even a slight 
silver mirror was observed when 66c.OTf was used in a complexation reaction), were 
removed by a counter ion exchange with sodium iodide to give 66c.I and 66b.I respectively. 
For the study of counter ion effects in the catalysis, iodine was also replaced by silver 
hexafluoroantimonate to give 66c.SbF6 (Scheme 98). 
 
X
N N+
RR
O O
Me Me
R = tBu
66c.OTf
66c.I, 73% NaI
AgSbF6 66c.SbF6, 95%
66b.OTf   
66b.I, 51% from diimine  NaI
R = iPr
66
 
Scheme 98: Series of imidazolium salts and counter-ion metathesis. 
 
V.2.4. Free Carbene  
In order to observe the free carbene via NMR spectroscopy, the imidazolium salt 66c.I was 
suspended in deuterated THF and solubilized by deprotonation. After adding potassium 
hydride, gas evolution was observed and the 1H-NMR showed clear and resolved signals 
which indicated that a new, more soluble species was formed. The new signals were assigned 
to the free carbene 67 (Scheme 99). This was supported by the signal of a quarternary carbon 
at 212 ppm in 13C-NMR (expected range for imidazolylidene carbene carbons: 205 – 
231 ppm)188 and by the 13C-1H long range correlation 2D-NMR (HMBC), where a long range 
interaction was observed between the carbene carbon and the benzylic proton (Scheme 99).  
 
N
+
N
BuBu
O O
Me Me
I-
NN
BuBu H
O O
Me Me
..
KH
long range correlation
13C-NMR (carbene): δ 212.6 ppm 
66c.I 67
d8-THF
t t t t
 
Scheme 99: Formation of the free carbene. 
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V.2.5. Coordination chemistry 
a)  Pd(NHC)2I2 
Since preformed palladium-NHC catalysts are already widely used, a palladium based catalyst 
bearing the new carbene ligand was envisaged.245 The most convenient way to synthesize 
stable Pd(II) complexes is to react the imidazolium salt with palladium acetate in the presence 
of potassium hydride and sodium iodide to form a biscarbene complex.235 
 
Carbene precursor 66a was subjected to the complexation as shown in Scheme 100. NMR and 
MS analysis provided evidence for the expected structure of complex 68. Attempts to purify 
did not succeed, even though the complex was chromatographed, the 1H-NMR showed a 
mixture which could not be further analyzed due to its complexity. 
N N
+
Me Me
O O
Me Me
N N
Pd
N N
II
Me
Me
Me
Me
MeO OMe
OMeMeO
 
TfO-
1) NaOtBu
2) Pd(OAc)2, NaI
66a.OTf
68
 
Scheme 100: Synthesis of the dicarbene complex. 
 
Application of the same method to the tert-butyl substituted imidazolium salt 66c.OTf did not 
provide the complex even after 24 h reaction time (Scheme 101). 
 
N N
+
Bu Bu
MeO OMe
TfO-t t
66c.OTf
69
N N
Pd
N N
OMeMeO
MeO OMe
II
Bu
Bu
Bu
Bu
t t
t t
1) KH
2) Pd(OAc)2, NaI
 
Scheme 101: Attempted complexation with the tert-butyl substituted imidazolium salt. 
 
This result clearly indicates that the very bulky tert-butyl groups hampered the complexation 
of a second ligand to palladium.  
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b) Pd(NHC)(η3−C3H5)Cl 
Faced with these difficulties to prepare a bis-(NHC)-complex, a monocarbene complex was 
envisaged as a suitable catalyst. One possibility to obtain palladium complexes bearing only 
one NHC ligand is the complexation with allyl palladium chloride dimer.226 Therefore the 
tert-butyl substituted free carbene 67 was reacted with allyl palladium chloride. In doing so 
the colour of the d8-THF solution turned from orange brown to slight green-brown (Scheme 
102).  
1) KH, d8-THF
2) [Pd(η3-C3H5)Cl]2
N+N
BuBu
O O
Me Me
I-
1H-NMR mixture of isomers.
MS shows [(η3C3H5)-Pd-66c] signal 
66c.I 70
NN
BuBu
MeO OMe
Pd
Cl
 
t t t t
 
Scheme 102: Complexation with allyl palladium chloride. 
 
While the reaction mixture changed colour, the 1H-NMR pattern changed, the ESI-MS 
showed a peak at m/z 568 which is consistent with the formation of 70. However, the isolation 
of the complex was not successful.  
 
c) Synthesis of a monocarbene monophosphine palladium complex 
A convenient route to monocarbene monophosphine palladium complexes leads through the 
complexation in pyridine, as pyridine coordinates weakly to palladium.246 In contrast to the 
original literature, [Py2PdI2] was formed as the major compound (Scheme 103). Complex 71 
could not be obtained in pure form, neither by column chromatography, nor by washing 
procedures. 
 
NN
Pd MeMe
MeO OMe
I I
N
N+N
MeMe
O O
Me Me
Py2PdI2
BF4-
71
Pd(OAc)2, NaI
pyridine
66a.BF4
+
 
Scheme 103: Attempted formation of the monocarbene pyridyl palladium complex. 
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Because of these serious problems of characterization and purification, a direct route to the 
formation of a monocarbene complex was chosen.206 By mixing Pd(OAc)2, the chiral 
imidazolium salt 66a.BF4, sodium iodide and potassium tert-butoxide in THF, the formation 
of the dicarbenediiodo-µµ’ -diiododipalladium(II) complex 72 was observed (Scheme 104). 
NMR analysis showed a complex spectrum which could not be completely interpreted. For 
the methoxy groups for example there are more than 12 singlets between 3.6 ppm and 4 ppm. 
Treatment of this µµ’ -diiodo bridged complex with triphenyl phosphine broke up the 
dinuclear complex to form the desired monocarbene monophosphine complex 73, indicated 
by an immediate colour change from red-orange to yellow. In the 1H-NMR spectrum, all 
methoxy signals collapsed to one main signal but still about 7 small methoxy signals were 
found aside.  
 
NN
PdI I
I Pd I
N N
Me Me
MeO
Me Me
OMe
MeO OMe
 
N
+N
MeMe
O O
Me Me
BF4
NN
Pd
MeMe
MeO OMe
I I
PPh3
66a.BF4
72
73
PPh3
tBuOK
Pd(OAc)2, NaI
THF, 23 °C, 24 h
 
Scheme 104: Formation of a monocarbene monophosphine complex. 
 
Again, the use of tert-butyl substituted imidazolium salt did not lead to the formation of the 
µµ’ -diiodo bridged dinuclear palladium complex, even though the colour changes were 
identical to the previous case (Scheme 105).  
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N
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BuBu
O O
Me Me
OTf
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Pd(OAc)2, NaI
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I Pd I
N N
Bu Bu
MeO
Bu Bu
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MeO OMe
 
Scheme 105: Attempted synthesis of dinuclear palladium-NHC complex. 
 
V.3. Application in Catalysis for Oxindole Synthesis 
V.3.1. Spirooxindols, Targets in Medicinal Chemistry and their Syntheses 
The spirooxindols belong to the class of indole alkaloids. Many of these exhibit biological 
activity and they are therefore interesting targets for synthesis. Examples are shown in Figure 
52. Rhynchophylline as well as its isomer Isorhynchophylline were isolated from cat’ s claw 
plants and belong to the tetracyclic oxindol alkaloids.247 They have long been used in 
traditional Oriental medicine as antipyretic (lowers fever), anti-hypertensive and 
anticonvulsant medications for the treatment of headache, vertigo and epilepsy.248  
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Figure 52: Selected spirooxindol natural products. 
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It has been found that their biological activity is associated with an increased tolerance to 
oxygen deficiency in the brain (hippocampus). Horsfiline is a popular synthetic target due to 
its simple structure for testing new synthetic methods. Gelsemine induces convulsion and can 
therefore be used in model studies for anticonvulsant drugs such as strychnine or 
bicucculine.249 (–)-Eseroline, a metabolite of physostigmine, shows morphine like effects i.e. 
analgesic (narcotic agonist activity), respiratory depression and induction of neuronal cell 
death.250-252 Pteropodine reduces the EC50 values of acetylcholine on muscarinic M1- and of 
serotonine on 5-HT2-receptors, which play a key role in cognitive processes such as memory 
and learning.253 Spirotryprostatin B inhibits the growth of human chronic myelogenous 
leukemia K562 cells and human promyelocytic leukemia HL-60 cells.254 Strychnofoline, 
isolated from the leaves of strychnos usambarensis, showed the highest activity in antimitotic 
activity against cultures of mouse melanoma and Ehrlich tumor cells.255 Citrinadin A and B 
were recently extracted and characterized and are interesting compounds from the synthetic 
point of view.256  
 
V.3.2. Asymmetric construction of quaternary carbons 
As mentioned above, many of these natural products have already been synthesized. A brief 
overview will be given over the asymmetric construction of spirocentres.  
 
Several methods have been developed to synthesize the spirocentres using chiral auxiliaries or 
internal stereogenic centres for stereodirection:  
 
a) Oxidative rearrangement sequences 
Based on a study of Taylor,257,258 Borschberg and coworkers showed the dependence of the 
oxidative spiro rearrangement from the substituent on the piperidine nitrogen atom.259,260  (–)-, 
(+)-horsfiline and (–)-elacomine (Borschberg), spirotryprostatin A (Danishefsky) and 
spirotryprostatin B (Ganesan) were synthesized using this methodology (Scheme 
106).238,261,262  
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a) NBS, AcOH
b) THF, H2O
R’’ = BOC
R’’ = Me, Cbz
 
Scheme 106: Spirooxindole synthesis by Borschberg. 
 
b) Dipolar cycloaddition 
Palmisano and coworkers used different chiral auxiliaries for the diasteroselective 
cycloaddition of N-methylazomethine ylide to chiral dipolarophiles (Scheme 107).263  
NO2
MeO CO2Xc
Xc = chiral auxiliary
NO2
MeO CO2Xc
NMe
CH2
N
+
up to 86% de
(-)-Horsfiline
 
Scheme 107: Spirooxindoles via dipolar cycloaddition. 
 
c) Ring-expansion reaction 
Carreira and coworkers used a magnesium iodide mediated ring-expansion reaction. With the 
appropriate chiral imine, they were able to obtain a single diastereomer (Scheme 108).254,255  
N
O
Ph
BnO
N OTBDPS
N
O
Ph
BnO
N H OTBDPS
N
OMgI
Ph
BnO
I
 
(±)strychnofoline
(±), single diastereomer
MgI2
THF, 80 °C
sealed tube
via:
 
Scheme 108: Diastereoselective spirooxindole formation by magnesium-enolate formation.  
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d) Transition-metal catalysed C-C-bond formation reactions  
Only two transition-metal catalyzed formations of the spirocentre have been published so far: 
Overman and coworkers used the asymmetric Heck reaction with (S)-BINAP to obtain the 
oxindole with high enantiomeric excess (Scheme 109).264-266  
 
I
N
Me
O
Me
OTIPSMeO
1) Pd2(dba)3.CHCl3
    (S)-BINAP, PMP, DMAC
    100 °C
2) H+
N
Me
O
O
Me
MeO
88%, 95% ee
(-)-physostigmine
 
Scheme 109: Asymmetric Heck reaction for the formation of the chiral quaternary centre. 
 
The palladium catalysed intramolecular C-C-bond formation with the enolate of an anilide 
with aryl bromide gave moderate enantioselectivity (42 – 76% ee) in a model study. So far, 
this approach has not been used for natural product spirooxindole synthesis.267,268  
Br
N
R
O
Ar N
Ar
O
R
L* 
[Pd] 
NaOtBu
DME
N N
+
BF4
L*:
up to 76% ee
 
Scheme 110: Oxindole synthesis by intramolecular D-arylation.
 
Recently, Trost and coworkers combined this reaction with their asymmetric allylic alkylation 
(AAA) to form allyl substituted oxindoles.269 
The asymmetric intramolecular α-arylation reaction is particularly interesting because even a 
ligand screen led to only moderate selectivity (vide infra). Interestingly, best results were 
obtained when a N-heterocyclic carbene ligand was applied. Scheme 111 shows the proposed 
catalytic cycle.  
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Scheme 111: Reaction mechanism for intramolecular D-arylation of anilides.
 
Hartwig and coworkers were able to isolate and characterize the palladium intermediate A by 
the reaction of a 1:1 mixture of palladium dibenzylidene acetone and phosphine ligand. The 
reaction time for the formation of the oxo-palladium intermediate was compared with the time 
which was needed to complete the formation of the product after adding the base. This 
allowed the assignment of the rate determining step, which was found to be the oxidative 
addition of the substrate.  
Br
N
R
O
Me
Ar
N
Me Ar
O
R
L* (5 mol%)
[Pd] (5 mol%)
NaOtBu
DME
Ar = 
R =                   Bn                         Me
ligand
A:                  76% ee                 57% ee
B:                                               43% ee
C:                                               67% ee
75b75a:
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N N+
N
+
O
N
O
Bu Bu
OTf
A B
t t
BF4
N N+
AdmAdm
Ph Ph
C
 
Scheme 112: Best results known for the asymmetric oxindole synthesis of Hartwig. 
 
With the camphor-derived ligand A (Scheme 112), substrate 75a was transformed into the 
oxindole 76a with 76% ee, which presents the best result known for this reaction for more 
than ten different classes of ligands.268 Substrate 75b has been used in three different papers 
with three different ligands. 57% ee was obtained with ligand A and 43% ee for the oxazoline 
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derived ligand B from the Glorius group.207 Recently, a NHC-ligand C based on the concept 
of chiral mimetic reached 67% ee with low conversion.270 
 
V.4. Results: Catalysis of Oxindole Synthesis using New Chiral Carbene 
Ligands 
Considering that best selectivities were obtained with chiral NHC-ligands, the palladium 
catalyzed oxindole synthesis of Hartwig and coworkers presents a suitable testing system for 
the new and highly bulky ligand 66c.268  
First, the monocarbene monophosphine complex 73 was used directly as the catalyst in order 
to probe its activity (Scheme 113). The reaction proceeded in the given time of 14 h to 
completion; unfortunately the product was racemic. When the carbene palladium complex 
was formed in situ from the same ligand 66a with palladium acetate prior to the addition of 
the substrate, an ee of 6% was observed. 
Surprisingly, with ligand 66c.OTf an ee of 74% was obtained without optimization (Table 4, 
Entry 1).  
X
N N+
BuBu
O O
Me Me
66c.OTf
66c.I
66c.SbF6
t t
Br
N
Me
O
Me N
Me
O
Me
L* (5 mol%)
[Pd] (5 mol%)
NaOtBu, solv.
75b 76b
N
+
N
MeMe
O O
Me Me
BF4
(R,R)-66a.BF4
NN
PdI I
PPh3
MeMe
MeO OMe
73
(((R,R)-5a)PdI2PPh3)
Yield: quant.
ee: 6%
Yield: quant.
ee: rac. results see table 2
  
Scheme 113: Ligand library used in the palladium catalysed asymmetric intramolecular D-arylation.  
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Table 4 
Entry Ligand [Pd] T t Solvent Yield ee 
N° L* source [°C] [h]  
[%] 
(conv.) 
[%] 
(opt. rot.) 
1 (S,S)-66c.OTf  Pd(OAc)2 50 14 1,4-Dioxane 88 (98) 74 (-) 
2 (S,S)-66c.OTf Pd(dba)2 50 14 1,4-Dioxane 98 (98) 79 (-) 
3 (S,S)-66c.I
 
Pd(OAc)2 50 14 1,4-Dioxane 83 (98) 80 (-) 
4 (S,S)-66c.SbF6 Pd(OAc)2 50 19 1,4-Dioxane 36 78 (-) 
5 (S,S)-66c.I Pd(OAc)2 23 24 1,4-Dioxane 60 (90) 82 (-) 
6 (S,S)-66c.I Pd(dba)2 23 24 1,4-Dioxane 94 (94) 85 (-) 
7 (R,R)-66c.OTf  Pd(OAc)2 50 14 1,2-Dimethoxyethane 98 84 (+) 
8 (R,R)-66c.OTf Pd(dba)2 50 14 1,2-Dimethoxyethane 96 83 (+) 
9 (S,S)-66c.I
 
Pd(OAc)2 50 14 1,2-Dimethoxyethane 90 84 (-) 
10 (S,S)-66c.I Pd(OAc)2 23 24 1,2-Dimethoxyethane 98 87 (-) 
11 (S,S)-66c.I Pd(dba)2 23 24 1,2-Dimethoxyethane 96 87 (-) 
Conditions: 0.25 mmol substrate, 0.05 M in the indicated solvent, [Pd] (5 mol%), L* (5 mol%), 1.5 eq. NatBuO. 
 
When exchanging the palladium source from palladium acetate to palladium dibenzylidene 
acetone, the ee slightly increased to 79% (Table 4, Entry 2). Changing the counter ion to 
iodide (ligand 66c.I) increased the ee slightly to 80% (Table 4, Entry 3). In order to obtain an 
indication whether the difference in enantioselectivity between 66c.OTf and 66c.I was due to 
a counter-ion effect or rather an effect of residual impurities (in case of 66c.OTf), 66c.SbF6 
with its non-coordinating counter ion was also tested in this reaction. Albeit the yield was 
unsatisfactorily low (probably because the solvent was not dry enough, reaction was not 
repeated), an ee of 78% showed only a small difference compared to the other counter ions 
(Table 4, Entry 4). Lowering the temperature to 23 °C while using ligand 66c.I, the reaction 
time had to be prolonged to 24 h, but the ee again increased to 82% in the case of palladium 
acetate and to 85% ee in the case of palladium dibenzylideneacetone (Table 4, Entries 5 
and 6).  
If the reaction was carried out in DME at 50 °C neither the palladium source (Pd(OAc)2 vs. 
Pd(dba)2) nor the ligand precursor (66c.OTf vs 66c.I) had a significant effect on selectivity 
(Table 4, Entries 7 to 9). However, if the temperature was reduced to room temperature, an 
increase in selectivity was observed for ligand precursor 66c.I (Table 4, Entries 10 and 11). 
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V.4.1. Influence of the solvent 
For different ligands, a different dependence on the solvent is expected. Surprisingly, ligand 
66c.I showed only little difference when exchanging the good coordinating solvent DME 
(Table 5, Entry 1) by the less chelating solvents 1,4-dioxane and THF. In this case the 
enantiomeric excess slightly decreased from 87% to 85% or 86% respectively (Table 5, 
Entries 2 and 3). Using toluene as a less coordinating, non-polar solvent, the ee dropped 
further to 73% and low conversion was observed. In benzene the reaction did not proceed at 
ambient temperature. Complete conversion required 24 h at 75 °C, but the ee dropped to 67%. 
This is still remarkable considering the high temperature. In dichloromethane, decomposition 
was observed but no product was formed even at 39 °C.  
Table 5 
Entry Solvent Yield [%] ee [%] 
1 DME 98 87 
2 1,4-Dioxane 94 85 
3 THF (10) 86 
4 Toluene (20) 73 
5 C6H6 (75 °C) 96 67 
6 CH2Cl2 (39 °C) -- -- 
Conditions: 0.25 mmol substrate, 0.05 M in the indicated solvent, 
Pd(dba)2 (5 mol%), 66c.I (5 mol%), 1.5 eq. NatBuO, 23 °C (unless 
otherwise stated), 24 h.  
V.4.2. Ligand modification 
In view of these promising results, the synthesis of two additional analogues (79a and 79b) 
was envisaged in order to study the effects of the ortho-substituents on the ligand (Scheme 
114). The enantiomerically pure amine 77 was synthesised following the literature 
procedures,271 in contrast the amine 78 has not been described in enantiomerically pure form.  
R
NH2
But t t I
(R)-77 R = H
(R)-78 R = Me
(R,R)-79a.I R = H
(R,R)-79b.I R = Me
N N
+
Bu Bu
R R
 
Scheme 114: Proposed new NHC-ligands 
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a) Synthesis of enantiomerically pure ortho-tolyl-neopentylamine 78 
The ortho-tolyl-neopentyl amine 78 was synthesised by a modified literature procedure from 
the ortho-methyl-benzonitrile (80) by alkylation and subsequent sodium borohydride 
reduction (Scheme 115).i,39,272,273 
 
Me
NH2
ButMe
CN
a) tBuMgCl,                  
    CuBr (cat.)
    THF, reflux,  
    18 h
b) NaBH4, 
    MeOH
rac-78
66%
80
 
Scheme 115: Synthesis of ortho-tolyl neopentylamine. 
 
Several attempts resolving of racemic 78 via formation of diastereomeric salts were 
unsuccessful (Table 6).274 
 
Table 6 
Acid Solvent, comment 
  1 2 3 
1) mandelic acid 
 
AcOEt 
no crystals 
+ Hex -> prec 
(rac) 
iPrOH 
no crystals 
(iPr)2O 
no crystals 
2) N-phenyl-lactic 
acide carbamate 
 
AcOEt 
no crystals 
iPrOH 
crystals (rac) 
(iPr)2O 
precipitate (rac) 
3) tartaric acid 
 
not soluble iPrOH precipitate (rac) 
(iPr)2O 
not soluble 
4) camphor sulfonic 
acid 
 
AcOEt 
no crystals 
iPrOH 
no crystals 
(iPr)2O 
crystals (rac) 
5) N-acetyl leucine 
Me N
H
O
Me
Me
O
OH
 
AcOEt 
gel 
iPrOH 
gel 
(iPr)2O 
gel 
 
                                                 
i
 These experiments were carried out in collaboration with Dr. Guillaume Godin.  
OH
O
OH
OH
OH
OH
O
OH
O
O OH
O
Me
N
H
O
O S
OH
O
O
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b) Chromatographic separation of diastereomers 
α-Chiral primary amines have been separated by the formation of diastereomeric carbamates 
with (-)-menthyl-chloroformate and column chromatography by Saigo and coworkers.275 
Adapted to the ortho-tolyl neopentylamine 78, carbamate formation with (-)-menthyl-
chlorofomate afforded the diastereomeric mixture of menthyl-carbamate 81. Separation of this 
mixture with column chromatography was possible (Scheme 116), although it was very 
inefficient. After crystallization of both enantiomeric fractions, 33% of the less polar 
diastereomer (S,R,S,R)-81 and 13% of the more polar diastereomer (R,R,S,R)-81 respectively 
were isolated (total yield of 46%, >98% de by GC).  
Me
NH2
Bu
Me
N
H
Bu
O
O
Me
Pr
Me
N
H
Bu
O
O
Me
Pr
Me
Pr
OCOCl
t
rac-78
i
i
+
1) 
    Et3N, ether, 0 °C, 2h
2) chromatography
    on SiO2
(S,R,S,R)-81
33%
(R,R,S,R)-81
15%
t
t
i
 
Scheme 116: Separation of enantiomers via diastereomer formation. 
 
Cleavage of the carbamate with DIBAL led to the formation of formamide 82 in 57% yield. 
The free amine was obtained by hydrolysis in methanolic hydrochloric acid in 64% yield and 
>98% ee.  
HCl/MeOH
reflux, 6h
    64%
(S)-82
(R)-82
(S)-78 ee >96%
(R)-78 ee >96%
(S,R,S,R)-81, de >96% 
(R,R,S,R)-81, de >96%
DIBAL
THF, 0 °C, 40 h
57%
Me Bu
N
H
O
O
Me
Pr
t
i
Me
N
H
Bu
CHO
t Me
NH2
But
 
Scheme 117 
The absolute configuration could be estimated by comparison of the optical rotation of amine 
78 and 77, as well as from the elution order in the chiral HPLC, with the first eluted 
diastereomer having the (S) configuration and the second having (R) configuration.275,276 
Crystal structure analysis of the final ligand allowed the definite assignment of the absolute 
configuration to be (R) for the more polar fraction (vide infra).  
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c) Synthesis of analoguous ligands 
The corresponding ligands 79a.I and 79b.I were synthesized via the formation of diimines 83 
and 84 respectively, and subsequent cyclization using silver triflate and chloromethyl pivalate 
followed by sodium iodide treatment (Scheme 118). There is no obvious reason for the low 
yield obtained in the case of 79a.I, but due to lack of primary material, this reaction was not 
repeated.  
R
NH2
But
t t I
> 98% ee
(R)-77 R = H
(R)-78 R = Me
(R,R)-79a.I R = H 14%
(R,R)-79b.I R = Me 49%
N N
+
Bu Bu
R R
1) glyoxale, formic acid (7mol%)
    Na2SO4, DCM, 0 °C, 6 h
2) chloromethyl pivalate 
    AgOTf, 40 °C, 24 h
3) NaI, acetone
R
N N
R
Bu But t
    (R,R)-83 R = H 89%
    (R,R)-84 R = Me 89%
 
Scheme 118: Synthesis of the new imidazolium salt analogues. 
 
d) X-ray structure for the determination of the absolute configuration 
The iodide of the imidazolium salt allowed directly the determination of the absolute 
configuration of 79b.I by x-ray, which was found to be (R,R)-79b.I (Figure 53). Interestingly, 
the ortho-substituent of the aryl ring sits syn periplanar to the benzylic proton.  
 
Figure 53: X-ray structure of (R,R)-79b.I.CH2Cl2. 
 
It is also noteworthy that both aryl groups are in the same hemisphere. This said it is clear that 
the x-ray structure of the ligand precursor cannot give any indication about the spatial 
arrangements of the ligand’ s substituents in the complex.  
CHAPTER V 
Carbene Based Ligands From 1-(2-Methoxyphenyl)-alkylamine 
 
103 
V.4.3. Comparison of different substitution patterns of the carbene ligand 
In order to study the influence of the benzylic group, catalytic reactions involving the 
different ligands 66a.BF4, 66b.I and 66c.I (Figure 54) were compared. Changing the tert-butyl 
(ligand 66c.I, Table 7, Entry 1) to an iso-propyl group (ligand 66b.I, Table 7, Entry 2) caused 
a slight decrease in selectivity and provided the product in an enantiomeric excess of 77%. As 
mentioned previously, benzylic methyl groups (ligand 66a.BF4, Table 7, Entry 3) led to a 
dramatic loss of ee (16%) while inversing the stereochemistry of the product. This clearly 
indicates the requirement of bulky substituents in the benzylic position for this reaction.  
 
Table 7 
Entry Ligand L* R R’  Yield [%] ee [%] 
1 (S,S)-66c.I  tert-butyl OMe 98 87 (-) 
2 (S,S)-66b.I  Iso-propyl OMe 93 77 (-) 
3 (R,R)-66a.BF4  Me OMe 72 16 (-) 
4 (R,R)-79a.I  tert-butyl H 98 57 (+) 
5 (R,R)-79b.I  tert-butyl Me 96 93 (+) 
Conditions: 0.25 mmol substrate, 0.05 M in DME, Pd(dba)2 (5 mol%), L* (5 mol%), 1.5 eq. 
NatBuO, 23 °C, 24 h.  
 
I
N N
+
BuBu
R’ R’
t tX
N N
+
RR
O O
Me Me
66c.I: R = tBu
66b.I: R = iPr
66a.BF4: R = Me
66c.I: R’ = OMe
79b.I: R’ = Me
79a.I: R’ = H
 
Figure 54: Ligands used for the comparison of different substitution patterns of carbine ligands 
 
Ligand precursor 66c.I possesses two methoxy groups in ortho-position of the aryls. The 
effect of these groups was probed by using ligands 79a.I and 79b.I in this reaction (Figure 
54).  
Due to the steric influence of the OMe substituents, it was expected that selectivity would be 
changed by applying ligand 79a.I. Indeed the selectivity dropped to 57% ee (Table 7, Entry 
4). 
Compared to a methoxy-group, a methyl group possesses a similar van der Waals radius, but 
would allow detecting a possible interaction of the methoxy group with the metal during the 
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catalytic cycle. To our delight, when ligand 79b.I was used in DME at 23 °C, 93% ee was 
obtained, that is so far the highest selectivity obtained for this reaction (Table 7, Entry 5).  
 
For further reactions, ligand 66c.I was used due to its easier access.  
 
V.4.4. Scope of Substrate 
The two substituents L (large) and S (small) on the substrate (Figure 55) are mainly 
responsible for the chiral recognition. In order to elaborate the scope of the substrate range for 
the new NHC-ligand in the palladium catalyzed asymmetric intramolecular α-arylation, 
naphthyl, substituted aryls or big aliphatic groups like cyclohexyl could be introduced for L 
(Ph in the previous examples). There is not much space for modification on the small 
substituent S (methyl in the previous examples). To replace it by a proton is problematic, 
since in the product formed by the catalysis it becomes a benzylic proton, α to a carbonyl, and 
any asymmetric induction would be followed by racemization under the basic reaction 
condition. The N-alkyl group (N-R) is expected to have a minor effect on the stereoselectivity 
since it is assumed to point away from the reaction centre. 
 
Br
N
O
S
L
R
 
 
Figure 55 
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Several modified substrates (Figure 56) were synthesized in order to elaborate systematically 
the scope of the ligand in the asymmetric palladium catalyzed α-arylation.  
Br
N
O
MeBn
Br
N
Me
O
F
Br
N
Me
O
Me
Br
N
Me
O
O
Br
N
O
MeMe
Br
N
O
MeMe
75b 75c 75d
75e 75f 75g
Br
N
Me
O
Me
O
O
Me
Br
N
O
MeMe OMe
Br
N
O
MeMe Me
75h 75i 75j
 
Figure 566XEVWUDWHVWHVWHGLQDV\PPHWULFSDOODGLXPFDWDO\]HG -arylation. 
 
Substrates 75b, 75c, 75e, 75g, 75j were synthesized according to Hartwig’ s procedures.268 
Substrate 75d was obtained by the anilide formation from 2-bromoanilide and 2-phenyl 
propionic acid (Eq. 1) and subsequent benzylation (Eq. 2) as shown in Scheme 119.  
Substrates 75f, 75h, 75i were formed by the anilide formation from the corresponding acid 
and N-methyl-2-bromoanilide (Scheme 119, Eq. 1). 
 
Br
N
O
S R
L
Br
NH
R
O
S
OHL
Br
N
O
Me H
Ph
Br
N
O
Me Bn
Ph
L, S, R = 
Ph, Me, H                 85     30% 
Ph, F, Me                  75f   47%
CO2Me, Me,Me         75h  87%
o-MeOC6H4, Me, Me 75i   90%
1) (COCl)2
    DMF (1 drop)
    CH2Cl2, rt, 1 h
2) 
             R = H, Me
    Et3N, 0 °C to rt, 16 h
Eq. 1
Eq. 2
NaH, THF 0 °C
then
BnBr, 24 h
87%
85 75d
L = large group
S = small group
 
Scheme 119 
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The series of substrates in Figure 56 was then subjected to the catalysis. The results for these 
substrates are summarized in Table 8. 
 
Br
N
R
O
S
L
N
S L
O
R
L* (5 mol%)
[Pd] (5 mol%)
NaOtBu, solv.
75 76
 
Scheme 120 
 
Table 8 
 Substrate L S R Product T  
/[°C] 
Time 
/[h] 
Yield 
(conversion) 
ee 
1 75b Ph Me Me 76b 23 24 98% 87% 
2 75c Naphthyl Me Me 76c 23 24 98% 84% 
3 75d Ph Me Bn 76d 50 24 75% 79% 
4 75e C6H11 Me Me 76e 50 36 27% 38% 
5 75f Ph F Me -- 23 24 decomposition -- 
6 75g -((CH2)3O)- Me -- 50 24 decomposition -- 
7 75h CO2Me Me Me -- 50 24 no reaction -- 
8 75i o-MeOC6H4 Me Me 76i 23 36 42% 84% 
9 75j o-tolyl Me Me 76j 23 36 98% 89% 
Conditions: 0.25 mmol substrate, 0.05 M in DME, Pd(dba)2 (5 mol%), L* (5 mol%), 1.5 eq. NatBuO. 
  
Replacement of the phenyl in the L position by a 1-naphthyl group, 75c led to a slight 
decrease of the ee (Table 8, Entry 2). Changing the N-methyl to an N-benzyl group produced 
76d with a slightly lower ee of 79% (Table 8, Entry 3). Cyclohexyl as an aliphatic substituent 
L afforded 76e in only 27% yield with an enantiomeric excess of only 38% (Table 8, Entry 4). 
This reaction formed several side products, presumably due to β-hydride elimination from the 
palladium enolate.i  
 
                                                 
i
 With tricyclohexyl phosphine as ligand, product 12e has been previously obtained in 64% yield.268  
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In case S would be a proton, most probably racemisation could not be avoided. An α-fluoro 
substituent would be closest in size to a proton (H: 1.20 Å, F: 1.35 Å) (Substrate 75f , L = Ph, 
S = F, R = Me). In addition, this substrate could be a model for an asymmetric synthesis of 
MaxiPostTM, a promising agent for treatment of stroke and developed by Bristol-Myers 
Squibbs (Figure 57).277 
N
H
O
F
Cl
OMe
F3C
 
Figure 57: Structure of BMS-204352; MaxiPostTM. 
 
Unfortunately, fast decomposition was observed when 75f was subjected to this reaction.  
 
Ligand precursor  66c.I possesses two methoxy groups. In principle, there could be not only a 
steric but also an electrostatic face discrimination of an incoming substrate. The 
tetrahydrofurylcarboxamide 75g would be the substrate of choice to test this hypothesis. 
Unlike in the racemic reaction catalyzed by tricyclohexyl phosphine, where 98% yield has 
been obtained, with ligand 66c.I no product formation was observed, but N-methyl-2-
bromoanilide was isolated as the main product instead. It has been observed previously, that 
the presence of an α-heteroatom on the anilide (in this case oxygen or fluoride) led to the 
cleavage of the anilide upon enolate formation, presumably via ketene formation.i  
 
The 2-methylmalonamic ester 75h did not furnish any product, and mainly starting material 
was isolated. The tight chelation of the 1,3-dicarbonyl to palladium might quench the 
reactivity of the catalyst.  
 
In case where L is α-(ortho-methoxyphenyl) also low reactivity was observed and 76i was 
isolated in 42% yield at 50 °C after 36 h with 84% ee. In contrast for L equals α-(ortho-tolyl), 
15j was converted quantitatively into 16j with the highest enantiomeric excess of 89% in this 
series of substrates.   
 
                                                 
i
 This fact was observed using different conditions in Hartwig’ s study.268 
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V.4.5. X-ray crystal structure of the product 
The absolute product configuration has been left open and it was not determined in the 
literature precedents either.268,270 Overman and coworkers have described the modification of 
a similar substrate in order to obtain crystals with an incorporated heavy atom for the 
determination of the absolute configuration by X-ray crystallography (Scheme 121).278  
 
N
H
O
TBDMSO
N
H
O
Br
OH
Br
N
O
Bn
TBDMSO
Li
NH3/THF
-78 °C
Br2
CCl4/CH2Cl2
0 °C
then
HCl/MeOH
 
Scheme 121 
 
This sequence would allow the formation of a brominated oxindole starting from 76d 
(Scheme 122).  
NH3/THF
Li-wire
-78 °C, 8 min
41%
Br2
CCl4/CH2Cl2
0 °C, 15 min
52%
N
H
Me
O
N
H
Me
O
Br
I
N N
+
BuBu
O O
Me Me
t t
Br
N
Bn
O
Me N
Me
O
Bn
L* (5 mol%)
[Pd] (5 mol%)
NaOtBu, DME
75d 76d
(S,S)-66c.I
86 87
L*:
 
Scheme 122: Modification of the product to render determination of the absolute configuration possible 
 
As stated previously, 76d was obtained by the asymmetric intramolecular α-arylation of 75d 
with ligand (S,S)-66c.I. This product showed an [α]D20 of – 34 in dichloromethane and an 
enantiomeric purity of 79%. The oxinole 76d was deprotected with lithium in ammonia to the 
free oxindole 86 using Li/NH3. Bromination in a mixture of dichloromethane and 
tetrachloromethane at 0 °C furnished the monobrominated oxindole 87 in rather low yield. In 
contrast to Overman’ s result, monobromination was observed. Crystals suitable for x-ray were 
obtained by crystallization from diisopropylether.  
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The absolute configuration was determined as (S) by x-ray crystallography (Figure 58). 
 
Figure 58: crystal structure of 87. 
 
To confirm that the crystal measured by x-ray analysis has the same absolute stereochemistry 
than the major isomer of the obtained material, the CD spectrum of both were compared and 
showed identical cotton effects (Figure 59).  
 
 
 
Figure 59: CD spectrum (red line: single crystal, green line: solution of 5-bromooxindole) 
 
Based on this observation the asymmetric induction was interpreted as follows: 
 
The first consideration is the coordination sphere of the palladium. Non-distorted 
palladium(II) complexes exhibit a square planar geometry. Apart from the NHC-ligand, the 
aryl and the enolate, as well as probably the bromide (if there is enough space in the reaction 
zone) are bound to palladium in the catalytic intermediate. In principle, the aryl ligand can 
coordinate to palladium either cis or trans to the NHC-ligand. The probably high trans-effect 
of the NHC-ligand should favour the cis-coordination of the aryl ligand.279 One of several 
crystal structures, which supports this hypothesis, has been resolved by Nolan and coworkers 
and shows particularly nicely the bidentate coordination of 2-(N,N-dimethylamino)-biphenyl 
230 nm                                                      350 nm 
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to a NHC-palladium complex as depicted in Figure 60 with the aryl coordinated in cis-
position.280-282  
Pd
NMe2
Cl
R NN R
Pr
Pr
R = 
i
i
 
Figure 60 
 
Conclusively, four different structures could be considered for an enantiodetermining catalytic 
intermediate, giving either the (R) or the (S) product (Figure 61). For the (S,S)-ligand, a pro 
(R) coordination of the substrate shows in one palladacycle conformer the steric interaction of 
the aryl group with the methoxy substituent of the ligand (A), in the other conformer the steric 
(and electrostatic) interaction of the amide oxygen with the same ligand substituent (B).  
 
For the pro (S)-substrate, one conformer shows steric interactions of the phenyl group and of 
the amide oxygen with the ligand methoxy substituent (C). On the other hand, best fit could 
be expected by the model D, where no considerable interactions are present, and will 
therefore lead to the (S)-substrate.  
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NNH H
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O
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NNH H
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N
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NNH H
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O
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O
Pd
NNH H
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O
(S/S)-L and pro (S) substrate(S/S)-L and pro (S) substrate
(S/S)-L and pro (R) substrate(S/S)-L and pro (R) substrate
DC
BA
 
Figure 61: Conformational analysis of the enantiodetermining palladium enolate. 
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The model A of the catalytic intermediate could explain the configuration observed by the 
palladium catalyzed intramolecular α-arylation with the new highly bulky NHC-ligand 
precursor 66c.I.  
 
V.5. Conclusion and Outlook 
A small library of new NHC-ligands was successfully synthesized. Their application in the 
palladium catalyzed intramolecular α-arylation of 2-bromoanilides showed a remarkable 
increase in enantioselectivity of the system.  Albeit, the overall yield in the synthesis of ligand 
79b.I is highly unsatisfying, this ligand has shown the best enantioselectivity of all the ligands 
tested in this reaction. The basic improvement of this NHC-ligand class derived from chiral α-
arylated alkylamines is the increase of steric bulk in the benzylic position and in the 
ortho-position of the aryl side arms.  
 
An interesting modification of the methoxyphenyl-alkylamine derived ligands 66a – 66c 
could be the deprotection of the methoxy groups, which would provide a new tridentate NHC 
ligand.  
 
It will be part of the ongoing research to find other applications for these highly potent 
ligands.  
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VI. Experimental Part 
VI.1. General remarks 
Solvents: THF, Et2O, toluene, hexane, and CH2Cl2 were purified using filtration over alumina 
in a Solvtek solvent purification system. EtOH and MeOH were dried over CaH2 prior to 
distillation. Benzene was distilled over Na/benzophenone ketal. Where ‘degassed’  solvents or 
solutions are noted, degassing was carried out by three freeze-pump-thaw cycles. Chemicals 
were purchased from Aldrich, Fluka or Acros and used without further purification. 
Butyllithium (500 µl) in hexane (2 ml) in the presence of phenantroline (excess) was titrated 
against sec-butanol using the equation [cBuLi=10.89VBuOH/VBuLi].283 LDA was produced by 
dropwise addition of n-butyllithium to 1 eq. diisopropylamine in dry THF at 0 °C under a 
nitrogen atmosphere and stirring for 15 min prior to use. 1-(2’ -Methoxy- and hydroxyphenyl)-
alkylamines (Methyl- (1a, 1b)38, iso-propy- (2a, 2b)34 and tert-butyl- (3a, 3b)34), 
bisaminophenol 9 and 2648 and Whitesell’ s amine (11):36,284were synthesized following the 
now procedures. The 2-Bromoanilide derivatives 75b, 75c, 75e, 75g and 75j were synthesized 
according to known procedures.268 If not mentioned separately all reactions were carried out 
under nitrogen atmosphere and the glassware was oven-dried prior to use. Molecular sieve (3 
Å and 4 Å) were heated (160 °C) under vacuum (0.4 mbar) for 16 h. Cold bath: 0 °C: 
ice/water; –12 °C: ice/NaCl; –40 °C acetonitrile/dry ice; –60 °C toluene/dry ice;  –78 °C 
acetone/dry ice; –100 °C acetone/N2(l). Flash chromatography (FC): silica gel 60 (40 µm), 
P.H. Stehlin A. G. Optical rotations: Perkin-Elmer 241 polarimeter, 10 cm cell, c in g/100ml. 
IR: Perkin-Elmer FT-IR 1650; ν in cm-1, bands classified by strong (s), medium (m) and weak 
(w). NMR: Bruker 300, 400, 500 MHz; Varian-XL-200 MHz; δ in ppm, pattern 
abbreviations: broad (b~), singlett (s), triplett (t), quadruplett (q), quintett (quint), multiplett 
(m); references: internal SiMe4 or residual solvent peak; J in Hz. MS: EI (70 eV) VG7070, 
m/z in amu; ESI:  t.l.c.: Merck SIL G/UV254; detection by UV/VIS or by treatment with 
staining reagents: Ce-Mo-staining: Ce(SO4)2 (4.0 g), H3PMo12O40 (8.0 g) and H2SO4 (80.0 g) 
in 320 ml water. KMnO4-solution: KMnO4 0.5% in 1 N NaOH. Ninhydrin-staining: 0.3 g 
ninhydrin in 100 ml butanol and 3 ml acetic acid. Anisaldehyde/sulphuric acid: 0.5 ml 
anisaldehyde in a soln. of 50 ml acetic acid and 1 ml sulphuric acid. 
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Chapter II 
N
H
O
F
F
F
OH
Me
 
(R)-2,2,2-Trifluoro-N-(1-(2-methoxyphenyl)-ethyl)-acetamide (15):130 The aminophenol 
(1a) (13.7 mg, 1 eq, 0.1 mmol) was dissolved in CH2Cl2 (1 ml) at 0 °C and 
trifluoroacetanhydride (15 µl, 1.1 eq, 0.11 mmol) in CH2Cl2 (1 ml) was added dropwise over 
5 min. The solution was stirred for 45 min at which time ice water (1 ml) was added at 0 °C 
and the solution was stirred for an additional 30 min at 24 °C. The organic layer was 
separated, dried over Na2SO4 and concentrated in vacuo to yield 1b (10 mg, 0.043 mmol, 
43%) as a white solid.  
1H-NMR (400 MHz, CDCl3) δ 1.61 (3H, d, J = 7.0 Hz); 5.25 (1H, q, J = 7.0 Hz); 6.84 (1H, 
dd, J = 8.5 Hz, 1.0 Hz), 6.93 (1H, dt, J = 7.6 Hz, 1 Hz); 7.18 – 7.22 (2H, m); 7.53 (1H, bs).  
 
NH2
Me
OMe
 
(R)-(2-hydroxyphenyl)-ethyl amine (1b):38 The protected amine (15) (23.3 mg, 1 eq, 
0.1 mmol) was dissolved in DMF (1 ml) and cooled to −12 °C. NaH (4.3 mg, 1 eq, 0.1 mmol) 
was added in one portion. The solution was stirred for 2 h and allowed to warm to 0 °C at 
which time MeI (24 µl, 4 eq, 0.4 mmol) was added dropwise at 0 °C. The cooling bath was 
removed and the solution was stirred for 24 h at rt. 1 N NaOH was added and the mixture was 
stirred for another 30 min. After addition of ether, the aq. layer was separated and extracted 
with CH2Cl2. The combined organic extracts were washed with NaHCO3 and brine, dried over 
Na2SO4 and concentrated to yield 1b (11 mg, 0.073 mmol, 73%). 
1H-NMR (400 MHz, CDCl3) δ 1.41 (3H, d, J = 6.7 Hz); 3.86 (3H s, 3 H); 4.36 (1H, q, J = 6.7 
Hz); 6.87 (1H, dd, J = 8.2 Hz, 0.6 Hz); +dt, J = 7.4 Hz, 1.0 Hz); 7.20 (1H, dt, J = 7.6 
Hz, 1.6 Hz); +dd, J = 7.5 Hz, 1.6 Hz).  
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General procedure (GP1): Formylation of secondary amines.  
To a solution of p-TSA (10 mol%, 1 mmol) in triethylorthoformate (50 ml) in a round bottom 
flask equipped with a distillation condenser was added the secondary amine (1 eq., 10 mmol,). 
The resulting solution was heated to 130 °C for the given time. After cooling to 24 °C the 
volatiles were removed by evaporation. The residue was taken up in CHCl2 and washed with 
1 N HCl (3x 50 ml), sat. aq. Na2CO3 (3x 50 ml) and brine. The organic layers were combined, 
dried over Na2SO4 and concentrated in vacuo. 
 
N
O
Me Me
H
(R,R)
 
(R,R)-N,N-Bis-(D-phenylethyl)-formamide (12). The secondary amine 11 (2 g, 8,9 mmol) 
was converted to formamide 12 using GP1 stirring for 3 d. Yield 1,98 g (7,8 mmol, 88%) as a 
slightly yellow oil. 
1H-NMR (400 MHz, CDCl3) δ 1.71 (3H, d, J = 7.2 Hz); 1.75 (3H, d, J = 7.2 Hz); 4.53 (1H, q, 
J = 7.2 Hz); 5.74 (1H, q, J = 7.2 Hz); 6.30 (1H, d, J = 8.2 Hz); 6.83 – 6.86 (2H, m); 7.17 – 
7.20 (3H, m); 7.28 – 7.32 (5H, m); 8.37 (1H, s).285 
 
N
O
Me MeOMe OMe
H
(R,R)/(S,S) racemate
 
rac. N,N-Bis-(1-(2’-methoxyphenyl)-ethyl)-formamide (10). The secondary amine 9 (28.5 
mg, 0.1 mmol) was converted to formamide 10 using GP1 stirring for 3 d. Yield: 25 mg (0.08 
mmol, 81%) as a slightly yellow oil. 
1H-NMR (300 MHz, CDCl3) δ 1.52 (3H, d, J = 7.3 Hz); 1.56 (3H, d, J = 7.1 Hz); 3.54 (3H, 
s); 3.61 (3H, s); 4.82 (1H, q, J = 7.3 Hz); 5.58 (1H, q, J = 7.3 Hz); 6.30 (1H, d, J = 8.2 Hz); 
6.46 (1H, d, J = 8.0 Hz); 6.7 – 7.1 (4H, m); 7.24 (1H, d, J = 6.3 Hz); 7.37 (1H, dd, J = 7.5 Hz, 
1.5 Hz); 8.63 (1H, s). 
13C-NMR (100 MHz, CDCl3) δ 17.1; 21.6; 46.7; 49.5; 54.6; 54.9; 108.9; 109.5; 119.3; 119.6; 
127.9; 128.1; 128.9; 129.8; 155.9; 156.8; 163.0. 
IR (ATR diam.) 752(s); 1028(m); 1118(m); 1131(m); 1162(m); 1177(m); 1245(s); 1290(m); 
1363(w); 1375(w); 1436(m); 1464(m); 1587(m); 1602(m); 1660(s); 2837(m); 2926(m). 
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MS (EI) m/z 313 [M+](1); 298 (2); 270 (21); 178 (60); 150 (33); 135 (100); 105 (32); 103 
(11); 91 (25); 79 (17); 77 (21); 57 (10). 
HRMS calcd. for C19H23O3N: 313.1678; found: 313.1690. 
 
N
O H
 
N,N-Dibenzylformamide (17). Dibenzylamine (1.92 ml, 10 mmol) was converted to the N,N-
dibenhzylformamide 17 using GP1 stirring for 14 h. Yield 2.2 g (9.7 mmol, 97%) as a slightly 
yellow oil. 
 
1H-NMR ( 300 MHz, CDCl3) δ 4.14 (2H, s); 4.46 (2H, s); 7.20 – 7.42 (10H, m); 8.47 (1H, 
s).286 
 
N
O H
OMe OMe
 
N,N-Bis-(2-methoxybenzyl)-formamide (23): 2-methoxybenzyl-(2’ -methoxyphenyl-
methylidene)-amine: To a solution of 2-methoxybenzylamine (1.3 ml, 10 mmol) in CH2Cl2 
(10 ml) was added 2-methoxy-benzaldehyde (1.36 g, 10 mmol), formic acid (4 µl, 10 mol%, 1 
mmol) and activated molecular sieve (4 Å, 1 g) and the mixture was stirred for 6 h at 25 °C.  
The reaction mixture was filtered through Celite and concentrated to give the corresponding 
diimine (2.54 g, 9.95 mmol, 100%) as a pale yellow oil. 
1H-NMR: (300 MHz, CDCl3) δ 3.87 (3H, s); 3.89 (3H, s); 4.85 (2H, s); 6.88-7.02 (4H, m.); 
7.25-40 (3H, m); 8.05 (1H, d, J = 7.68
.
); 8.86 (1H, s).  
Bis-(2-methoxybenzyl)-amine: To a stirred solution of this diimine (2.5 g, 1 eq., 10 mmol) in 
MeOH (40 ml) at 0 °C was added NaBH4 (0.76 g, 2 eq., 20 mmol) in portions. The reaction 
was stirred for 30 min at rt and subsequently quenched with H2O. All volatiles were removed 
by rotatory evaporator. The residue was taken up in CH2Cl2 and extracted with 1 N HCl. The 
aq. layer was basified using NaOH pellets and extracted with CH2Cl2 (5x 50 ml, controlled by 
TLC). The combined organic layers were dried over K2CO3, filtered and evaporated to 
dryness to yield the corresponding secondary amine (1.71 g, 6.7 mmol, 67%). 
1H-NMR: (200 MHz, CDCl3) δ 3.82 (6H, s); 3.84 (4H, s); 6.80-6.70 (4H, m); 7.18-7.30 (4H, 
m
.
).  
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N,N-Bis-(2-methoxybenzyl)-formamide (23): The secondary amine (1,56 g, 6,0 mmol) was 
converted to the formamid 23 using GP1 stirring for 3 d. Yield 1,01g (3.54 mmol, 59%) as a 
slightly yellow oil. 
1H-NMR (400 MHz, CDCl3) δ 3.81 (1H, s); 3.82 (1H, s); 4.35 (1H, s); 4.48 (1H, s); 6.86 (2H, 
t, J = 7.56 Hz); 6.93 (2H, t, J = 7,32 Hz); 7,10 (1H, dd, J = 7.6, 1.5 Hz); 7.23 (1H, dt, J = 7.6, 
1.5 Hz); 8.43 (1H, s). 
 
General pprocedure for the preparation of aryl lithium reagents (GP2):  
General procedure (GP2A): Anisyl lithium:287 To n-BuLi (0.63 ml, 1 mmol, 1.6 M in 
hexane) at 0 °C under N2 was given dropwise TMEDA (0.165 ml, 1.1 mmol) and, after 
stirring for 10 min at rt the solution was cooled to 0 °C and anisol (0.12 ml, 1 eq, 1 mmol) 
was added. The resulting slurry was stirred for 40 min at 40 °C. The slightly yellow 
suspension was allowed to cool to rt and all volatiles were removed in vacuo and the system 
was purged with N2 before further manipulations.  
General procedure (GP2B): Phenyl lithium:288 To a stirred solution of PhI (1 eq., 1.2 M in 
hexane) at rt under N2 was added n-BuLi (1 eq., 1.6 M in hexane) and the mixture was stirred 
for 5 min. All volatiles were removed in vacuo before further manipulations.  
 
N
Me
MeO
rac
 
rac-Dibenzyl-(1-(2-methoxyphenyl)ethyl)amine (18). Anisyl lithium was prepared using 
GP2A. Dry ether (4 ml) was added and the reaction mixture was cooled to –78 °C. N,N-
Dibenzylformamide 17 (225 mg, 0.9 eq, 0.9 mmol) was added and the reaction was stirred for 
3 h at –78 °C after which time freshly distilled (COCl)2 (0.105 ml, 1.2 eq, 1.2 mmol) was 
added dropwise. The reaction mixture was allowed to warm to 24 °C within 30 min and a 
thick slurry was formed. All volatiles were removed in vacuo. The residual solid was 
suspended in dry ether (8 ml) and after cooling to 0 °C MeMgCl (0.4 ml, 1.2 eq, 1.2 mmol, 
3 M in THF) was added cautiously and the reaction mixture was stirred for 2 h at 45 °C. After 
cooling to 24 °C, H2O was added and the organic layer was separated, dried over Na2SO4 and 
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evaporated to dryness. Purification by column chromatography (cyclohexane/ethylacetate 
100:3) yielded 18 (131 mg, 0.40 mmol, 44%). 
1H-NMR (400 MHz, CDCl3) δ 1.43 (3H, d, J = 7.0 Hz); 3.46 (2H, d, J = 14.2 Hz); 3.77 (3H, 
s); 3.79 (2H, d, J = 14.2 Hz); 6.71 (1H, q,  J = 7 Hz); 6.93 (1H, d, J = 8 Hz); 7.02 (1H, t, J = 
7.6 Hz); 7.2 – 7.45 (11H, m); 7.50 (1H, dd, J = 1.8 Hz, 7.6 Hz). 
13C-NMR (100 MHz, CDCl3) δ 17.9 (CH3); 51.6 (CH); 54.7 (2xCH2); 55.2 (CH3); 110.8 
(CH); 120.3 (CH); 126.6 (2xCH); 127.9 (CH); 128.1 (4xCH); 128.7 (CH); 128.8 (4xCH); 
131.4 (C); 141.3 (2xC); 157.8 (C).  
IR (ATR diam.) 744(s); 794(m); 1028(m); 1106(m); 1239(s); 1287(m); 1453(m); 1490(m); 
1599(m); 1806(w); 1870(w); 1945(w); 2304(w); 2795(m); 2826(m); 2928(m); 3027(m). 
MS (EI) m/z 331 [M+] (8); 316 (74); 240 (2); 224 (9); 196 (2); 135 (35); 105 (11); 91 (100). 
HRMS calcd. for C23H25ON: 331.1936; found: 331.1940. 
 
General procedure (GP3): Double nucleophilic attack on formamide.  
A suspension of the formamide (1 eq.) in Et2O (0.1 M) at -78 °C was treated dropwise with 
the freshly prepared ArLi using GP2 and then stirred for the given time at the same 
temperature. (COCl)2 (1.2 eq.) was added dropwise and the mixture was allowed to stir for 25 
min at –78 °C after which time MeMgCl (10 eq.) was added. The resulting mixture was 
stirred for another 45 min before warming slowly to rt. Excess Grignard reagent was 
quenched by the cautious addition of cold water (1.2 ml per 1 mmol of formamide) and all 
volatiles were removed by evaporation under reduced pressure. The residue was partitioned 
between CH2Cl2 and water, the layers were separated and the aq. phase was extracted with 
CH2Cl2. The combined organic extracts were washed with sat. aq. NaCl, dried over Na2SO4 
and evaporated to dryness. 
 
N
Me
Me
Me
(R,R,R)
 
(R,R,R)-Tris-(1-phenylethyl)amine (7). Formamide 12 (500 mg, 1.98 mmol) was converted 
to the tertiary amine 7 according to GP3 using phenyl lithium (GP2B) as the nucleophile 
(1.9 ml, 1,5 eq., 1.8 M in hexane/Et2O 7:3.), stirring 1 h at -78 °C after addition of the phenyl 
CHAPTER VI 
Experimental Part 
 
118 
lithium reagent. Purification by chromatography (5% ethylacetate/ether) and recrystallization 
from EtOH yielded 7 (469 mg, 1.426 mmol, 72%) as a white powder. 
1H-NMR: (CDCl3; 400 MHz) δ 1.62 (9 H, d, J = 7.0 Hz); 4.20 (3 H, q, J = 6.9 Hz); 6.75 – 
6.79 (6 H, m); 7.12 – 7.15 (9 H, m).  
 
N
Me
Me
Me
MeO
(R,R,R)/(R,R,S)
 
(R,R,R)/(R,R,S)-N,N,N-[1-(2’-methoxyphenyl)ethyl]-bis-(1’’-phenylethyl)amine (21). 
Formamide 11 (125 mg, 0.5 mmol) was converted to the tertiary amine 12 according to GP3 
using anisyl lithium (GP2A) as the nucleophile (1.5 ml, 3 eq., 1 M in Et2O), stirring 3 h at –78 
°C after addition of the anisyl lithium reagent. (Estimated yield from crude 1H-NMR: ~60 to 
70%, ratio dr 3:1). 
Isomer A:  
1H-NMR: (CDCl3; 400 MHz) δ 1.54 (3H, d, J = 7.0 Hz); 1.59 (6H, d, J = 7.0 Hz); 3.46 (3H, 
s); 4.30 (2H, q, J = 7.0 Hz); 4.73 (1H, q, J = 7.0 Hz); 6.78 - 6.84 (6H, m); 7.02 – 7.04 (6H, m); 
7.10 (1H, t, J = 7.6 Hz), 7.26 (1H, d, J = 7.6 Hz).  
13C-NMR: (100 MHz, CDCl3) δ 18.8 (2xCH3); 19.5 (CH3); 48.6 (CH); 53.4 (2xCH); 54.8 
(OMe); 110.01 (CH); 119.7 (CH); 125.6 (2xCH); 127.2 (4xCH); 127.4 (CH); 127.9 (4xCH); 
128.3 (CH); 133.7 (C); 146.0 (2xC); 156.7 (C). 
Isomer B:  
1H-NMR: (CDCl3; 400 MHz) δ 0.99 (3H, d, J = 7.0 Hz); 1.50 (6H, d, J = 7.0 Hz); 3.88 (3H, 
s); 4.18 (2H, q, J = 7.0 Hz); 4.80 (1H, q, J = 7.0 Hz); 6.91 (1H, dd, J = 8.16, 0.8 Hz), 7.0 – 7.4 
(12H, m); 7.72 (1H, dd, J1 = 7.6, 1.7 Hz). 
13C-NMR: (100 MHz, CDCl3) δ 15.6 (2x CH3); 23.5 (CH3); 48.5 (CH); 53.7 (2x CH); 55.4 
(OMe); 110.7 (CH); 120.9 (CH); 125.9 (CH); 127.4 (2xCH); 127.5 (4xCH); 127.7 (4xCH); 
128.8 (CH); 135.0 (C); 146.5 (2xC); 156.6 (C). 
IR (ATR diam.) 3059(w), 3023(w), 2961(m), 2919(s), 2847(m), 1940(w), 1888(w), 1801(w), 
1734(m), 1599(m), 1491(m), 1450(m), 1373(m), 1244(s), 1088(s), 1031(s), 908(s), 795(s). 
MS (EI) m/z 359 (M+, 3); 344 (15); 240 (16); 210 (24); 135 (66); 105 (100); 77 (22).  
HRMS calcd. for C25H29ON: 359.22491; found: 359.22577. 
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Me
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rac-N,N,N-Bis-[1-(2’-methoxyphenyl)ethyl]-(1’’-phenylethyl)amine (22). Formamide 10 
(141 mg, 0.45 mmol) was converted to the tertiary amine 22 according to GP3 using phenyl 
lithium (GP2B) as the nucleophile (0.5 ml, 2 eq., 1.8 M in H/Et2O 7:3). The reaction mixture 
was stirred for 1 h at –78 °C after addition of the phenyl lithium reagent. (Estimated yield 
from crude 1H-NMR: ~60%, dr 2.4:1). The sample could not be purified enough for a 
reasonable characterization. 
IR (ATR diam.) 2931(m); 2869(w); 2833(w); 1803(w); 1734(w); 1599(w); 1490(m); 
1463(m); 1373(w); 1293(s); 1032(m); 752(m). 
MS (EI) m/z 389 (M+, 1); 374 (5); 270 (1); 240 (26); 135 (100); 105 (58); 91 (32); 86 (22); 77 
(22); 57 (25); 55 (15). 
 
N
Me
Me
Me
OMe OMe
MeO
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rac-N,N,N-Tris-[1-(2-methoxyphenyl)-ethyl]-amine (20). Formamide 10 (141 mg, 
0.45 mmol) was converted to the tertiary amine 20 according to GP3 using anisyl lithium 
(GP2A) as the nucleophile (1.35 ml, 3 eq., 1 M in Et2O), stirring 3 h at –78 °C after addition 
of the anisyl lithium reagent. (Yield estimated from crude 1H-NMR: ~40%). The sample 
could not be purified satisfyingly for a reasonable characterization. 
MS: (ESI) m/z 420.3. 
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rac-N,N,N-Bis-(2-methoxybenzyl)-[’’-(2’-methoxyphenyl)-ethyl]amine (24).  
Formamide 23 (127 mg, 0.45 mmol) was converted to the tertiary amine 24 according to GP3 
using anisyl lithium (GP2A) as the nucleophile (1.35 ml, 3 eq., 1 M in Et2O), stirring 75 min 
at –78 °C after addition of the anisyl lithium reagent. (Estimated yield from crude 1H-NMR: 
~60 to 70%). The sample was subjected to column chromatography. Unfortunately, purity for 
a reasonable characterization could not be obtained. 
 
N
MeOH OH
 
(+)-(R)-2-salicylideneaminoethyl)-phenol ((+)-(R)-32): To a stirred solution of the chiral 
amine 1a (0.685 g, 5 mmol) in methanol (20 ml, dry) in the presence of molecular sieve (3 Å, 
2 g) was added salicylic aldehyde (0.52 ml, 5 mmol) and the mixture was stirred for 3 h. The 
reaction mixture was filtered through a plague of Celite and the solvent was removed by 
evaporation to obtain 32 (1.21 g, 5.0 mmol, 100%) as orange-yellow foam. 
[D]D20  +150.1° (c = 1.90 in EtOH). 
1H-NMR (400 MHz, CDCl3) δ 1.74 (3H, d, J = 6.8 Hz); 4.94 (1H, q, J = 6.8 Hz); 6.82 (1H, t, 
J = 7.2 Hz);  6.89 – 6.95 (2H, m); 6.99 (1H, d, J = 8.4);  7.16 (1H, t, J = 7.4); 7.25 (1H, d, J = 
7.6); 7.31 – 7.38 (2H, m); 8.38 (1H, s).  
13C-NMR (100 MHz, CDCl3) δ 22.4 (CH3); 62.6 (CH); 116.1 (CH); 117.5 (CH); 117.8 (C); 
118.7 (CH); 120.3 (CH); 127.4 (CH); 128.6 (C); 128.7 (CH); 132.2 (CH); 133.8 (CH); 153.9 
(C); 163.6 (N=CH); 165.1 (C). 
IR (ATR diam.) 2000 – 3600 (broad, m); 3051(m); 2972(m); 2940(m); 2717(m); 2615(m); 
1634(s); 1610(m); 1532(m); 1489(m); 1454(m); 1397(m); 1336(w); 1282(m); 1224(m); 
1193(m); 1151(m); 1078(w); 1040(w); 897(w); 837(w); 755(s).289 
MS (ESI) m/z 242.3 [M + H]+.  
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(R)-1-(2-hydroxyphenyl)ethyl-(2-hydroxybenzyl)amine ((+)-(R)-28): Imine 32 (1.21 g, 
5.0 mmol) was dissolved in methanol (20 ml) and Pd on activated carbon (2.71 mg, 0.5 mmol, 
10 mol%) was added. The mixture was shaken for 1 h at rt under H2 atmosphere. The reaction 
mixture was filtered through Celite and the solvent was removed by evaporation. The residue 
was taken up in CH2Cl2 and extracted with 1 N HCl (3x 30 ml), the aq. layer was cautiously 
basified using NaHCO3 until pH 8 was reached and after extraction with CH2Cl2, drying over 
Na2SO4 and evaporation of the solvent, amine 28 (0.869 g, 3.57 mmol, 71%) was obtained as 
a slightly brownish white powder. 
mp 150 – 151 °C.  
[D]D20 +21.2° (c = 0.25 in EtOH) 
1H-NMR (400 MHz, CDCl3) δ 1.52 (3H, d, J = 6.7 Hz); 3.75 (1H, d, J = 13.2 Hz); 3.94 (1H, 
d, J = 13.2 Hz); 4.05 (1H, q, J = 6.7 Hz); 6.8 – 7.0 (4H, m); 7.0 – 7.15 (2H, m); 7.15 – 7.3 
(2H, m). 
13C-NMR (100 MHz, d3-MeOD) δ 20.7 (CH3); 47.1 (CH2); 55.8 (CH); 115.0 (CH); 115.8 
(CH); 118.8 (CH); 118.9 (C); 123.9 (C); 127.2 (CH); 127.9 (CH); 128.2 (CH); 129.6 (CH); 
156.5 (C); 156.7 (C). 
IR (ATR diam.) 2975(broad, m); 2323(m); 1591(m); 1456(m); 1253 (m); 754 (m). 
MS (ESI) m/z 350.3 [M + H]+.  
HRMS calcd for C15H18NO2: 244.1337; found 244.1343. 
 
N
Me OH
OH
O
 
(R)-2-[3-(2-hydroxy-benzyl)-4-methyl-3,4-dihydro-2H-benzo[e][1,3]oxazin-2-yl]-phenol 
(30): Amine 28 (448 mg, 1.8 mmol), salicylic aldehyde (0.193 ml, 1.8 mmol) and AcOH 
(10 O mmol, 10 mol%) were dissolved in dry methanol (10 ml) and stirred at 36 °C for 
40 h in the presence of molecular sieve (3 Å, 1 g). The reaction mixture was filtered through 
Celite and the solvent was removed by evaporation. The residue was extracted with a 
minimum amount of cyclohexane, filtered and concentrated to dryness; this extraction was 
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repeated with the obtained residue. Then the residue was extracted with a minimum amount of 
acetonitril, filtered and concentrated to dryness, this extraction was repeated with the obtained 
residue. The pale yellow oil was dried in vacuo (0.1 mbar) to yield benzoxazin 30 (565 mg, 
1.6 mmol, 90%). (Caution, this product is very hygroscopic and hydrolyses readily to the 
secondary amine and the salicylic aldehyde. Keep dry). 
[D]D20  +45.5° (c = 0.15 in EtOH). 
1H-NMR (400 MHz, CDCl3) δ 1.75 (3H, d, J = 7 Hz); 3.56 (1H, d, J = 14 Hz); 4.13 (1H, q, 
J = 7 Hz); 4.275 (1H, d, J = 14 Hz); 6.35 (1H, s); 6.7 – 7.3 (11H, m); 7.68 (1H, d, J = 7.6 Hz). 
13C-NMR (75 MHz, CDCl3) δ 21.9 (CH3); 48.3 (CH2); 52.6 (CH); 83.0 (CH); 116.37 (C); 
116.40 (CH); 117.0 (CH); 119.9 (CH); 120.2 (CH); 121.7 (C); 121.8 (CH); 124.1 (C); 127.96 
(CH); 128.01 (CH); 128.4 (CH); 128.7 (CH); 129.0 (CH); 129.9 (CH); 130.2 (CH); 153.1 (C); 
154.2 (C); 156.3 (C). 
IR (ATR diam.) 3301(broad, m); 2925(m); 2854(m); 1664(w); 1587(m); 1488(s); 1458(s); 
1375(m); 1263(m); 1230(m); 1186(w); 1152(w); 1109(m); 1034(m); 991(m); 947(w); 858(w); 
754(s). 
MS (ESI) m/z 348.3 [M + H]+.  
HRMS calcd for C22H24NO3: 348.1599; found 348.1609. 
 
N
Me OH
OH
OH
.HCl 
(R)-Bis-(2-hydroxybenzyl)-[1-(2-hydroxyphenyl)-ethyl]-ammonium chloride (27): To a 
stirred solution of the benzoxazine 30 (374 mg, 1.08 mmol) in dry methanol (12 ml) at 0 °C 
(ice water bath) was added NaBH4 (41 mg, 1.08 mmol) in portions. The reaction mixture was 
stirred for 16 h during which time the temperature rose to 18 °C. The reaction mixture was 
cooled to 0 °C and sat. aq. NH4Cl solution (10 ml) was added. The suspension was extracted 
with CH2Cl2 (3x 10 ml) and the combined extracts were kept over ice. The organic layer was 
dried over Na2SO4 and evaporated to dryness in vacuo to yield ligand 27 (383 mg, 100%) as a 
slightly yellow oil. For analysis, the amine was suspended in Ether and Ether/HCl (0.5 M) 
was added until no more precipitate was formed. Ether was evaporated and the residue was 
washed with ether and dried in vacuo.  
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[D]D20 –31.2° (c = 0.22 in EtOH). 
1H-NMR (400 MHz, CDCl3) δ 1.79 (3H, d, J = 7 Hz); 3.6 (1H, m); 3.85 (1H, m); 4.385 (1H, 
d, J = 11 Hz); 4.575 (1H, d, J = 11 Hz); 4.91 (1H, bs); 6.7 – 7.3 (12H, m); 9.1 (1H, s, NH
.
); 
9.37 (1H, s, OH
.
); 9.45 (1H, s, OH
.
); 9.58 (1H, s, OH).  
13C-NMR (100 MHz, CDCl3) δ 8.9 (CH3); 50.8 (CH2), 52.1 (CH2); 55.4 (CH); 115.6 (C); 
115.8 (C); 116.88 (CH); 116.91 (CH); 117.0 (CH); 119.6 (C); 119.98 (CH); 120.04 (2xCH); 
127.3 (CH); 130.8 (CH); 131.3 (CH); 131.7 (CH); 132.0 (CH); 132.2 (CH); 155.4 (C); 155.8 
(C); 156.3 (C).  
IR (ATR diam.) 3159(broad, m); 3093(s); 1718(w); 1608(m); 1461(s); 1505(w); 1395(m); 
1246(m); 1203(m); 1157(w); 1112(m); 1039(m); 909(m); 752(s); 732(s).  
MS (ESI) m/z 350.3 [M + H]+.  
HRMS calcd for C22H24NO3: 350.1756; found 350.1748. 
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Iron(III)-(Bis-(2-oxyidobenzyl)-((R)-1-(2-oxydophenyl)-ethyl)-amine)-(1-methyl-
imidazole) (37). To a solution of ligand (R)-27.HCl (23 mg, 0.07 mmol, 1 eq.) in THF (2 ml) 
at 0 °C under N2 was cautiously added MeLi (0.18 ml, 4.4 eq., 0.29 mmol, 1.6 M in hexane). 
The cooling bath was removed and the mixture was stirred for 20 min at rt. The solvent was 
removed and dry MeOH (1 ml) was added, followed by addition of Fe(III)Cl (10.7 mg, 1 eq., 
0.07 mmol) and MeIm (15.7 µl, 3 eq., 0.20 mmol). The dark red reaction mixture was stirred 
for 2 h at 23 °C. The solvent was evaporated.  
Few crystals suitable for X-ray crystallography were obtained by slow diffusion of toluene 
into a solution of the complex in CH2Cl2. 
 
General procedure (GP4): Formation of trioxaazaphenalenes. Salicylaldehyde derivative 
(3 eq.), ammonium acetate (1.5 eq.) and acetic acid (2 eq.) were refluxed in either benzene or 
toluene by means of a Dean-Stark distillation head for a given time. Then the solvent volume 
was reduced to half by evaporation and upon cooling a pale yellow spongy solid was build 
which was filtered and washed successively with toluene and water and dried in an exsiccator.  
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5aH.10aH.15aH-tribenzo[b.f.j][1.4.7]trioxa[9b]-azaphenalen (34a):137,138 From salicyl-
aldehyde (3 g, 24.6 mmol) azaphenalen 34a (890 mg, 2.7 mmol, 33%) was obtained after 3 h 
refluxing using GP4. (Recrystallization from toluene.) 
1H-NMR (400 MHz, C6D6) (C3 isomer) δ 5.22 (3H, s); 6.84 (3H, dt, J = 7.0, 1.5 Hz); 6.91 – 
7.01 (2H, m); 7.53 (1H, d, J = 7.6 Hz). 
13C-NMR (100 MHz, C6D6) δ 83.02 (CH); 116.97 (CH); 119.87 (C); 121.51 (CH); 127.08 
(CH); 128.33 (C); 1229.98 (CH); 153.90 (C). 
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4,9,14-Triphenyl-5aH.10aH.15aH-tribenzo[b.f.j][1.4.7]trioxa[9b]-azaphenalen (34b): 
From 2-hydroxy-biphenyl-3-carbaldehyde (0.98 g, 4.95 mmol) azaphenalen 34b (377 mg, 
0.62 mmol, 38%) was obtained using GP4. 
 1H-NMR (300 MHz, CDCl3) (mixture of 2 diastereomers (C3/C1 1:1.2)) δ 5.95 (1.2H, s); 
5.96 (3H, s); 6.29 (1.2H, s); 6.56 (1.2H, s); 6.98 (1.2H, t, J = 7.6 Hz); 7.06 – 7.21 (8.4H, m); 
7.33 – 7.69 (44.4H, m). 
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2,4,7,9,12,14-hexa(2,2-dimethylpropyl)-5aH.10aH.15aH-tribenzo[b.f.j][1.4.7]trioxa-[9b]-
azaphenalen (34c): From 2,4-di-(2,2-dimethylethylen)salicylaldehyde (1.25 g, 5.35 mmol) 
azaphenalen 34c (188 g, 0.28 mmol, 16%) was obtained using GP4. 
1H-NMR (400 MHz, CDCl3) mixture of two diastereomers (C3/C1 1:0.4) δ 1.3 (3.9H, s); 1.35 
– 1.37 (34.8H, m,); 1.44 (3.9H, s); 1.50 (27H, s); 1.53 (3.9H, s); 1.54 (3.9H, m); 5.79 (3.9H, 
s); 5.96 (3.9H, s); 7.34 (0.4H, bd, J = 2.0 Hz); 7.37 (3.4H, d, J = 2.3 Hz); 7.41 – 7.43 (0.8H, 
m); 7.46 (0.4H, d, J = 2.0 Hz); 7.56 (0.4H, d, J = 2.3 Hz); 7.68 (0.4H, d, J = 2.3 Hz). 
13C-NMR (100 MHz, CDCl3) (major isomer (C3)) δ 29.48 (CCH3); 31.72 (C); 83.59 (CH); 
119.3 (C); 121.83 (CH); 124.46 (CH); 137.39 (C); 143.70 (C); 150.24 (C). 
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2-Hydroxybiphenyl-3-carbaldehyde (44):62 Biphenyl-2-ol (17 g, 0.1 mol) was dissolved in 
THF (200 ml) and treated with Et3N (27 ml, 0.2 mol) followed by MgCl2 (14.3 g, 0.2 mol). 
The mixture was stirred for 20 min at rt, after which time (H2CO)n (15 g, 0.5 mol) was added. 
The resultant mixture was refluxed for 3 h and diluted with EtOAc (200 ml). The solution was 
washed with 1 N HCl followed by brine, dried over Na2SO4, filtered, and concentrated under 
reduced pressure. Column chromatography (pentane/ether 19:1) yielded aldehyde 44 (19.6 g, 
99 mmol, 99%). 
1H-NMR (200 MHz, CDCl3) δ 7.1 – 7.8 (8H, m); 10.04 (1H, s); 11.62 (1H, s, OH).  
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Me
 
rac-3-(1-Hydroxyethyl)-biphenyl-2-ol (45): MeMgBr (51 ml, 152 mmol, 3 M in Et2O) was 
added dropwise to a stirred solution of 2-Hydroxybiphenyl-3-carbaldehyde (44) (12.2 g, 
61 mmol) in dry Et2O (200 ml) over a period of 1 h. The solution was refluxed for 16 h. Sat. 
aq. NH4Cl (200 ml) was added and the product was extracted with Et2O (3x 100 ml). The 
combined organic layers were washed with water and brine, dried over Na2SO4 and 
concentrated to afford the pure product 45 (12.98 g, 60.6 mmol, 99 %) as a green-yellow oil. 
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1H-NMR: (200 MHz, CDCl3) δ 1.70 (3H, d, J = 6.6 Hz); 5.20 (1H, q, J = 6.6 Hz); 6.9 – 7.7 
(8H, m). 
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1-(2’-Hydroxybiphenyl-3’-yl)-ethanone (46): Best procedure: To a flask containing alcohol 
45 (214 mg, 1 eq., 1 mmol) was added hexane (10 ml) and it was heated to 40 °C under 
rigorous stirring. Then MnO2 (783 mg, 9 eq., 9 mmol) was added. The resulting slurry was 
refluxed under N2 atmosphere for 24 h with rigorous stirring. After cooling to rt, the reaction 
mixture was diluted with CH2Cl2, filtered through Celite and evaporated to dryness to give 
686 mg of a dark red foam. Flash chromatography (cyclohexane/Et2O 9:1) provided ketone 46 
(89 mg, 0.42 mmol, 42 %,) as a yellow oil. 
1H-NMR (300 MHz, CDCl3) δ 2.70 (3H, s); 7.01 (1H, t, J = 8.0 Hz); 7.3 – 7.5 (3H, m); 7.5 – 
7.6 (3H, m); 7.81 (1H, dd, J = 8.0, 1.6  Hz); 12.85 (1H, s, OH).62  
13C-NMR (75.47 MHz, CDCl3) δ 27.0 (CH3); 118.8 (CH); 119.9 (C); 127.5 (CH); 128.2 
(2xCH); 129.4 (2xCH); 130.1 (CH); 131.2 (C); 137.0 (C); 137.3 (CH); 159.9 (C); 204.9 (C). 
IR (ATR diam.) 3245(sh, w); 3033 (m); 1635 (s); 1498(w); 1478(w); 1450(m); 1425(s); 
1362(m); 1320(m); 1289(m); 1238(m); 1183(w); 1137(m); 1094(w); 1024(m); 969(m). 
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(R)-3-(1-(1-Phenylethylimino)-ethyl)-biphenyl-2-ol (47): A mixture of 2-hydroxy-3-phenyl-
acetophenone (1.77 g, 8.3 mmol), R-(+)-methyl-benzylamine (1.06 ml, 8.3 mmol), p-TSA 
(160 mg, 10 mol%, 0.8 mmol) and molecular sieve (4 Å, 4 g) in dry toluene (15 ml) was 
boiled under reflux for 16 h. The solution was filtered through a pad of Celite and 
concentrated to afford 47 (2.39 g, 7.57 mmol, 91 %) as a yellow oil. The product was used 
without further purification. An analytical sample was chromatographed 
(cyclohexane/Et2O/Et3N 9:1:0.1).  
CHAPTER VI 
Experimental Part 
 
127 
1H-NMR (400 MHz, CDCl3) δ 1.70 (3H, d, J = 6.6 Hz); 2.43 (3H, s); 5.02 (1H, q, J = 6.6 
Hz); 6.88 (1H, t, J = 7.6 Hz); 7.2 – 7.6 (10H, m); 7.69 (2H, dd, J = 7.0 Hz).  
13C-NMR (100.61 MHz, CDCl3) δ 15.2 (CH3); 25.2 (CH3); 58.57 (CH); 116.71 (CH); 119.4 
(C); 126.4 (2xCH); 126.9 (CH); 127.3 (CH); 127.7 (CH); 128.1 (2xCH); 128.9 (2xCH); 129.5 
(2xCH); 131.5 (C); 133.7 (CH); 138.6 (C); 144.0 (C); 162.1 (C); 171.3 (C=N).  
IR (ATR diam.) 3173(sh, w); 3050(m); 3028(m); 2971(m); 2926(m); 2430(b, w); 1956(w); 
1873(w); 1808(w); 1723(w); 1675(w); 1598(s); 1493(m); 1451(m); 1436(m); 1374(m); 
1307(m); 1288(m); 1261(m); 1201(w); 1150(m); 1082(m); 1024(m). 
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3-(1-(1-Phenylethyl)amino)-ethyl)-biphenyl-2-ol (48): NaBH4 (17 mg, 2eq., 0.44 mmol) 
was added in one portion to a mixture of 47 (70 mg, 1 eq., 0.22 mmol), CeCl3Â7H2O (41 mg, 
0.5 eq., 0.11 mmol) and MeOH (2 ml) at –100 °C. The temperature of the mixture was 
allowed to raise to 20 °C over a period of 12 h and CH2Cl2 (5 ml) was added, followed by sat. 
aq. NH4Cl (5 ml). The solution was extracted with CH2Cl2 and the combined organic layers 
were dried over MgSO4 and concentrated to afford 67 mg of crude product. The resulting oil 
was diluted in Et2O (2 ml) and the hydrochloride salt was precipitated by adding Et2O/HCl 
(0,5 M). The HCl salt was washed with Et2O. The amine was liberated by treatment with a 
solution of NaOH (1 N) to obtain the free amine 48 (55.2 mg, 0.17 mmol, 79%) as a 
colourless oil with a diastereomeric ratio of 87:13 in favour of the (R,R) diastereomer as 
determined by integration of the benzylic protons in the 1H-NMR. 
1H-NMR (300 MHz, CDCl3) δ 1.44 (3H, d, J = 6.6 Hz); 1.46 (3H, d, J = 6.6 Hz); 3.76 (1H, q, 
J = 6.6 Hz); 3.81 (1H, q, J = 6.6 Hz); 6.8 – 7.0 (2H, m); 7.2 – 7.5 (9H, m); 7.71 (2H, dd, J = 
8.4, 1.4 Hz).  
13C-NMR (75.5 MHz, CDCl3) δ 22.8 (CH3); 23.5 (CH3); 55.4 (CH); 56.5 (CH); 119.1 (CH); 
126.4 (2xCH); 126.7 (CH); 126.8 (C); 127.6 (CH); 127.7 (CH); 128.1 (2xCH); 128.9 (2xCH); 
129.5 (2xCH); 138.9 (C); 143.6 (C); 154.8 (C). 
IR (ATR diam.) 3310(bw); 3029(m); 2963(m); 2925(m); 2867(m); 1948(w); 1873(w); 
1806(w); 1721(w); 1672(w); 1591(s); 1499(m); 1460(m); 1429(m); 1374(m); 1356(w); 
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129(w); 1262(m); 1246(m); 1209(w); 1176(w); 1101(m); 1069(m); 1028(m); 909(m); 826(m); 
800(m); 757(s); 733(m); 697(s). 
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2-Benzyloxy-biphenyl-3-carbaldehyde (49): A suspension of K2CO3 (9.6 g, 4.4 eq., 
69.5 mmol) in CHCl3/MeOH 2:1 (285 ml) in a 500 ml two neck flask equipped with a 
condenser was refluxed for 15 min. 2-hydroxybiphenyl-3-carbaldehyde 44 (3.17 g, 1 eq., 
16.0 mmol) and benzyl bromide (2.12 ml, 1,1 eq., 17.8 mmol) were added and the resulting 
yellow mixture was refluxed for 12 h. All volatiles were removed under reduced pressure. 
The crude product was taken up in Et2O (100 ml) and filtered through Celite. The filtrate was 
washed with 3 N NaOH (3x 50 ml), dried over MgSO4, filtered and concentrated by rotatory 
evaporater. The resulting yellow oil was crystallized from hot cyclohexane/ethylacetate 9:1 to 
afford 49 (2.04 g, 7.1 mmol, 44%) as white crystals.  
mp 99 – 101 °C. 
1H-NMR (500 MHz, CDCl3) δ 4.56 (2H, s); 7.06 – 7.09 (2 H, m); 7.27 – 7.32 (4H, m); 7.42 – 
7.51 (3H, m); 7.64 – 7.66 (3H, m); 7.84 (1H, dd, J = 7.8, 1.8); 10.35 (1H, s). 
13C-NMR (125 MHz, CDCl3) δ 77.1 (CH2); 124.7 (CH); 127.4 (CH); 127.9 (CH); 128.49 
(CH); 128.53 (2xCH); 128.6 (2xCH); 128.7 (2xCH); 129.2 (2xCH); 130.2 (C); 135.5 (C); 
136.4 (C); 137.2 (C); 137.3 (CH); 159.2 (C); 190.3 (CHO).  
IR (ATR diam.) 3344(w); 3061(m); 3032(m); 2878(m); 1953(w); 1901(w); 1878(w); 
1804(w); 1683(s); 1583(m); 1573(m); 1497(m); 1453(m); 1433(m); 1373(m); 1298(w); 
1274(w); 1245(m); 1220(w); 1205(m); 1173(w); 1072(w); 1026(w); 963(m); 918(m); 868(m); 
803(m); 769(m); 743(m); 695(s). 
MS (ESI) m/z 306.3 [M + NH4]+. 
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(–)-(S)-2-((1-(2-Benzyloxybipheny-3-yl)-methylidene)-amino)-2-phenylethanol ((–)-(S)-
50). A solution of (S)-(+)-2-amino-2-phenylethanol (303 mg, 1 eq., 2.21 mmol) and 2-
methoxybenzaldehyde (49) (637 mg, 1 eq., 2.21 mmol) in ethanol (5 ml) was refluxed for 30 
min in the presence of activated molecular sieve (4 Å, 0.5 g). The hot reaction mixture was 
filtered through Celite and then cooled to rt. The product crystallized upon standing over 
night. The brownish crystals were filtered and dried in vacuo to give 50 (798 mg, 1.95 mmol, 
88%). 
mp 97 – 99 °C. 
[D]D20 –55.6 (c = 0.40 in CH2Cl2).  
1H-NMR (500 MHz, CDCl3) δ 3.90 (1H, dd, J = 11.1, 4.6); 3.96 (1H, dd, J = 11.1, 8.2 Hz); 
4.38 – 4.49 (3H, m); 6.97 – 7.01 (2H, m); 7.23 – 7.32 (3H, m); 7.36 – 7.50 (10H, m); 7.62 – 
7.64 (2H, m); 8.11 (1H, dd, J = 7.75, 1.85 Hz); 8.74 (1H, s). 
13C-NMR (125 MHz, CDCl3) δ 67.7 (CH2); 75.6 (CH); 76.1 (CH); 124.6 (CH); 126.88 (CH); 
127.4 (CH); 127.48 (CH); 127.52 (2xCH); 128.2 (CH); 128.35 (2xCH); 128.42 (2xCH); 
128.57 (2xCH); 128.63 (2xCH); 129.3 (2xCH); 130.0 (C); 133.8 (CH); 135.8 (C); 136.1 (C); 
137.9 (C); 140.7 (C); 156.3 (C); 159.1 (CH).  
IR (ATR diam.) 3339 (broad, m); 3061(m); 3030(m); 2961(m); 2927(m); 2868(m); 1950(w); 
1876(w); 1808(w); 1663(s) 1601(m); 1581(m); 1497(m); 1453(m) 1429(m); 1375(m); 
1307(w); 1256(w); 1201(m); 1173(w); 1156(w); 1072(w); 1026(w); 981(m); 911(m); 865(w); 
803(w); 761(m); 734(m); 698(s). 
MS (ESI) m/z 408.4 [M + H]+. 
HRMS calcd for C28H26NO2: 408.1963; found 408.1965.  
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(+)-(S)-2-((S)-1-(2-Benzyloxybiphenyl-3-yl)-ethylamino)-2-phenylethanol ((+)-(S,S)-51). 
MeLi (4.3 ml, 4 eq., 6.4 mmol, 1.5 M in Et2O) was added dropwise to a stirred solution of 
(S)-50 (637 mg, 1 eq., 1.61 mmol) in dry, degassed THF (30 ml) at –78 °C under N2. This 
mixture was stirred for 24 h at –78 °C. It was then brought to –30 °C over a 4 h period and 
stirring was continued for an additional 20 h. The reaction was quenched at –30 °C by the 
addition of sat. aq. NH4Cl and was allowed to warm to 20 °C. The organic layer was 
separated. After evaporation of the solvent, the residue was taken up in Et2O (20 ml), and 
washed with sat. aq. NaHCO3 (3x 10 ml). The combined organic layers were dried over 
Na2SO4 and concentrated in vacuo to give an orange oil. Purification by flash chromatography 
(CH2Cl2/MeOH/Et3N 98:1:1) gave (+)-(S,S)-51 (276 mg, 0.65 mmol, 40%) as a pale yellow 
oil. The other diastereoisomer could not be detected by 1H-NMR (de 95%).  
[D]D20 +45.0 (c = 0.10 in CH2Cl2).  
1H-NMR (500 MHz, CDCl3) δ 1.37 (3H, d, J = 6.5); 3.56 (1H, dd, J = 10.7, 7.9); 3.75 (1H, 
dd, J = 10.7, 4.7); 3.91 (1H, dd, J = 7.9, 4.7); 4.17 (1H, d, J = 10.4); 4.22 (1H, d, J = 10.4); 
4.31 (1H, q, J = 6.6);  6.77 – 6.80 (2H, m); 7.18 – 7.44 (14H, m); 7.57 – 7.60 (2H, m).  
13C-NMR (125 MHz, CDCl3) δ 22.3 (CH3); 48.6 (CH); 61.6 (CH); 66.0 (CH2); 75.0 (CH2); 
124.7 (CH); 126.4 (CH); 127.15 (2xCH); 127.23 (CH); 127.5 (CH); 127.8 (CH); 128.1 
(2xCH); 128.2 (2xCH); 128.3 (2xCH); 128.6 (2xCH); 129.2 (2xCH); 129.9 (CH); 135.3 (C); 
135.8 (C); 136.7 (C); 138.7 (C); 139.3 (C); 140.9 (C); 153.2 (CH). 
IR (ATR diam.) 3557(w); 3326(broad, m); 3062(m); 3030(m); 2965(m); 2928(m); 2867(m); 
1951(w); 1881(w); 1806(w); 1714(w); 1655(broad, m); 1601(m); 1584(w); 1497(m); 
1454(m); 1430(m); 1376(m); 1328(w); 1309(w); 1255(m); 1201(m); 1071(m); 1027(m); 
980(m); 914(m); 865(w); 803(w); 760(s); 734(m); 699(s). 
MS (ESI) m/z 424.3 [M + H]+.  
HRMS calcd for C29H30NO2: 424.2276; found 424.2278. 
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(+)-(S)-1-(2-Benzyloxybiphenyl-3-yl)-ethylamine ((+)-(S)-52): A 250 ml flask was charged 
with anhydrous K2CO3 (124.5 mg, 6 eq., 0.9 mmol) and methanol (0.3 ml). The resulting 
white suspension was cooled to 0 °C with an ice bath. A solution of (S,S)-52 (63 mg, 1 eq., 
0.15 mmol) in CH2Cl2 (0.6 ml) and a solution of Pb(OAc)4 (78.6 mg, 1.2eq., 0.18 mmol) in 
CH2Cl2 (0.6 ml) were simultaneously added dropwise over a 12 min period. After 10 min, the 
reaction was quenched with sat. aq. Na2CO3 (0.5 ml). The mixture was filtered through Celite. 
The filter was washed with CH2Cl2 and sat. aq. Na2CO3. The combined aq. phases were 
extracted with CH2Cl2. The combined organic layers were dried over K2CO3 and the solvents 
were removed in vacuo.  
The crude imine was taken up in THF (1 ml) and hydrolyzed with an aq. AcOH (30%, 1 ml) 
for 20 h at 20 °C. The mixture was concentrated under vacuum and the aq. layer was 
extracted with Et2O. The combined organic layers were washed with aq. AcOH (30%). The 
combined aq. layers were cooled to 0 °C, brought to pH 14 by addition of NaOH (6 N) and 
extracted with Et2O. The combined organic layers were dried over K2CO3 and concentrated. 
The crude amine was dissolved in Et2O and Et2O/HCl (0.5 M) was added until no more 
precipitation was observed. The precipitate was filtered and washed with cold hexane and 
dried to afford the ammonium salt 52.HCl (30.6 mg, 0.10 mmol, 60%). A sample was 
crystallized from cyclohexane/ethyl acetate (4:1). The enantiomeric purity of the free amine 
was determined by chiral HPLC (Chiralcel OD-H, hexane/2-propanol 97:3, 1 ml/min: 10.0 
min (minor, R), 13.2 min (major, S): ee 95%.  
mp 118 – 121 °C.  
[D]D20 +22.7 (c = 1.90 in CH2Cl2). 
1H-NMR (300 MHz, CD3OD) δ 1.47 (3H, d, J = 6.9 Hz); 4.41 (1H, d, J = 10.8 Hz); 4.54 (1H, 
d, J = 10.9 Hz); 4.70 (1H, q, J = 7.0 Hz); 7.1 – 7.2 (2H, m); 7.2 – 7.6 (9H, m); 7.66 (2H, bd, 
J = 6.8 Hz).  
13C-NMR (100 MHz, CD3OD) δ 19.7 (CH3); 46.3 (CH); 76.5 (CH2); 123.8 (CH); 126.3 
(CH); 126.4 (CH); 129.0 (C and CH); 129.6 (C and CH); 129.7 (CH); 129.8 (4xCH); 130.2 
(2xCH); 133.2 (C); 133.5 (CH); 139.5 (C); 154.8 (C). 
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IR 3024 (broad, m, NH3+); 2873(m); 1981(w); 1943(w); 1881(w); 1803(w); 1603 (broad, m); 
1520(m); 1598(m); 1455(m); 1432(m); 1367(m); 1266(m); 1202(m); 1112(w); 1070(m); 
973(m); 917(w); 865(w); 804(w); 757(s); 696(s).  
MS (ESI) m/z 304.4 [M + H]+.  
HRMS calcd. for C21H22NO: 304.1701 found 304.1703. 
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(R,R)-N,N’-Bis-(1-(2-methoxyphenylene)-ethyl)-ethane-1,2-diimine) ((R,R)-56). Aq. 
glyoxal (114 µl, 1 eq, 1 mmol, 40% in water) was introduced into CH2Cl2 (5 ml) at 0 °C and 
vigorously stirred in presence of freshly dehydrated Na2SO4 (1.6 g). After the addition of 
formic acid (98%) (5.5 µl, 14 mol %, 0.13 mmol) and amine 1b (302 mg, 2 eq., 2 mmol), the 
mixture was allowed to stir for 5 min, after which time another 1.6 g of Na2SO4 were added. 
During 3 h of stirring at 0 °C the solution turned slightly yellow. The mixture was filtered, 
and the solvent was removed in vacuo to yield 56 (308 mg, 0.95 mmol, 95%) as a slightly 
brown oil.  
1H-NMR (400 MHz, CDCl3) 1.53 (6H, d, J = 6.8 Hz); 3.80 (6H, s); 4.98 (2H, q, 6.8 Hz); 6.85 
(2H, d, J = 8.4 Hz); 6.95 (2H, t, J = 7.3 Hz); 7.19-7.24 (2H, m); 7.42-7.45 (2H, m); 8.04 (2H, 
s). 
13C-NMR: (400 MHz, CDCl3) 22.5 (CH3); 27.1 (OCH3); 62.0 (CH); 110.6 (CH); 120.9 (CH); 
127.3 (CH); 128.2 (CH); 131.9 (C); 156.6 (C); 161.5 (CH). 
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(S,S)-N,N’-Bis-(1-(2-methoxyphenylene)-2’,2’-dimethylpropyl)-ethane-1,2-diimine) (57): 
Aq. glyoxal (57 µl, 0.5 eq, 0.5 mmol, 40% in water) was introduced into CH2Cl2 (2 ml) and 
vigorously stirred in presence of freshly dehydrated Na2SO4 (500 mg). After the addition of 
formic acid (98%) (3 µl, 7 mol%, 0.07 mmol) and (S)-1-(2-methoxy-phenyl)-2,2-
dimethylpropylamine (5b) (193 mg, 1 eq, 1 mmol), the mixture was allowed to stir for 5 min, 
after which time another 500 mg of Na2SO4 were added. During 3 h of stirring at room 
temperature the solution turned slightly yellow. The mixture was filtered, and the solvent was 
removed in vacuo to yield 57 (188 mg, 0.46 mmol, 92%) as a slightly brown oil.  
[α]D20: +97° (c = 1.57 in CH2Cl2).  
1H-NMR (500 MHz, CDCl3) δ 0.93 (18H, s); 3.79 (6H, s); 4.62 (2H, s); 6.82 (2H, d, J = 8.3 
Hz); 6.88 (2H, t, J = 7.5 Hz); 6.15 (2H, t, J = 8.0 Hz); 7.46 (2H, d, J = 7.6 Hz); 8.00 (2H, s). 
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13C-NMR (125 MHz, CDCl3) δ 26.7 (CH3); 36.2 (C); 55.3 (OCH3); 75.09 (CH); 110.2 (CH); 
119.9 (CH); 127.4 (CH); 130.1 (CH); 130.3 (C); 156.7 (C); 161.9 (CH). 
IR (ATR diam.) 3065(w); 3028(w); 2953(m); 2904(m); 2868(m); 2837(m); 1675(m); 
1627(m); 1600(m); 1585(m); 1490(s); 1462(s); 1439(m); 1392(m); 1288(m); 1238(s); 
1187(m); 1162(w); 1111(m); 1050(m); 1031(m); 1001(w); 986(w); 909(w); 887(w); 836(w); 
781(w); 753(s); 730(s); 671(w); 693(w); 614(w). 
 
N N
OH OH
Bu But t
 
(S,S)-N,N’-Bis-(1-(2-hydroxyphenyl)-2,2-dimethylpropyl)-ethylenediimine ((S,S)-58): To 
a stirred solution of (+)-(S)-5a (179 mg, 1 eq., 1 mmol) in EtOH (2 ml, 0.5 M) was added 
glyoxal (57 µl, 0.5 eq, 0.5 mmol, 40% in H2O). The resulting mixture was stirred for 18 h to 
go to completion. The volatiles were removed in vacuo to obtain 58 (179 mg, 0.47 mmol, 
94%) as a slightly beige solid. A small amount was washed with few drops of EtOH and dried 
in the oven (50 °C).  
1H-NMR (500 MHz, CDCl3) δ 0.99 (18H, s); 4.01 (2H, s); 6.71 – 6.75 (4H, m); 6.84 (2H, d, J 
= 7.6 Hz); 7.07(2H, t, J = 8.0 Hz); 7.96 (2H, s, HC=N). 
13C-NMR (125 MHz, CDCl3) δ 27.0 (C(CH3)3); 37.4 (C); 86.65 (CH); 117.3 (CH); 118.80 
(CH); 123.4 (C); 128.8 (CH); 130.1 (CH); 156.1 (C); 162.8 (N=CH). 
IR (ATR diam.) 3179(m); 3033(w); 2961(s); 2320(w); 1637(m); 1614(m); 1587(m); 1487(s); 
11366(m); 1242(s). 
 
Cu
N N
Bu Bu
O O
t t
 
(S,S)-Copper(II)-(N,N’-bis-(1-(2-hydroxyphenyl)-2,2-dimethylpropyl)-ethylenediimine) 
(59a): The diimine ligand 58 (6 mg, 0.016 mmol) was dissolved in hot ethanol (0.5 ml) and a 
solution of Cu(OAc)2 dissolved in hot ethanol (0.1 ml) was added whereupon the solution 
turned deep black green. After cooling to rt, the ethanol was removed by rotatory evaporation 
to yield a black green solid. Crystallization was not successful (used solvents: CHCl3, MeOH, 
EtOH and mixtures of it).  
MS (ESI) m/z 442.2. 
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Ni
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Bu Bu
O O
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(S,S)-Nickel-(N,N’-bis-(1-(2-hydroxyphenyl)-2,2-dimethylpropyl)-ethylenediimine) 
((S,S)-59b): The diimine ligand 58 (6 mg, 0.016 mmol) was dissolved in hot ethanol (0.5 ml) 
and was added to a solution of Ni(OAc)2 dissolved in hot ethanol (0.1 ml) whereupon an 
immediate colour change was observed from colourless to deeply black red. After cooling to 
rt, the ethanol was removed by rotatory evaporation to yield a black red solid. Crystallization 
was not successful (used solvents: CHCl3, MeOH, EtOH and mixtures of it). 
1H-NMR (400 MHz, DMSO) δ 1.12 (18H, s); 4.00 (2H, s); 6.4 (2H, t, J = 7.3 Hz); 6.65 (2H, 
d, J = 7.2 Hz); 6.83 (2H, d, J = 7.5 Hz); 6.93 (2H, t, J = 7.6 Hz); 7.84 (2H, s, HC=N). 
MS (ESI) m/z 437.1. 
 
OH
NHBOC
Me
 
(R)-(1-(2-Hydroxyphenyl)-ethyl]-carbamic acid tert-butyl ester (61). The amine 1a (137.5 
mg, 1 mmol) was dissolved in CH2Cl2 (5 ml) and the solution was cooled to 0 °C with an 
ice/water bath. (BOC)2O (237 mg, 1.09 mmol) was added in one portion and the reaction 
mixture was stirred for 12 h in an open flask and the temperature of the reaction mixture was 
allowed to warm up to 18 °C. The solvent was evaporated. The residue was taken up in Et2O, 
washed with sat. aq. NaHCO3, aq. 1 N HCl and brine, dried over Na2SO4 and the ether was 
evaporated to obtain the protected amine 61 (237.3 mg, 1 mmol, quant.). 
1H-NMR (200 MHz, CDCl3) δ 1.42 (9 H, s); 1.56 (3 H, d, J = 7.0 Hz); 4.98 (2 H, bs); 6.84 – 
6.95 (2 H, m), 7.14 – 7.25 (2 H, m). 
13C-NMR (100.6 MHz, CDCl3) δ 22.1 (C(CH3)3); 28.4 (C(CH3)3); 38.3 (CH3); 44.9 (C); 85.2 
(CH); 122.2 (CH); 118.80 (CH); 126.9 (CH); 127.5 (CH); 128.5 (CH); 146.5 (C); 146.8 (C); 
154.8 (NCO2). 
 
OSO2Me
NHBOC
Me
 
(R)-Methanesulfonic acid 2-(1-tert-butoxycarbonylaminoethyl)-phenyl ester (62): To a 
solution of carbamide 61 (237.3 mg, 1 eq., 1 mmol) and Et3N (0.35 ml, 2.5 eq., 2.5 mmol) in 
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dry THF (10 ml) at 0 °C under N2 was added methanesulfonyl chloride (0.19 ml, 2.5 eq., 2.5 
mmol,) and the resulting mixture was stirred for 2 h at 0 °C. The reaction was quenched with 
NaHCO3 (4 ml) and stirred for an additional ½ h. The organic layer was diluted with Et2O. 
The aq. layer was separated and extracted with Et2O (2 x 10 ml). The combined organic layer 
was dried over Na2SO4 and concentrated under reduced pressure to afford the mesyl sulfonic 
ester 62 (315 mg, 1 mmol, quant.). 
1H-NMR: (400 MHz, CDCl3) 1.41 (9H, s); 1.45 (3H, d, J = 3.0 Hz); 3.29 (3H, s); 4.86 (1H, 
bs); 5.09 (1H, bs); 7.29 – 7.31 (2H, m), 7.39 – 7.44 (2H, m). 
13C-NMR: (100.6 MHz, CDCl3) 22.1 (C(CH3)3)); 28.4 (C(CH3)3)); 38.3 (CH3); 44.9 (C); 85.2 
(CH); 122.2 (CH); 118.80 (CH); 126.9 (CH); 127.5 (CH); 128.5 (CH); 146.5 (C); 146.8 (C); 
154.8 (NCO2). 
 
NH2.HCl
Me
OSO2Me
 
(R)-1-(2’-Methanesulfonyloxyphenylene)-ethylammonium chloride (63.HCl): The methyl 
sulfonic ester 62 was dissolved in dioxane (20 ml) and HCl (g) (freshly prepared from H2SO4 
(conc.)/NaCl, dried by bubbling through H2SO4 (conc.)) was passed through the solution 
during 3 h. All volatiles were removed by rotatory evaporation. Et2O (3 ml) was added and 
the suspension was stirred for another 1 h. The precipitate was filtered and dried in vacuo to 
afford the desired ammonium chloride salt 63.HCl (210 mg, 0.96 mmol, 96%). 
1H-NMR (400 MHz, d3-MeOD) δ 1.65 (3H, d, J = 6.9 Hz); 3.45 (3H, s); 4.90 (1H, q, J = 6.9 
Hz); 7.48 – 7.55 (3H, m), 7.66 – 7.68 (1H, dd, J = 6.8, 1.7 Hz). 
13C-NMR (100.6 MHz, CDCl3) δ 22.3 (CH3); 41.0 (CH3); 48.6 (CH); 127.1 (CH); 130.8 
(CH); 132.1(CH); 134.4 (CH); 135.9 (C); 150.1 (C). 
 
N
Me
N OSO2Me
MeO2SO
PhPh
Me
 
1,2-Diphenyl-N,N’-bis-((R)-1-(2-methanesulfonyloxyphenyl)-ethyl)-ethane-1,2-diimine 
(64): The HCl salt of 63.HCl (210 mg, 0.96 mmol) was stirred for 1 h in sat. aq. Na2CO3 (10 
ml) and Et2O (10 ml). The two layers were separated and the aq. phase was washed with Et2O 
(2 x 10 ml). The combined organic layers were dried over Na2SO4 and the solvent was 
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evaporated in vacuo. The free amine was dissolved in dry benzene (1.5 ml) under N2 and 
benzil (10.5 mg, 0,05 mmol) was added. The resulting solution was cooled to 0 °C and 
titanium(IV) chloride (0.08 ml, 1 M in CH2Cl2) was added dropwise via syringe over a period 
of 5 min whereupon the reaction mixture turned orange-red. The ice bath was removed and 
the reaction was stirred for 4 d. The resulting slightly beige solution was diluted with Et2O, 
acidified by bubbling HCl (g) through the solution for 5 min, filtered and the obtained clear 
solution was evaporated to dryness (43 mg, 3.3:1 double-/mono-addition determined from 1H-
NMR). Separation by chromatotron (1 mm disk, cyclohexane/ethylacetate 8.5:1.5) provided 
64 (29 mg, 0.048 mmol, 96%).  
Isomer A (inseparable from B): 1H-NMR (300 MHz, CDCl3) δ 1.16 (6H, d, J = 6.2 Hz); 
2.71 (6H, s); 4.61 (2 H, q, J = 6.3 Hz); 7.12 – 7.98 (18 H, m).  
Isomer B: 1H-NMR (300 MHz, CDCl3) δ 1.73 (6H, d, J = 6.4 Hz); 2.81 (6H, s); 5.00 (2H, q, 
J = 6.3 Hz); 7.12 – 7.98 (18H, m). 
13C-NMR (100.6 MHz, CDCl3) δ 23.6 (CH3); 24.4 (CH3); 37.7 (SO2CH3); 38.0 (SO2CH3); 
56.3 (CH); 56.6 (CH); 121.9 (CH); 122.1 (CH); 127.0 (CH); 127.4 (CH); 127.7 (CH); 127.80 
(CH); 127.84 (CH); 128.0 (CH); 128.4 (CH); 128.8 (CH); 128.90 (CH); 128.94 (CH); 131.0 
(CH); 131.3 (CH); 135.2(C); 137.4 (C); 137.43 (C); 137.6 (C); 145.0 (C); 145.4 (C); 163.8 
(N=C).  
IR (ATR diam.) 3065(w), 3028(w), 2966(w), 2927(m), 2853(m), 1726(w), 1669(w), 1615(m), 
1578(m), 1485(m), 1448(m), 1351(s), 1275(m), 1210(m), 1184(s), 1154(s)1121(w), 1073(m), 
1041(w), 1001(w), 950(m), 874(s), 795(m), 777(m), 696(m). 
MS (ESI) m/z 605.5 ([M+H]+). 
 
N
Me
N OHOH
PhPh
Me
 
1,2-Diphenyl-N,N’-bis-((R)-1-(2-hydroxyphenyl)-ethyl)-ethane1,2-diimine (60): To a 
solution of n-BuLi (0.12ml, 4 eq., 0.2 mmol, 1.6 M in hexane) in THF (1 ml) at –78 °C under 
N2 was added iPr2NH (0.033 ml, 4.8 eq., 0.24 mmol) and the mixture was stirred for 30 min. 
The resulting mixture was transferred via a cannula to a solution of methanesulfonate aryl 
ester 64 in THF (1 ml) at –78 °C under N2. The reaction mixture was stirred for another 30 
min. Sat. aq. NH4Cl was added and the organic layer was diluted with ethylacetate and 
separated. The aq. layer was extracted with CH2Cl2. The combined organic layers were dried 
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over Na2SO4, filtered and dried in vacuo to obtain 35 mg of crude diimine 60. Flash 
chromatography (3.5 bar, silica gel, cyclohexane, 25 % CH2Cl2) yielded 60 (15 mg, 0.03 
mmol, 80%) of a mixture of two isomers (in a ratio of A:B is 2:1) 
Isomer A: 1H-NMR (500 MHz, CDCl3) δ 1.25 (6H, d, J = 6.7 Hz, CH3); 4.41 (2H, q, J = 6.7 
Hz); 6.11 (2H, dd, J = 7.56, 1.6 Hz); 6.47 (2H, DT, J = 7.4, 1.0 Hz); 6.87 – 6.90 (2H, m); 7.08 
– 7.12, (2H, m); 7.49 (4H, t, J = 7.7 Hz); 7.54 (2H, t, J = 6.6 Hz); 7.84 (4H, d, J = 7.3 Hz). 
13C-NMR (100.6 MHz, CDCl3) δ 23.0 (CH3); 65.1 (CH); 116.8 (CH); 120.0 (CH); 127.2 (C); 
127.9 (CH); 128.4 (2xCH); 128.3 (CH); 129.2 (2xCH); 132.3 (CH); 134.9(C); 155.6 (C); 
163.0 (N=C).  
Isomer B: 1H-NMR (300 MHz, CDCl3) δ 1.67 (6H, d, J = 6.5 Hz, CH3); 4.65 (2H, q, J = 6.5 
Hz); 6.31 (2H, dd, J = 7.6, 1.4 Hz); 6.55 (2H, dt, J = 7.4, 1.1 Hz); 6.87 – 6.90 (2H, m);  7.08 – 
7.12 (2H, m); 7.21 (4H, t, J = 7.7 Hz); 7.37 (2H, t, J = 7.6 Hz); 7.54 (4H, t, J = 6.6 Hz). 
13C-NMR (100.6 MHz, CDCl3) δ 23.6 (CH3); 65.4 (CH); 117.2 (CH); 119.6 (CH); 127.2 
(CH); 127.8 (2xCH, C); 128.5 (CH); 128.9 (2xCH); 132.0 (CH); 134.0 (C); 155.6 (C); 163.0 
(N=C).  
IR (ATR diam.) 3182(bw); 3053(w); 2923(m); 2854(m); 1958(w); 1897(w); 1731(m); 
1670(m); 1631(m); 1614(m); 1586(m); 1490(m); 1447(m); 1377(m); 1287(m); 1245(m); 
1182(m); 1103(w); 1035(w); 1000(w); 933(w); 843(m); 751(m); 693(m). 
MS (ESI) m/z 449.3 ([M+H]+). 
 

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VI.3. Chapter IV 
N
Me
O OP
Me
 
(R,R)-11,12-Dimethyl-11H,12H-5,6-dioxa-11a-aza-5a-phospha-naphthacene 
((R,R)-65): Distilled and degassed Et3N (1.2 ml, 11.6 mmol) and PCl3 (0.2 ml, 2.32 mmol) 
were stirred in dry THF (5 ml) under inert atmosphere at 25 °C for 40 min. The reaction was 
cooled to 0 °C and a solution of (R,R)-bis(1-(2-hydroxyphenyl)-ethyl) amine ((R,R)-26) (0. 6 
g, 2.32 mmol) in dry THF (1.0 ml) was added at 0°C . The reaction was allowed to reach rt 
over 16 h. The resulting yellowish milky suspension was filtered through Celite and the 
solvent was evaporated to dryness. To this oily residue dry toluene (5 ml) was added and 
BH3.Me2S (1.5 eq, 1 M in THF) was added at –78 °C. The reaction mixture was allowed to 
reach rt for 12 h. The resulting reaction mixture was filtered through Celite and evaporated to 
afford the crystalline stable borane complex. The borane complex was then dissolved in dry 
toluene (5 ml) and treated with DABCO (0.5 g, 2 eq., 4.64 mmol) and the reaction was heated 
to 50°C for 12 h. Filtration afforded a solution which was concentrated to get the pure 
phosphoramidite ligand 65 (348 mg, 1.22 mmol, 52%) as an oil. 
31P-NMR (161 MHz, CDCl3) δ 113.  
1H-NMR (400 MHz, CDCl3) δ 1.38 (3H, d, J = 6.8 Hz), 1.67 (3H, d, J = 6.9 Hz), 3.78 (1H, 
dq, J
 
 = 7.0, 3.4 Hz), 4.46 (1H, q, J = 6.3 Hz), 6.30 (1H, d, J = 7.9 Hz), 6.41 (1H, dd, J1 = 7.5, 
J2 = 1.3 Hz), 6.6 – 7.3 (6H, m). 
13C-NMR (100 MHz, CDCl3) δ 15.0 (CH3); 27.3 (CH3); 47.3 (CH); 48.2 (CH); 117.3 (CH); 
119.5 (CH); 121.2 (CH); 123.6 (CH); 124.2 (CH); 126.3 (CH); 127.9 (CH); 128.7 (CH); 
130.3 (C); 133.7 (C); 147.7 (C); 155.1 (C). 
IR (ATR diam.) cm-1 3065(w); 3034(w); 2973(m); 2920(m); 2863(w); 1602(m); 1588(m); 
1486(s); 1453(s); 1375(m); 1295(m); 1274(m); 1256(m); 1223(s); 1186(s); 1124(m). 
MS (EI) m/z 285([M+], 10); 270(100); 150(63); 123(12); 91(9). 
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VI.4. Chapter V 
BF4
-
N N
+
MeMe
MeO OMe
 
1,3-Bis-((R)-1-(2-methoxyphenyl)-ethyl)-imidazolium tetrafluoroborate (66a.BF4): In 
toluene (1 ml) (R)-o-methoxyphenylethylamine 1b (151 mg, 1.0 mmol) was dissolved and 
formaldehyde (30 mg, 1.0 mmol, 32% in H2O) was added in one portion. The resulting 
solution was stirred and heated to reflux until clarification of the solution. After cooling to 0 
°C, a second portion of (R)-ortho-methoxyphenylethylamine 1b (151 mg, 1.0 mmol) and 
HBF4 (0.125 ml, 1.0 mmol, 8 M in H2O) was slowly added while keeping the temperature at 0 
°C. Finally glyoxale (0.115 ml, 1.0 mmol, 40 % in H2O) was added dropwise and the reaction 
mixture was heated to 35 °C for 15 h. The reaction was quenched with excess NaHCO3 and 
the volatiles were removed by evaporation. The residual mixture was washed with ether, 
extracted with CH2Cl2 (3x), The combined extracts were dried over Na2SO4 and evaporated to 
dryness to yield 66a.BF4 (369 mg, 0.87 mmol, 87%) as a brownish solid. 
19F-NMR (282 MHz, CDCl3) δ -151.72. 
1H-NMR (200 MHz, CDCl3) δ 9.27 (1H, s); 7.41 – 7.31 (4H, m); 7.05 – 6.85 (6H, m); 5.99 
(2H, q, J = 7.0 Hz); 3.76 (6H, s); 1.97 (6H, d, J = 7.0 Hz).243 
13C-NMR (300 MHz, CDCl3) δ 19.20 (CH3); 54.83 (CH); 55.41 (OCH3); 111.14 (CH); 
120.59 (CH); 121.12 (CH); 125.73 (C); 127.24 (CH); 130.84 (CH); 135.07 (C); 157.00 (C).  
IR (ATR diam.) 3142.1(m), 2927.8(m), 1718.4(sh), 1669.4(m), 1602.6(m), 1548.3(m), 
1494.6(s), 1464.7(m), 1292.2(m), 1250.0(s), 1146.8(m), 1058.2(s), 1023.6(s), 757.1(m).  
 
General procedure (GP5): Formation of imidazolium triflates:  pivalate (1.5 eq.) was 
added to AgOTf (1.5 eq., 0,25 M in CH2Cl2) and stirred for 45 min in the absence of light 
under N2. The resulting suspension was transferred via a cannula, equipped with a filte, into a 
dry sealed tube preloaded with the diimine and the tube was set under nitrogen. The solution 
was stirred in the absence of light at 40 °C for 20 h. The reaction was cooled to ambient 
temperature and the solvent was evaporated.  
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1,3-Bis-((R)-1-(2-methoxyphenyl)-ethyl)-imidazolium triflate ((R,R)-66a.OTf):  pivalate 
(210 µl, 1.5 eq., 0.1.40 mmol), AgOTf (360 mg, 1.5 eq., 1.40 mmol) and diimine 56 (295 mg, 
1 eq., 0.96 mmol) were converted to the imidazolium triflate at 30 °C for 20 h using GP5. 
Flash chromatography (CH2Cl2/MeOH/Et3N 95:5:1) afforded imidazolium triflate (R,R)-
66a.OTf (50.8 mg, 0.105 mmol, 11 %) as a brown glassy oil.  
1H-NMR (400 MHz, CDCl3) δ 2.00 (6H, d, J = 7.1 Hz); 3.79 (6H, s); 6.04 (2H, q, J = 7.1 
Hz); 6.91 (2H, d, J = 8.3 Hz); 7.04 (2H, dt, J = 7.5, 0.7 Hz); 7.09 (2H, d, J = 1.0 Hz); 7.15 – 
7.35 (2H, m); 7.37 – 7.44 (4H, m), 9.44 (1H, s). 
13C-NMR (400 MHz, CDCl3) δ 19.4 (CH3); 54.8 (CH); 55.4 (OCH3); 111.2 (CH); 120.54 
(CH); 121.2 (CH); 125.6 (C); 127.2 (CH); 130.9 (CH); 135.4 (NCHN); 157.0 (C). 
MS (ESI) m/z 337 [M – OTf]+.  
 
N
+
N
BuBu
MeO OMe
TfO-t t
 
1,3-Bis-((S)-1-(2-methoxyphenyl)-2,2-dimethylpropyl)-imidazolium triflate ((S,S)-
66c.OTf): Chloromethyl pivalate (540 µl, 1.5 eq., 3.75 mmol), AgOTf (964 mg, 1.5 eq., 
3.75 mmol) and diimine 57 (1.02 g, 1.0 eq., 2.50 mmol) were converted to the imidazolium 
triflate in 20 h using GP5. Flash chromatography (CH2Cl2/Et2O 1:1) afforded imidazolium 
triflate (S,S)-66c.OTf (860 mg, 1.50 mmol, 60%) as a brown glassy solid.  
19F-NMR (282 MHz, CDCl3) δ –78.1.  
1H-NMR (200 MHz, CDCl3) δ 1.19 (18H, s); 3.90 (6H, s); 6.08 (2H, s); 6.97 (2H, dd, J = 8.0, 
1.2 Hz); 7.10 (2H, dt, J = 7.4, 1.0 Hz
.
); 7.3 – 7.5 (4 H, m); 7.79 (2H, dd, J = 8.2, 1.5 Hz);. 9.82 
(1H, s). 
13C-NMR (50 MHz, CDCl3) δ 27.5 (CCH3); 36.1 (CCH3); 55.5 (CH3); 66.3 (CH); 111.3 
(CH); 120.6 (CH); 122.0 (CH); 123.4 (C); 129.2 (CH); 130.4 (CH); 138.5 (CH); 157.4 (C).  
IR (ATR diam.) 3121(w), 3085(w), 3039(w), 2964(m), 2873(m), 1669(m), 1602(m), 
1586(w), 1539(w), 1492(m), 1480(m), 1464(m), 1439(m), 1401(w), 1370(w), 1247(s), 
1225(m), 1189(w), 1154(m), 1114(w), 1054(w), 1031(s), 757(m), 666.8(w), 638(m). 
MS (ESI) m/z 421.3. 
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General procedure (GP6): counter ion exchange. To a stirred solution of the imidazolium 
salt (1 eq.) in dry acetone was added NaI (1.1 eq.) (OTf/I exchange) or AgSbF6 (1.1 eq.) 
(I/SbF6 exchange) and the reaction was stirred for 6 h. All volatiles were removed by 
evaporation. The residue was taken up in a small amount of CHCl3 and filtered through 
cotton. (For OTf/I exchange, the entire procedure was repeated with 1 eq. of NaI). 
 
N
+
N
BuBu
MeO OMe
t t I
 
1,3-Bis-((R)-1-(2-methoxyphenyl)-22-dimethylpropyl)-imidazolium iodide ((S,S)-66c.I): 
Imidazolium triflate (S,S)-66c.OTf (1.43 g, 2.50 mmol) was converted to the imidazolium 
iodide using GP6 in the presence of NaI (375 mg, 2.50 mmol). Flash chromatography 
(CH2Cl2/Et2O 1:1) afforded (S,S)-66c.I (1.00 g, 1.83 mmol, 73%) as a brown powder.  
[D]D20 +2 (c = 0.06 in CH2Cl2). 
1H-NMR (400 MHz, CDCl3) δ 1.16 (18H, s); 3.84 (6H, s, OMe); 6.23 (2H, s); 6.88 (2H, dd, J 
= 8.4, 0.8 Hz); 7.04 (2H, dt, J = 7.6, 0.8 Hz); 7.33 (2H, dt, J = 8.0, 1.6 Hz); 7.38 (2H, d, J = 
1.2 Hz); 7.86 (2H, dd, J = 7.6, 1.6 Hz);. 10.51 (1H, s). 
13C-NMR (100 MHz, CDCl3) δ 28.0 (C(CH3)3); 36.5 (C(CH3)3); 55.9 (CH); 66.7 (CH); 111.5 
(CH); 121.0 (CH); 122.0 (CH); 123.6 (C); 130.0 (CH); 130.6 (CH); 138.4 (CH); 157.6 (C). 
IR (ATR diam.) 3049(m); 2964(s); 2873(w); 2842(w); 1621(w); 1602(m); 1532(m); 1492(s); 
1463(s); 1434(m), 1367(m); 1290(m); 1248(s); 1186(m); 1148(m); 1026(m); 757(s). 
 
N
+
N
BuBu
MeO OMe
t t SbF6
 
1,3-Bis-((S)-1-(2-methoxyphenyl)-22-dimethylpropyl)-imidazolium 
hexafluoroantimonate ((S,S)-66c.SbF6): Imidazolium idodide (S,S)-66c.I (100 mg, 0.18 
mmol) was directly converted to the imidazolium hexafluoroantimonate using GP5 in the 
presence of AgSbF6 (68.7 mg, 0.20 mmol). (S,S)-66c.SbF6 (112 mg, 0.17 mmol, 95 %) was 
obtained as a brown oil.  
1H-NMR (400 MHz, CDCl3) δ 1.10 (18H, s); 3.80 (6H, s); 5.88 (2H, s); 6.90 (2H, d, J = 8.3 
Hz); 7.03 (2H, t, J = 8.0 Hz); 7.32 (2H, t, J = 8.0 Hz); 7.41 (2H, s); 7.66 (2H, d, J = 7.6 Hz); 
8.90 (1H, s).  
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13C-NMR (400 MHz, CDCl3) δ 27.6 (C(CH3)3); 36.3 (C); 55.7 (OCH3); 66.6 (CH); 111.5 
(CH); 120.9 (CH); 122.5 (CH); 123.4 (C); 129.0 (CH); 130.8 (CH); 137.3 (C); 157.6 
(NCHN). 
 
N
+
NMeO OMe
PrPr Ii i
 
1,3-Bis-((S)-1-(2-methoxyphenylene)-2-methypropyl)-imidazolium iodide ((S,S)-66b.I): 
(S,S)-N,N’ -Bis-(1’ -(2’ ’ -methoxyphenyl)-2’ -methylpropyl)-ethane-1,2-diimine): Aq. glyoxal 
(690 µl, 0.5 eq, 6 mmol, 40% in water) was introduced into CH2Cl2 (25 ml) and vigorously 
stirred in presence of freshly dehydrated Na2SO4 (6 g). After the addition of formic acid 
(98%) (34 µl, 7 mol%, 0.9 mmol) and (S)-1-(2-methoxyphenyl)-2-methylpropylamine 2b 
(2.15 mg, 1 eq, 12 mmol), the mixture was allowed to stir for 5 min, after which time another 
6 g of Na2SO4 were added. During 5 h of stirring at rt the solution turned slightly yellow. The 
mixture was filtered, and the solvent was removed in vacuo to yield the diimine (2.15 g, 11.2 
mmol, 93%) as a beige oil. 
[D]43620 –5 (c = 1.20 in CH2Cl2).  
1H-NMR (CDCl3, 400 MHz) δ 0.84 (6H, d, J=7 Hz); 0.97 (6H, d, J = 7 Hz); 2.33 (2H, m); 
3.82 (6H, s, OMe); 4.47 (2H, d, J = 8 Hz); 6.87 (2H, d, J = 8 Hz); 6.97 (2H, t, J = 8 Hz); 7.22 
(2H, t, J = 8 Hz); 7.49 (2H, d, J = 8 Hz); 8.06 (2H, s). 
13C-NMR (CDCl3, 100 MHz) δ 19.5; 19.8; 55.4; 73.9; 110.6; 120.7; 127.7; 128.4; 130.9; 
156.8; 161.9. 
IR (ATR diam.) 2958; 1490; 1464; 1239; 1029; 909; 753; 729. 
MS (EI) m/z 380 (20) [M+]; 337 (90); 175 (30); 163 (90); 121 (100); 91 (50); 55 (20). 
HRMS calcd. for  C24H32N2O2 380.24496, found 380.24638. 
1,3-Bis-((S)-1-(2-methoxyphenylene)-2-methypropyl)-imidazolium iodide ((S,S)-66b.I): 
Chloro-methyl-pivalate (1.2 ml, 1.5 eq.,8.4 mmol), AgOTf (2.16 g, 1.5 eq., 8.4 mmol,) and 
diimine (2.15 g, 1 eq., 5.6 mmol) were converted to the imidazolium triflate in 20 h using 
GP5. The resulting imidazolium triflate was directly converted to the imidazolium iodide 
(S,S)-66b.I using GP6 in the presence of NaI (495 mg, 3.3 mmol). Column chromatography 
(CH2Cl2/Et2O 1:1) afforded (S,S)-66b.I (1.50 g, 2.89 mmol, 51% over two steps) as a brown 
powder.  
[D]D20 –10 (c = 1.33 in CH2Cl2).  
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1H-NMR (CDCl3, 400 MHz) δ 0.98 (12H, m); 3.05 (2H, m); 3.87 (6H, s); 5.70 (2H, d, J = 12 
Hz); 6.88 (2H, d, J = 8 Hz); 7.03 (2H, t, J = 8 Hz); 7.34 (2H, t, J = 8 Hz); 7.74 (2H, d, J = 8 
Hz); 10.60 (2H, s). 
13C-NMR (CDCl3, 100 MHz) δ 19.7; 20.0; 30.2; 55.7; 65.7; 111.2; 120.6; 121.24; 124.3; 
128.9; 130.6; 136.6; 157.4. 
IR (ATR diam.) 2965; 1493; 1462; 1437; 1248; 1140; 1023; 918; 755; 724; 660. 
MS (EI) m/z 393 (2) [M-I], 230 (15); 187 (20); 163 (80);  147 (10); 128 (25); 121 (100); 91 
(60); 77 (15); 55 (15). 
HRMS calcd. for C25H33N2O2: 393.25272 found: 393.25420. 
 
N NMeO OMe
BuBu
..
tt
 
1,3-Bis-[(R)-1-(2-methoxyphenylene)-2,2-dimethylpropyl]-imidazol-2-ylidene (67): An 
NMR Young tube was charged in the glovebox with imidazolium salt (S,S)-66b.I (10 mg, 
0.018 mmol) in THF-d8 and an excess of KH (35% in paraffin oil) was added. After 2 d in the 
glovebox, the evolution of hydrogen has stopped and the NMR tube was closed.  
1H-NMR (300 MHz, THF-d8) 1.07 (18H, s); 3.84 (6H, s); 5.54 (2H, s); 6.74 (2H, s); 6.83-
6.91 (4H, m); 7.11-7.18 (2H, m); 8.38-8.42 (2H, dd, J = 7.8, 1.6 Hz). 
13C-NMR (300 MHz, THF-d8) 30.0 (C(CH3)3); 54.7 (OCH3); 64.0 (CHtBu); 109.8 (CH); 
119.4 (CH); 119.9 (CH); 127.5 (CH); 128.6 (C); 132.0 (CH); 156.8 (C); 212.6 (NCN). 
NN
Pd
MeMe
MeO OMe
I I
NN
MeMe
MeO OMe
 
Bis[(R,R)-1,3-bis(1-(2-methoxyphenylene)-ethyl)-2,3-dihydro-1H-imidazol-2-ylidene]-
diiodo-palladium(II) (68): Pd(OAc)2 (3 mg, 0.015 mmol), NaI (9 mg, 0.057 mmol), NaOtBu 
(4 mg, 0.46 mmol), and imidazolium triflate ((R,R)-66a.TfO (20 mg, 0.043 mmol) were 
dissolved in THF (1 ml) and the solution was stirred at rt for 15 h. The solution was 
evaporated to dryness in vacuo. The residue was taken up in CH2Cl2 and filtered through a 
plug of Celite. The solvent was reduced to a minimum amount and the resulting saturated 
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solution was dropped into hexane (20 ml). After filtration and evaporation of the hexane, 
complex 68 (5 mg, 0.006 mmol, 41 %) was obtained as a yellow solid.  
1H-NMR (400 MHz, CDCl3) mixture of isomers (cis/trans) 1.87 (12H, d, J = 7.1 Hz), 3.73 
(6H, s); 3.84 - 3.89 (6H, m); 6.76 (4H, q, J = 7.1 Hz); 6.80 – 7.00 (12H, m); 7.08 (4H, s); 7.50 
(4H, d, J = 7.6 Hz). 
MS (ESI) m/z 815 [M-2xI+Cl]+ 
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[1,3-bis(1-(2-methoxyphenyl)-ethyl)-2,3-dihydro-1H-imidazol-2-ylidene]-diiodo-
triphenylphosphine palladium(II) (73): In a dry Schlenk tube under Ar imidazolium 
tetrafluoroborate 66a.BF4 (75.6 mg, 0.178 mmol) was dissolved in degassed THF (14 ml) and 
after addition of tBuOK (23.5 mg, 0.21 mmol) the mixture was stirred for 3 h. Then Pd(OAc)2 
(39.9 mg, 0.178 mmol) was added and the reaction was stirred for another 10 min. When NaI 
(106.8 mg, 0.712 mmol) was added, an immediate colour change from yellow to deep red was 
observed. The reaction was stirred for 20 h. All solvent was evaporated and the residue was 
washed with hexane, then taken up in toluene and filtered through a cannula equipped with a 
filter and the toluene was evaporated to obtain the crude diiodo complex (91 mg, 0.065 mmol, 
73 %). 
The residue was taken up in dry and degassed CH2Cl2 (1 ml) and triphenylphosphine (39 mg, 
0.15 mmol) was added, which provoked an immediate colour change from red to yellow. 
After 10 h stirring, the solvent was evaporated over 15 h and the yellow-orange residue was 
washed with hexane to obtain 73 (90 mg, 0.09 mmol, 53% over two steps) as a yellow-orange 
powder.  
31P-NMR (CDCl3, 162 MHz) δ 16.43. 
1H-NMR (400 MHz, CDCl3) 1.84 (6H, d, J = 7.0 Hz), 3.83 (6H, s); 6.55 (2H, q, J = 7.0 Hz); 
6.87 – 7.00 (4H, m); 7.18 (2H, d, J = 7.6 Hz); 7.23 – 7.30 (2H, m); 7.33 – 7.38 (8H, m); 7.43 – 
7.50 (3H, m); 7.62 – 7.72 (6H, m). 
MS (ESI) m/z 831.2 [M - I]+. 
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1-(o-tolyl)-2,2-dimethylpropylamine (78): To o-toluonitrile 80 (13.5 ml, 1eq., 114.4 mmol) 
were added tBuMgCl (68 ml, 1 eq., 115 mmol, 1.7M in THF) and CuBr (329 mg, 0.02 eq., 
2.29 mmol) in portions. The reaction was refluxed for 14 h after which time TLC showed 
completion. 
After cooling to –78°C, dry methanol (100 ml, prepared by addition of K2CO3 in a fresh bottle 
of MeOH) was added cautiously to destroy excess magnesium. NaBH4 was added in portions 
(5g, 132 mmol) and the reaction was allowed to warm to rt and was stirred for 4 h at rt. H2O 
(60 ml) was added and the precipitate was removed by filtration and washed with Et2O (3x 
200 ml). The filtrate was evaporated and distillation afforded 78 (13.1 g, 73.9 mmol, 65%). 
1H-NMR (200 MHz, CDCl3) δ 0.95 (9H, s); 2.36 (3H, s); 4.07 (1H, s);  7.11 – 7.21 (3H, m); 
7.35 (1H, d, J = 6.8 Hz).39 
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(±)-(1R,2S5R)-N-methoxycarbonyl-1’-tolyl-2’,2’-dimethylpropylamine (81): To a solution 
of 1-(o-tolyl)-2,2-dimethylpropylamine (1.04 g, 1 eq., 5.87 mmol) and Et3N (1.24 ml, 1,5 eq., 
8.81 mmol) in anhydrous ether (6 ml) was added (1R,2S,5R)-(–)-menthyl chloroformate (1.87 
ml, 1.5 eq., 8.81 mmol) in anhydrous ether (2 ml) at 0 °C. The mixture was allowed to stir at 
rt for 2 h. The reaction mixture was washed with 1 N NaOH, and the aq. phase was extracted 
with ether. The combined organic phases were dried over MgSO4 and evaporated to dryness 
to obtain 2.81 g of the crude diastereomeric mixture of (1R,2S5R)-N-methoxycarbonyl-1’ -
tolyl-2’ ,2’ -dimethyl-propylamine 81. Separation of the diastereomers: Column 
chromatography (6x 200 g SiO2, 4% ethylacetate in hexane) furnished 700 mg (1.95 mmol, 
33% of 50% theoretical yield) of the less polar isomer (S,R,S,R)-81, 580 mg of mixtures and 
320 mg (0.89 mmol, 15% of 50% theoretical yield) of the more polar (R,R,S,R)-81 (75% total 
yield). Repeated recrystallization from MeOH/H2O gave a diastereomeric ratio of >96% as 
evaluated by GC.  
(S,R,S,R)-81: 1H-NMR (400 MHz, CDCl3) δ 0.60 (2.3H, bs); 0.65 – 1.05 (18.5H, m); 1.20 – 
1.30 (1.3H, m); 1.35 – 1.50 (1H, m); 1.55 – 1.70 (2.1H, m); 1.80 (0.8H, bs); 2.06 (1H, bs); 
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2.45 (3H, bs); 4.42 (1H, m); 4.68 (0.3H, bs); 4.87 (0.7H, m); 5.0 – 5.23 (1H, m); 7.10 – 7.20 
(4H, bs). 
13C-NMR (100 MHz, CDCl3) δ 16.38 (CH3); 20.60 (CH3); 20.82 (CH3); 22.06 (CH3); 23.54 
(CH2); 26.12 (CH); 26.70 (C(CH3)3); 31.40 (CH); 34.37 (CH2); 36.22 (C(CH3)3); 41.47 
(CH2); 47.33 (CH); 57.94 (NCH); 74.91 (OCH); 125.35 (CH); 126.6 (CH); 130.42 (CH); 
136.95 (C); 139.80 (C); 156.38 (C). 
(R,R,S,R)-81: 1H-NMR (400 MHz, CDCl3) δ 0.37 (1H, bd, J = 5.8 Hz); 0.53 (1H, bd, J = 5.8 
Hz); 0.7 – 1.15 (19H, m); 1.15 – 1.70 (6H, m); 1.82 – 2.00 (1.4H, m); 2.06 (0.4H, bs); 2.38 
(1H (CH3), bs); 2.46 (2H (CH3), bs); 4.40 – 4.58 (1H, m); 4.63 (0.33H, bd, J = 7.08 Hz); 4.91 
(0.66H, bd, J = 9.6 Hz); 5.0 – 5.23 (1H, m); 7.05 – 7.20 (4H, bs). 
13C-NMR (100 MHz, CDCl3, 2 rotamers: major A, minor B) δ 15.52 (B CH3); 16.84 (A 
CH3); 20.53 (B CH3); 20.84 (A CH3); 20.98 (A, CH3); 21.15 (B, CH3); 21.23 (B, CH3) 22.18 
(A, CH3); 22.90 (B, CH2); 23.96 (A, CH2); 26.75 (CH); 26.83 (C(CH3)3); 31.59 (CH); 34.51 
(CH2); 36.39 (C(CH3)3);  41.77 (CH2); 47.83 (CH); 57.88 (A, NCH); 59.00 (B, NCH); 74.70 
(A, OCH); 74.95 (B, OCH); 125.59 (CH); 126.85 (CH); 126.97 (A, CH); 127.15 (B, CH); 
130.35 (B, CH); 130.68 (A, CH); 136.37 (B, C); 136.83 (A, C); 139.80 (A, C); 140.03 (B, C); 
156.31 (A, C); 156.47 (B, C). 
IR (ATR diam.) 3278(m); 2955 – 2846(s); 1701(s); 1494(m); 1464 (m); 1398 (m); 1370(m); 
1315(m); 1232(m); 1045(m). 
MS (EI) m/z 344 [M+– Me]; 302 (48) [M+ – tert-Bu]; 258 (11); 164 (71); 139 (23); 120 (100); 
83 (94); 69 (52); 57 (58). 
GC (OV-17, 100 °C (2 min), 10 °C/min, 250 °C, flow 1 ml/min) less polar fraction: 18.3 min, 
more polar fraction: 18.7 min. 
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(S)-N-(2,2-Dimethyl-1-o-tolyl-propyl)-formamide (82): To a solution of carbamate 
(S,R,S,R)-81 (121mg, 0.34 mmol) in THF (5 ml) was added dropwise DIBAL (1.02 ml, 
1.0 M in THF) at 0 °C under N2. The ice/water bath was removed and the solution was stirred 
for 60 h at rt. The reaction mixture was quenched with MeOH (until no more gas evolution). 
After addition of a sat. aq. solution of Rochelle’ s salt (1 ml) the organic layer was separated, 
and the water layer was extracted with ether (5 ml). The combined organic layers were dried 
over Na2SO4 and filtered. After evaporation of the solvent, a clear oil was obtained (166 mg). 
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The crude product was purified by column chromatography to obtain formamide  (40 mg, 
0.19 mmol, 57%). 
1H-NMR (400 MHz, CDCl3) δ 0.97 (9H, s); 2.39 (0.7H, s); 2.25 (2.3H, s); 4.58 (0.22H, d, J = 
9.8 Hz); 5.34 (0.76H, d, J = 9.6 Hz); 6.37 (0.72H, bs); 6.80 (0.2H, bs); 7.13 – 7.28 (4H, m); 
8.07 (0.22H, d, J = 11.6 Hz); 8.22 (0.75H, s). 
13C-NMR (100 MHz, CDCl3) δ 20.63 (B, CH3); 20.68 (A, CH3); 26.64 (B, C(CH3)3); 26.69 
(A, C(CH3)3); 35.88 (A, C(CH3)3); 36.32 (B, C(CH3)3); 54.42 (CH); 125.51 (A, CH); 126.07 
(B, CH); 126.72 (A, CH); 126.98 (CH); 127.28 (B, CH); 130.67 (A, CH); 130.76 (B, CH); 
135.34 (B, C); 136.84 (A, C); 138.20 (B, C); 138.77 (A, C); 160.49 (A, CH); 164.82 (B, CH). 
IR (ATR diam.) 3286.6(m); 3051.2(w); 3024.3(w); 2962.8 – 2870.6(m); 1657.2(s); 
1533.0(m); 1489.2(m); 1479.7(m); 1465.1(m); 138.1(m); 1367.8(m); 1237.5(m); 1053.1(w); 
755.6(m); 734.6(m). 
MS (EI) m/z 205([M+]); 190([M+] – Me); 162([M+] – CO); 148(100); 120(37); 118(36); 
104(36); 93(31); 91(18); 77(14); 57(11). 
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(–)-(S)-1-(o-tolyl)-2,2-dimethylpropylamine ((S)-78): To a solution of (S)-82 (40 mg, 
0.19 mmol) in MeOH (2 ml) was added dropwise conc. HCl (0.13 ml) and the solution was 
refluxed for 5 h. After cooling to rt, the solution was concentrated under reduced pressure. 
The resultant residue was taken up in 1 N HCl (0.6 ml) and the solution was washed with 
ether (5 ml). The vigorously stirred water layer was basified by cautious addition of Na2CO3 
(pH=12) and extracted with ether (5 ml). The combined extracts were dried over K2CO3, 
filtered and evaporated to dryness and the pure amine (S)-78 (22 mg, 0.12 mmol, 64%) was 
obtained. The corresponding NMR spectrum was identical to the one described previously. 
[D]D20 = -106 (c = 0.03 in CH2Cl2). 
 
N N
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(R,R)-N,N’-Bis-(1-phenyl-2,2-dimethylpropyl)-ethane-1,2-diimine) ((R,R)-83):  Aq. 
glyoxal (115 µl, 0.5 eq, 1 mmol, 40% in water) was introduced into CH2Cl2 (4 ml) and 
vigorously stirred in presence of freshly dehydrated Na2SO4 (1 g). After the addition of formic 
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acid (98%) (5 µl, 7 mol%, 0.14 mmol) and (R)-77 (326 mg, 1 eq, 2 mmol), the mixture was 
allowed to stir for 5 min, after which time another 1 g of Na2SO4 were added. During 3 h of 
stirring at rt the solution turned slightly yellow. The mixture was filtered, and the solvent was 
removed in vacuo. The residue was taken up in cyclohexane, filtered and evaporated to yield 
(R,R)-83 (309.7 mg, 0.89 mmol, 89%) as a white solid. 
[D]D20 +55 (c = 1.10 in CH2Cl2). 
1H-NMR (CDCl3, 500 MHz) δ 0.94 (18H, s); 3.92 (2H, s.); 7.20-7.35 (10H, m); 8.01 (2H, s). 
13C-NMR (CDCl3, 100 MHz) δ 26.8; 35.5; 85.3; 126.8; 127.5; 128.7; 141.4; 161.4. 
IR (ATR diam.) : 2954; 1363; 741; 705. 
MS (EI) m/z 348 (1) [M+]; 319 (7); 291 (52); 235 (58); 145 (56); 105 (50); 91 (100); 69 (15); 
57 (15). 
 
N+ N
BuBut t I
 
1,3-Bis-((R)-2,2-dimethyl-1-phenylpropyl)-imidazolium iodide ((R,R)-79a): Chloro-
methyl pivalate (183 µl, 1.5 eq., 1.28 mmol), AgOTf (329 mg, 1.5 eq., 1.28 mmol) and 
diimine (R,R)-83 (296 mg, 1 eq., 0.85 mmol) were converted to the imidazolium triflate in 20 
h using GP5. The resulting imidazolium triflate was directly converted to the imidazolium 
iodide (R,R)-79a using GP6 in the presence of NaI (21 mg, 0.14 mmol). Flash 
chromatography (CH2Cl2/Et2O 1:1) afforded (R,R)-79a (60 mg, 0.12 mmol, 14% over two 
steps) as a beige powder.  
[D]D20 +16 (c = 0.70 in CH2Cl2). 
1H-NMR (CDCl3, 400 MHz): 1.16 (18H, s); 6.10 (2H, s); 7.35-7.45 (6H, m); 7.70-7.80 (6H, 
m); 10.97 (1H, s). 
13C-NMR (CDCl3, 100 MHz) δ 27.4; 36.5; 73.9; 121.9; 129.1; 134.8; 136.8. 
IR (ATR diam.) 2959; 1144; 740; 704. 
MS (EI) m/z 361(7); 214(15); 158(100); 147(36); 131(48); 105(60); 91(100); 77(25); 69(27); 
57(45). 
HRMS calcd. for C25H33N2 361.2644, found 361.2646. 
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(R,R)-N,N’-Bis-(1’-(o-tolyl)-2’,2’-dimethylpropyl)-ethane-1,2-diimine) ((R,R)-84): Aq. 
glyoxal (69 µl, 0.5 eq, 0.6 mmol,40% in water) was introduced into CH2Cl2 (5 ml) and 
vigorously stirred in presence of freshly dehydrated Na2SO4 (500 mg). After addition of 
formic acid (98%) (3.5 µl, 7 mol%, 0.09 mmol) and (R)-78 (212 mg, 1 eq, 1.2 mmol), the 
mixture was stirred for 5 min, after which time another 500 mg of Na2SO4 were added. 
During 5 h of stirring at rt the solution turned slightly yellow. The mixture was filtered, and 
the solvent was removed in vacuo to obtain diimine (R,R)-84 (200 mg, 0.53 mmol, 89%). 
1H-NMR (CDCl3, 500 MHz) δ 0.96 (18H, s); 2.35 (6H, s); 4.31 (2H, s); 7.05 – 7.12 (6H, m); 
7.47 (2H, d, J = 10.0 Hz); 7.96 (2H, s, imine). 
13C-NMR (CDCl3, 125 MHz) δ 20.7(CH3); 27.0(C(CH3)3); 36.8(C); 125.2(CH); 126.4(CH); 
129.5(CH); 130.(CH); 135.5(C); 139.8(C); 161.4(CH). 
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(R,R)-1,3-Bis-(2,2-dimethyl-1-o-tolylpropyl)-imidazolium iodide- (79b): Chloromethyl 
pivalate (108 µl, 1.5 eq., 0.75 mmol), AgOTf (193mg, 1.5 eq., 0.75 mmol) and diimine (R,R)-
84 (190 mg, 1 eq., 0.50 mmol) were converted to the imidazolium triflate in 20 h using GP5. 
The resulting imidazolium triflate was directly converted to the imidazolium iodide using 
GP6 in the presence of NaI (42 mg, 0.25 mmol). Flash chromatography (CH2Cl2/Et2O 1:1) 
afforded (R,R)-79b (125 mg, 0.24 mmol, 49% over two steps) as a brown powder.  
[D]D20 +35 (c = 1.42 in CH2Cl2). 
1H-NMR (CDCl3, 400 MHz) δ 1.20 (18H, s); 2.60 (6H, s); 6.05 (2H, s); 7.22 (2H, d, J = 7 
Hz); 7.27 (2H, t, J = 7 Hz); 7.31 (2H, t, J = 7 Hz); 7.51 (2H, s); 7.90 (2H, d, J = 7 Hz); 11.06 
(1H, s). 
13C-NMR (CDCl3, 100 MHz) δ 22.1 (CH3); 27.6 (C(CH3)3); 27.7(C); 68.4(CH); 122.2(CH); 
126.7(CH); 128.2(CH); 129.0(CH); 131.8(CH); 133.5(C); 137.7(CH); 138.4(C). 
IR (ATR diam.) 2962; 1479; 1143; 918; 751; 731. 
MS (EI) m/z 389 (1) [M-I]; 228 (20); 171 (65);  161 (40); 145 (25); 128 (20); 119 (40); 105 
(100); 91 (25); 69 (25); 57 (25). 
CHAPTER VI 
Experimental Part 
 
151 
HRMS calcd. for C27H37N2: 389.2956, found:389.2959. 
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N-(2-Bromophenyl)-N-benzyl-2-phenylpropionamide (75d): (not optimized) To a solution 
of 2-bromoaniline (1.14 g, 6.62 mmol) in CH2Cl2 (25 ml) in the presence of Et3N (1.38 ml, 
10.0 mmol)was added 2-Phenylpropionyl chloride (1.34 g, 7.94 mmol) and the reaction 
mixture was stirred for 16 h at 23 °C. After dilution of the reaction mixture with Et2O, the 
reaction was quenched with sat. aq. NH4Cl, the organics were separated and washed with sat. 
aq. NaCl, dried over MgSO4 and concentrated to dryness. The product was repeatedly 
crystallized from the crude mixture from AcOEt/cH 1:4. The crystals were collected by 
filtration, yielding anilide (595 mg, 1.96 mmol, 30%). To the suspension of NaH (~80 mg, 
from an oil dispersion, washed 3 times with hexane) in dry THF (7.3 ml) under N2 was added 
the anilide (373 mg, 1,22 mmol) and the reaction was stirred for 19 h at 24 °C. After the 
addition of benzylbromide, the reaction was allowed to stir for another 24 h. The reaction was 
quenched by adding sat. aq. NH4Cl, the organic layer was separated, washed with brine, 
filtered and evaporated to dryness. Column chromatography (AcOEt/cH 1:4) yielded the 
desired benzylated anilide 75d (419 mg, 1.06 mmol, 87%). 
1H-NMR (500 MHz, CDCl3) mixture of 2 rotamers (2.7:1) δ 1.42 (minor, 3H, d, J = 6.9 Hz); 
1.47 (major, 3H, d, J = 6.9 Hz); 3.35 (major, 1H, q, J = 6.9 Hz); 3.48 (minor, 1H, q, J = 6.9 
Hz); 3.92 (minor, 1H, d, J = 14.2 Hz); 4.04 (major, 1H, d, J = 14.5 Hz); 5.61 (major, 1H, d, J 
= 14.5 Hz; 5.72 (minor, 1H, d, J = 14.2 Hz); 6.16 (major, 1H, dd, J = 7.9, 1.6 Hz); 6.83 – 6.86 
(minor, 1H, m); 6.92 – 6.96 (major, 3H, m); 7.04 – 7.07 (minor, 2H, m); 7.08 – 7.12 (major, 
2H, m); 7.14 – 7.28 (major: 7H + minor: 10H, m); 7.55 – 7.62 (minor, 1H, m); 7.70 (major, 
1H, dd, J = 7.9, 1.3 Hz).  
13C-NMR (1225 MHz, CDCl3) mixtures of 2 rotamers: δ 20.2(minor, CH3); 20.7(major, 
CH3); 43.5(minor, C); 44.5(major, C); 51.4(minor, CH2); 51.7(major, CH2); 124.12(major, C); 
124.5(minor, C); 126.7(major, CH); 126.8(minor, CH); 127.3(minor, 2xCH); 127.39(major, 
2xCH); 127.44(minor, CH); 127.7(major, CH); 129.9(minor, CH); 128.1(major, CH); 
128.20(minor, 2xCH); 128.23(major, 2xCH); 128.3(minor, 2xCH); 128.4(major, 2xCH); 
129.0, (major, 2xCH); 129.3(minor, 2xCH); 129.6, major, CH); 129.7(minor, CH); 
131.9(minor, CH); 132.2(major, CH); 133.4(major, CH); 133.9(minor, CH); 137.0(major, C); 
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137.1(minor, C); 140.2(major, C); 140.3(minor, C); 140.5(minor, C); 141.7(major, C); 
173.6(major and minor, C). 
IR (ATR diam.) 3059(w); 3029(w); 2972(w); 2931(w); 1863(w); 1664(s); 1599(w); 1584(w); 
1495(w); 1475(m); 1455(m); 1432(w); 1390(m); 1328(w); 1282(m); 1241(m); 1205(m); 
1181(m); 1080(w); 1056(w); 1030(m); 1008(w); 766(m); 727(m); 699(s). 
MS (ESI) m/z 396 [M+H]+ (for 81Br), 394 [M+H]+ (for 79Br). 
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N-(2-Bromo-phenyl)-N-methyl-2-fluoro-2-phenyl-acetamide (75f): 2-Fluoro-2-phenyl 
acetic acid (100 mg, 1.1 eq., 0.65 mmol) in CH2Cl2 (5 ml) under N2 was treated with (COCl)2 
(0.11 ml, 2.2 eq., 1.3 mmol) and DMF (1 drop) and the reaction mixture was stirred for 1½ h 
at which time no more hydrogen evolution was observed. The solution was cooled to 0 °C and 
all volatiles were removed in vacuo. The residue was dissolved in CH2Cl2 (5 ml) and kept at 0 
°C. After addition of N-methyl bromoanilide (110 mg, 1 eq., 0.6 mmol) the reaction was 
stirred for 3 min and Et3N (0.09 ml, 1.1 eq., 0.66 mmol) was added dropwise. The ice bath 
was removed and the reaction was stirred for 1½ h. Ether was added and the suspension was 
poured into sat. aq. NH4Cl. The organic phase was separated and washed with brine, dried 
over MgSO4, filtered and the filtrate was evaporated to dryness. Column chromatography 
(cH/AcOEt 4:1) yielded 75f (91 mg, 0.28  mmol, 47%).  
19F-NMR: -167.86 (dd, JHF = 48 Hz); -170.89 (d, JHF = 48 Hz). 
1H-NMR (200 MHz, CDCl3) δ 3.17 (1.65H, s); 3.23 (0.6H, s); 3.25 (1.35H, s); 5.44 (0.55H, d, 
J = 48 Hz); 5.80 (0.44H, d, J = 48 Hz); 6.62 (0.55H, dd, J = 7.6, 1.8 Hz); 7.05 – 7.55 (7.46H, 
m); 7.56 (0.44H, dd, J = 7.8, 1.6 Hz); 7.74 (0.55H, d, J = 8.2, 1.6 Hz).  
13C-NMR (100 MHz, CDCl3) Two isomers: δ 36.7; 89.0 (d, JCF = 178.4 Hz); 89.5 (d, JCF = 
178.5 Hz); 123.7; 124.6; 127.9; 128.0; 128.7; 128.80; 128.82; 129.1; 129.76, 129.79; 129.95; 
129.99; 130.4; 130.5; 131.5; 134.1; 134.3; 134.5; 140.5; 140.9; 168.15. 
IR (ATR diam.):3059(w); 2956(sh); 2925(m); 2852(m); 1685(s); 1584(w); 1477(m); 
1385(m); 1289(m); 1041(m); 1002(m); 761(m); 698(m). 
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N-(2-Bromophenyl)-2,N-dimethyl-malonamic acid methyl ester (75h): 2-Methyl-malonic 
acid monomethyl ester (434 mg, 1.2 eq., 3.29 mmol) in CH2Cl2 (5 ml) under N2 was treated 
with (COCl)2 (0.29 ml, 1,2 eq., 3.3 mmol) and DMF (1 drop) and the reaction mixture was 
stirred for 1½ h after which time no more hydrogen evolution was observed. The solution was 
cooled to 0 °C and all volatiles were removed in vacuo. The residue was dissolved in CH2Cl2 
and kept at 0 °C. After addition of N-methyl bromoanilide (500 mg, 1 eq., 2.7 mmol) the 
reaction was stirred for 3 min and Et3N (0.46 ml, 1.2 eq., 3.3 mmol,) was added dropwise. 
The ice bath was removed and the reaction was stirred for 1½ h. Et2O was added and the 
suspension was poured into sat. aq. NH4Cl. The organic phase was separated and washed with 
brine, dried over MgSO4, filtered and the filtrate was evaporated to dryness. Column 
chromatography (cH/ AcOEt 4:1) yielded 75h (709 mg, 2.36 mmol, 87%).  
1H-NMR (500 MHz, CDCl3) mixture of 2 rotamers (2.6:1) δ 1.32 (0.8H, d, J = 6.9 Hz); 1.39 
(2.2H, d, J = 6.9 Hz); 3.15 – 3.26 (4H, m); 3.66 (2.2H, s); 3.68 (0.8H, s); 7.25 – 7.32 (1.2H, 
m); 7.37 – 7.43 (1.8H, m); 7.70 (0.7H, bd, J = 8.2 Hz); 7.73 (0.3H, dd, J = 7.9, 1.3 Hz).  
13C-NMR (100 MHz, CDCl3) Two isomers: δ 14.5(major, CH3); 14.7(minor, CH3); 36.5; 
44.02; 44.06; 52.54; 52(CH), 130.7(CH); 134.1(major, CH); 134.6(minor, CH); 142.4(C); 
169.9(C); 170.8(C); 171.3(C). 
IR (ATR diam.) 2992(w); 2941(w); 1745(s); 1665(s); 1582(w); 1477(m); 1455(m); 1383(m); 
1315(m); 1261(m); 1248(m); 1205(m); 1127(m); 1086(m); 1049(m); 1026(m); 766(m). 
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N-(2-Bromophenyl)-2-(2’-methoxy-phenyl)-N-methyl-propionamide (75i): 2-(2’ -
Methoxyphenyl)-propionic acid (216 mg, 1.2 eq., 1.20 mmol,) in CH2Cl2 (5 ml) under N2 was 
treated with (COCl)2 (0.11 ml, 1.26 eq., 1.26 mmol,) and DMF (1 drop) and the reaction 
mixture was stirred for 1½ h after which time no more hydrogen evolution was observed. The 
solution was cooled to 0 °C and all volatiles were removed in vacuo. The residue was 
dissolved in CH2Cl2 and kept at 0 °C. After addition of N-methyl bromoanilide (180 mg, 1 
eq., 1.00 mmol) the reaction was stirred for 3 min and Et3N (0.17 ml, 1.2 eq., 1.23 mmol) was 
added dropwise. The ice bath was removed and the reaction was stirred for 1½ h. Et2O was 
added and the suspension was poured into sat. aq. NH4Cl. The organic phase was separated 
and washed with brine, dried over MgSO4, filtered and the filtrate was evaporated to dryness. 
Column chromatography (cH/ AcOEt 4:1) yielded 75i (314 mg, 0.9 mmol, 90%).  
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1H-NMR (400 MHz, CDCl3) δ 1.34 (2.4H, d, J = 6.8 Hz); 1.35 (0.6H, d, J = 6.8 Hz); 3.17 
(2.4H, s); 3.19 (0.6H, s); 3.39 (3H, s); 3.91 (0.8H, q, J = 6.8 Hz); 4.21 (0.2H, q, J = 6.8 Hz); 
6.51 (0.8H, d, J = 7.6 Hz); 6.62 (1H, d, J = 8.0 Hz); 6.83 – 6.95 (1H, m); 7.02 (0.8H, t, J = 7.6 
Hz); 7.10 – 7.23 (2H, m); 7.30 – 7.49 (1.6H, m); 7.66 (0.8H, d, J = 8.0 Hz).  
13C-NMR (100 MHz, CDCl3) Two isomers: δ 19.1; 19.7; 34.5; 36.07; 36.15; 54.73; 54.79; 
109.5; 109.8; 120.66; 120.70; 123.8; 123.9; 127.7; 128.0; 128.5; 128.7; 129.0; 129.17; 
129.19; 130.3; 130.7; 133.2; 133.5; 142.1; 142.3; 155.6; 155.7; 174.6. 
IR (ATR diam.): 3062(m); 2965(m); 2931(m); 2835(m); 1907(w); 1804(w); 1660(s); 
1598(m); 1585(m); 1492(s); 1475(s); 1437(m); 1454(m); 1417(m); 1375(s); 1329(m); 
1284(s); 1243(s); 1189(w); 1161(w); 1132(m); 1066(m); 1047(s); 1029(s); 991(w); 798(m); 
752(s); 726(s).  
 
General procedure (GP7): Preparation of oxindoles:  
In the glovebox, Pd(dba)2 (5 mol%), Ligand 66 or 79 (5 mol%) and NaOtBu (1.5 eq.) were 
stirred in 2/3 of the amount of DME (0.1 M in substrate, freshly distilled over Na) for 1 min in 
a dry Schlenk tube equipped with a stirrer. 2-bromo-N-methylanilide (1 eq.) was added as a 
solution of the last 1/3 of DME. The Schlenk tube was closed with a septum and removed 
from the glovebox. The reaction was stirred at the defined temperature. After the defined time 
the reaction was poured into sat. aq. NH4Cl and extracted with Et2O. The combined organic 
extracts were washed with brine, dried over MgSO4, and filtered. The solvent was removed in 
vacuo, and the resulting crude product was purified by flash chromatography.  
In order to get the racemic oxindols, for each substrate the reaction was repeated with PCy3 as 
the ligand under identical conditions. 
 
N
O
Me Ph
Me
 
1,3-Dimethyl-3-phenyloxindole (76b): 75b (46 mg, 1 eq., 0.15 mmol) was subjected to GP7 
using ligand (S,S)-79b.I at 23 °C for 24 h to yield 76b (18 mg, 0.07 mmol, 51%) with 93% ee.  
[D]D20 –8° (c = 0.44 in CH2Cl2). 
1H-NMR (200 MHz, CDCl3) 1.81 (s, 3 H); 3.25 (s, 3 H); 6.93 (d, J = 7.6 Hz, 1 H); 7.07 –
 7.38 (m, 8 H).268 
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HPLC CHIRALCEL OD-H, hexane/isopropanol (98:2), flow 1 ml/min: 13.3 min (-)-(S); 15.5 
min (+)-(R). 
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1,3-Dimethyl-3-naphthalen-1’-yl-1,3-dihydro-indol-2-one (76c): 75c (92 mg, 1 eq., 
0.25 mmol) was subjected to GP7 using ligand (S,S)-66.I at 23 °C for 24 h to yield 76 (72 mg, 
0.25 mmol, quant.) with 84% ee.  
[D]D20 +5 (c = 0.13 in CH2Cl2). 
1H-NMR (300 MHz, CDCl3) δ 1.97 (3H, s), 3.50 (3H, s); 6.8 – 7.0 (3H, m); 7.10 (1H, d, J = 
7.8 Hz); 7.22 (1H, t, J = 8.3 Hz); 7.25 – 7.42 (2H, m); 7.61 (1H, t, J = 7.8); 7.84 – 7.93 (3H, 
m). 
HPLC: Chiralcel OD-H, hexane/isopropanol (97:3): 39.4 min (major); 96.4 min (minor).  
 
N
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1-Benzyl-3-methyl-3-phenyl-1,3-dihydro-indol-2-one (76d): 75d (98 mg, 1 eq., 0.25 mmol) 
was subjected to GP7 using Pd(OAc)2 (5 mol%) and ligand (S,S)-66.I at 50 °C for 24 h to 
yield 76d (59 mg, 0.19 mmol, 75%) with 79% ee.  
[D]D20 –34 (c = 0.05 in CH2Cl2).  
1H-NMR (300 MHz, CDCl3) δ 1.93 (3H, s); 5.02 (2H, dd, J = 23.7, 15.7 Hz); 6.87 (1H, d, J = 
7.5 Hz); 7.12 (1H, t, J = 6.9 Hz); 7.2 – 7.4 (12H, m).  
13C-NMR (75 MHz, CDCl3) δ 23.9(CH3); 43.9(CH2); 52.2(C); 109.4(CH); 122.9(CH); 
124.3(CH); 126.7(Ch); 127.30(CH); 127.35(CH); 127.7(CH); 128.0(CH); 128.7(CH); 
128.9(CH); 135.1(C); 136.1(C); 140.9(C); 142.4(C); 179.6(C). 
IR (ATR diam.) 3059(w); 3028(w); 2961(m); 2926(m); 2853(w); 1712(s); 1610(m); 1488(m); 
1466(m); 1452(m); 1373(m); 1347(m); 1259(m); 1176(m); 1077(s); 1018(s); 863(w); 793(s); 
752(m); 696(s). 
HPLC: Chiralcel OD-H, hexane/isopropanol (98:2): 14.37 min (major), (S); 16.76 min 
(minor), (R).  
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1,3-Dimethyl-3-naphthalen-1’-yl-1,3-dihydro-indol-2-one (76e): 75e (81 mg, 1 eq., 
0.25 mmol) was subjected to GP7 using ligand (S,S)-66.I at 50 °C for 36 h. After column 
chromatography, 61 mg of an inseparable mixture of starting material, oxindole 76e and an 
unidentified side product was obtained (1.5:1:0.7) (~16 mg of 76e, 0.07 mmol, 27%) with 
38% ee.  
1H-NMR (400 MHz, CDCl3) δ 0.8 – 1.9 (14H, m); 3.25 (3H, s), 6.87 (3H, d, J = 7.8 Hz); 7.10 
(1H, t, J = 7.6, 1.0 Hz); 7.25 (1H, dd, J = 7.3, 0.8 Hz); 7.31 (1H, dt, J = 7.6, 1.3 Hz). 
SFC: (Chiralcel OJ-H, MeOH: 2% (2min.), then gradient 1% to 15%; 200 bar; 2 ml/min, 30 
°C): 2.53 min (major); 2.95 min (minor).  
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3-(2’-Methoxyphenyl)-1,3-dimethyl-1,3-dihydro-indol-2-one (76i): 75i (87 mg, 1 eq., 0.25 
mmol) was subjected to GP7 using ligand (S,S)-66.I at 23 °C for 24 h to yield 76i (28 mg, 
0.10 mmol, 42%) with 84% ee.  
[D]D20 +53 (c = 0.53 in CH2Cl2). 
1H-NMR (400 MHz, CDCl3) δ 1.76 (3H, s); 3.38 (3H, s); 3.47 (3H, s); 6.80 (1H, d, J = 8.0 
Hz); 6.90 (1H, d, J = 8.0 Hz); 6.92 (1H, d, J = 8.4 Hz); 6.98 (1H, t, J = 7.6 Hz); 7.10 (1H, t, J 
= 7.6 Hz); 7.27 (1H, d, J = 7.6 Hz); 7.32 (1H, d, J = 8.0 Hz); 7.64 (1H, d, J = 7.6 Hz). 
13C-NMR (100 MHz, CDCl3): δ 23.4; 26.5; 49.9; 55.9; 107.5; 112.1; 120.9; 122.2; 127.4; 
127.6; 128.8; 129.8; 135.7; 143.6; 157.0; 181.1. 
IR (ATR diam.) 3053(w); 2967(m); 2933(m); 2836(w); 1711(s); 1611(s); 1492(s); 1468(m); 
1436(w); 1374(m); 1343(m); 1304(w); 1250(m); 1145(w); 1127(w); 1113(w); 1098(m); 
1022(m); 906(w); 872(w); 813(w); 779(w); 753(w); 730(s); 695(w). 
HPLC: Chiralcel AD-H, hexane/isopropanol (95:5): 15.9 min (minor); 18.5 min (major).  
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1,3-Dimethyl-3-o-tolyl-1,3-dihydro-indol-2-one (76j): 75j (83 mg, 1 eq., 0.25 mmol) was 
subjected to GP7 using ligand (S,S)-66.I at 23 °C for 24 h to yield 76j (62 mg, 0.07 mmol, 
99%) with 89% ee.  
[D]D20 +56 (c = 1.37 in CH2Cl2). 
1H-NMR (400 MHz, CDCl3) δ 1.62 (3H, s); 1.79 (3H, s); 3.34 (3H, s); 6.87 (1H, dd, J = 7.6, 
0.8 Hz); 6.93 (1H, d, J = 7.6 Hz); 7.00 (1H, dt, J = 7.6, 1.2 Hz); 7.04 (1H, d, J = 7.6 Hz); 7.21 
(1H, dt, J = 7.6, 1.6 Hz); 7.26 – 7.33 (2H, m); 7.66 (1H, dd, J = 8.0, 0.8 Hz). 
HPLC: Chiralcel OD-H, hexane/isopropanol (98:2): 16.3 min (major); 25.6 min (minor).  
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3-Methyl-3-phenyl-1,3-dihydro-indol-2-one (86): To a solution of lithium metal (2 mg, 0.3 
mmol) in dry ammonia (3 ml) at –78 °C under N2 was added oxindole 76d (59 mg, 0.19 
mmol) in THF (1 ml). After stirring at –78 °C for 8 min the reaction was quenched with 
sodium benzoate (2 tips of a spatula, excess) and ammonia was allowed to evaporate while 
the solution warmed up to rt. The remaining solution was diluted with Et2O, washed with sat. 
aq. Na2CO3 and water, dried over Na2SO4, filtered and evaporated. The residue was 
chromatographed (SiO2, cH/AcOEt 3:1) yielding the deprotected oxindole 86 (24 mg, 0.11 
mmol, 57%).  
[D]D20 –63 (c = 0.15 in CH2Cl2). 
1H-NMR (400 MHz, CDCl3) δ 1.89 (3H, s); 7.03 (1H, d, J = 7.8 Hz);  7.10 (1H, dt, J = 7.6, 
1.0 Hz); 7.18 (1H, d, J = 7.3 Hz); 7.26 – 7.39 (6H, m); 9.08 (1H, bs).  
13C-NMR (100 MHz, CDCl3) δ 23.4(CH3); 52.8(C); 110.3(CH); 124.4(CH); 126.7(CH); 
127.4(CH); 128.1(CH); 128.7(CH); 135.7(C); 140.5(C); 182.3(C). 
IR (ATR diam.): 3213(broad, m); 3060(w); 2971(w); 2931(w); 1707(s); 1619(m); 1600(w); 
1484(w); 1472(s); 1372(w); 1324(m); 1215(m); 751(m); 696(m).  
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5-Bromo-3-methyl-3-phenyl-1,3-dihydro-indol-2-one (87): To a solution of oxindole 86 
(16 mg, 1 eq., 0.07 mmol) a mixture of CCl4/CH2Cl2 (2:1, 0.75 ml) at 0 °C was added 
bromine (11 mg, 0.7 mmol, 10 fold excess) and the reaction was allowed to warm to 23 °C in 
15 min after which time 1 N NaOH (2 ml) was added. The mixture was extracted with CH2Cl2 
(3x 5 ml) and the combined organic phases were dried over Na2SO4, filtered and concentrated 
to dryness. The residue was purified by chromatotron (1 mm plate, cH/AcOEt 3:1) to yield the 
monobrominated oxindole 87 (11 mg, 0.036 mmol, 52%). By recrystallization in 
diisopropylether (the presence of traces of CHCl3 or CH2Cl2 seems to lead to better crystals) 
crystals suitable for X-ray analysis were obtained. 
[D]D20 –77 (c = 0.15 in CH2Cl2).  
1H-NMR (500 MHz, CDCl3) δ 1.81 (3H, s); 6.86 (1H, d, J = 8.4 Hz); 7.24 – 7.39 (7H, m).  
13C-NMR (75 MHz, CDCl3) δ 21.0(CH3); 52.9(C); 111.5(CH); 115.5(C); 126.5(CH); 
126.6(CH); 127.61(CH); 127.64(CH); 128.8(CH); 131.0 (CH); 137.7 (C); 139.2(C); 139.7(C); 
181.2(C). 
IR (ATR diam.) 3222(broad, m); 2966(w); 1930(w); 2853(w); 1709(s); 1616(m); 1494(w); 
1476(m); 1372(w); 1300(w); 1259(w); 1216(w); 1026(m); 1080(broad, w); 1026(w); 910(w); 
812(m); 737(m); 695(m). 
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Université de Genève: Laboratoire de cristallographie aux rayons X 
Service de résolution structurale par diffraction des rayons X 
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